













This thesis has been submitted in fulfilment of the requirements for a postgraduate degree 
(e.g. PhD, MPhil, DClinPsychol) at the University of Edinburgh. Please note the following 
terms and conditions of use: 
 
This work is protected by copyright and other intellectual property rights, which are 
retained by the thesis author, unless otherwise stated. 
A copy can be downloaded for personal non-commercial research or study, without 
prior permission or charge. 
This thesis cannot be reproduced or quoted extensively from without first obtaining 
permission in writing from the author. 
The content must not be changed in any way or sold commercially in any format or 
medium without the formal permission of the author. 
When referring to this work, full bibliographic details including the author, title, 
awarding institution and date of the thesis must be given. 
 
  1 
Describing the evolution of Iran’s health research 
system over 50 years, understanding the profile of 






Thesis in fulfilment of the requirement of the degree of Doctor of 
Philosophy 
 










  i 
Abstract 
Introduction: Health research is essential towards improvement of population health and 
development. Hence, it is of much interest to study the low- and middle-income countries 
(LMICs) that have improved their health research performance. A substantial growth has been 
reported in the number of Iran’s research publications over the past three decades, throughout 
the times of socio-economic and political instability. Some criticise this growth for having had 
led to a decline in citation impact of health research in Iran. The overall aim of my PhD was 
to obtain a better understanding of the changes in different components of Iran’s health 
research system (HRS) over 50 years and investigate different patterns in the growth of its 
health research publications. As a way to move forward, I also aimed to identify Iran’s health 
research priorities for achieving its long-term health targets. The policy recommendations 
raised from the findings of this PhD should provide lessons to share with other LMICs. 
Notably, the priority-setting study provides a model on how to implement a systematic and 
inclusive method towards improving health research governance at the national level. 
Methods: My PhD consisted of four studies. For the first study, I conducted a narrative review 
of the literature on HRS in Iran. My search strategy was guided by the HRS framework 
developed by the World Health Organization (WHO). I searched MEDLINE and Google 
Scholar; after removing the duplicates, 805 articles were retrieved, of which 601 were 
irrelevant. I categorised and reviewed the remaining 204 records according to the WHO HRS 
framework. For the second and the third studies, I undertook bibliometric analyses of Iran’s 
biomedical, clinical, and public health research publications for the period 1965-2014. I used 
Web of Science Core Collection and its different tools for retrieving and analysing the 
publications and used Journal Citation Reports® to find information about the journals. I also 
investigated different types of collaborations across the highly-cited papers based on the 
affiliations, the characteristics of the language of the authors’ names, and the authors’ study 
and work backgrounds. In the last study, using the Child Health and Nutrition Research 
Initiative (CHNRI) method, I engaged 48 prominent Iranian academic leaders in the areas 
related to Iran’s long-term health targets, a group of research funders and policymakers, and 
68 stakeholders from the wider society to set Iran’s health research priorities.  
Results: Iran’s number of health research publications has substantially increased since 2000: 
a surge was seen in 2007, and the figure reached a peak in 2011. The first surge could be the 
result of an increased visibility, due to the addition of new Iranian medical journals to 
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international bibliographic databases, while the peak could be due to increased financial and 
infrastructural resources and incentives that had promoted publications. H-index of 
publications has also increased (almost doubled between 2000 and 2010). 30.9% of the most-
cited publications had only relied on Iranian resources (including 48 publications); of which 
the majority were original basic sciences research; and had been published in journals with 
impact factors ranging between 0.4 and 8.3. In general, it does not seem that the growth of the 
quantity and the citation impact of Iran’s publications has led to a significant impact on 
decision making and practice. Iran has made some progress in different functions of its HRS 
over the last 50 years, such as starting a discourse surrounding health research ethics, priority-
setting, and placing monitoring mechanisms while increasing the capacity for conducting and 
publishing research.  However, significant improvements are still required to address the gap 
between the knowledge producers and users. In the prioritisation study which I conducted, 128 
proposed research questions were scored independently using a set of five criteria: (i) 
feasibility, (ii) impact on health, (iii) impact on economy, (iv) capacity building, and (v) 
equity. The top-10 priorities were focused on: health insurance system reforms to improve 
equity; integration of non-communicable diseases (NCDs) prevention strategy into primary 
healthcare; cost-effective population-level interventions for NCDs and road traffic injury 
prevention; tailoring medical qualifications; epidemiological assessment of NCDs by 
geographic areas; equality in the distribution of health resources and services; current and 
future common health problems in Iran’s elderly and strategies to reduce their economic 
burden; the status of antibiotic resistance in Iran and strategies to promote rational use of 
antibiotics; the health impacts of water crisis; and research to replace the physician-centred 
health system with a team-based one.  
Conclusions: A great capacity for health research lies in Iran. This capacity can be 
strengthened with further investment in national priorities; fostering collaboration with Iranian 
diaspora who have shown interest and capacity in collaboration with peers at home; supporting 
institutions that are lagging behind while ensuring allocation of adequate resources to 
academics in Iran with proved capacity; and avoiding excessive use of bibliometrics in health 
research assessment practices. Furthermore, the findings highlighted consensus amongst 
various prominent Iranian researchers and stakeholders over the research priorities that require 
investment to generate information and knowledge relevant to the long-term health targets. 
Finally, it was concluded that the CHNRI method is an appropriate tool to use in the contexts 
where participants have limited freedom to express opinions on a panel of experts; and/or 
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where the macro-level decision-making system is highly centralised and stakeholders from the 
wider society are rarely engaged in decision-making processes. 
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Lay summary 
Health research is essential towards improvement of population health and development. 
Hence, it is of much interest to study the low- and middle-income countries (LMICs) that have 
improved their health research performance. A substantial growth has been reported in the 
number of Iran’s research publications over the past three decades, throughout the times of 
social, economic, and political instability. Some criticise this growth for having had happened 
in the quantity without having had any impact on the international scientific community. In my 
PhD, I aimed to obtain a better understanding of different aspects of this growth, while I also 
sought to better understand the changes in other components of Iran’s health research over 50 
years. The aim was to identify the strengths and limitations of health research in the context of 
Iran, based on which I could propose policy recommendations. I also aimed to implement one 
of the recommendations which seemed to be essential and effective for improvement of health 
research in Iran. This was to identify the research questions that Iran should address in order to 
achieve its long-term health targets.  
Drawing on the literature from the field of health policy and system research (HPSR), I aimed 
to understand how Iran’s health research system organised itself in achieving collective health 
goals through research, and how different actors interact in health research policy and 
implementation process. To achieve these aims, I read and studied publications about health 
research system in Iran and categorised the information into four groups. I searched through 
PubMed and Google Scholar databases, through which I could retrieve documents that could 
be potentially relevant to my research question. After removing the duplicates, 805 articles 
were retrieved, of which 601 were irrelevant. I categorised and reviewed the remaining 204 
records according to the a framework proposed by the World Health Organization (WHO). For 
the second and the third studies, I undertook bibliometric analyses of Iran’s health research 
publications for the period 1965-2014. I used Web of Science Core Collection online database 
and its different tools for retrieving and analysing the publications and used Journal Citation 
Reports® to find information about the journals. I also investigated different types of 
collaborations across the papers that had been cited the most, based on the affiliations, the 
characteristics of the language of the authors’ names, and the authors’ study and work 
backgrounds. In the last study, using the Child Health and Nutrition Research Initiative 
(CHNRI) method, I engaged 48 prominent Iranian academic leaders in the areas related to 
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Iran’s long-term health targets, a group of research funders and policymakers, and 68 
stakeholders from the wider society to set Iran’s health research priorities.  
In my studies, I found out that Iran’s number of health research publications has substantially 
increased since 2000: a surge was seen in 2007, and the figure reached a peak in 2011. The 
first surge could be the result of an increased visibility, due to the addition of new Iranian 
medical journals to international bibliographic databases, while the peak could be because of 
increased financial and infrastructural resources and incentives that had promoted publications. 
H-index of publications has increased too (almost doubled between 2000 and 2010). 30.9% of 
the most-cited publications had only relied on Iranian resources (including 48 publications); of 
which the majority were original basic sciences research; and had been published in journals 
with impact factors ranging between 0.4 and 8.3. In general, it does not seem that the growth 
of the quantity and the citation impact of Iran’s publications has led to a significant impact on 
decision making and practice. Iran has made some progress in different functions of its HRS 
over the last 50 years, such as starting a discourse surrounding health research ethics, priority-
setting, and placing monitoring mechanisms while increasing the capacity for conducting and 
publishing research.  However, still, significant improvements are required to address the gap 
between the knowledge producers and users. In the prioritisation study which I conducted, 128 
proposed research questions were scored independently using a set of five criteria: (i) 
feasibility, (ii) impact on health, (iii) impact on economy, (iv) capacity building, and (v) equity. 
The top-10 priorities were focused on: health insurance system reforms to improve equity; 
integration of non-communicable diseases (NCDs) prevention strategy into primary healthcare; 
cost-effective population-level interventions for NCDs and road traffic injury prevention; 
tailoring medical qualifications; epidemiological assessment of NCDs by geographic areas; 
equality in the distribution of health resources and services; current and future common health 
problems in Iran’s elderly and strategies to reduce their economic burden; the status of 
antibiotic resistance in Iran and strategies to promote rational use of antibiotics; the health 
impacts of water crisis; and research to replace the physician-centred health system with a 
team-based one. 
I concluded that a great capacity for health research lies in Iran. This capacity can be 
strengthened with further investment in national priorities; fostering collaboration with Iranian 
diaspora who have shown interest and capacity in collaboration with peers at home; supporting 
institutions that are lagging behind while ensuring allocation of adequate resources to 
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academics in Iran with proved capacity; and avoiding excessive use of bibliometrics in health 
assessment practices. Furthermore, the findings highlighted consensus amongst various 
prominent Iranian researchers and stakeholders over the research priorities that require 
investment to generate information and knowledge relevant the long-term health targets. 
Finally, it was concluded that the CHNRI method is an appropriate tool to use in the contexts 
where participants with limited freedom to express opinions on a panel of experts; and/or where 
the macro-level decision-making system is highly centralised and stakeholders from the wider 
society are rarely engaged in decision making processes. 
The findings of this PhD should provide lessons to share with other LMICs. Notably, the 
priority-setting study provides a model on how to implement a systematic and inclusive method 
towards improving health research governance at the national level. 
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Chapter 1 Introduction 
1.1 Overview of the thesis  
Health research is increasingly regarded as an essential tool both for improving 
population health and for development (1-3). Hence, numerous efforts at the national, 
regional, and global levels have attempted to strengthen health research capacity in 
low- and middle-income countries (LMICs) (2, 4, 5). However, most LMICs continue 
to have limited capacity for health research (2, 6, 7). Many have remained largely 
dependent on international academic institutions and donors: on the former for 
research-relevant knowledge and expertise, and on the latter for financial resources (2, 
6, 8). Evidence shows that many of the barriers impeding improvement of health 
research capacity are shared across LMICs (2). Thus, studying the approaches that 
each country takes for overcoming some common obstacles could provide important 
lessons to other LMICs. 
Iran is a middle-income country in which studying the changes in health research could 
lead to valuable lessons for exchange. A substantial growth in Iran’s health research 
output has occurred over the last few decades (9), throughout the times of social, 
political, and economic instability, including almost 40 years of international sanctions 
(10). An increase has been reported both in the quantity and in the citation impact of 
Iranian publications that are indexed in international bibliographic databases (9, 11-
14). There has clearly been a rather significant evolution in the development of Iran’s 
capacity for health research. There is a need to explore and explain the various 
stakeholders, institutions, policies, the structures, and incentives in the academic 
community, and funding sources that underlie the observed increase in Iran’s health 
research output.  
In my PhD, I aimed to obtain a better understanding of the changes in different 
components of Iran’s health research system (HRS) before and during the time that the 
growth has happened. I also visualised the landscape of Iranian health research 
publications that have found their way into international bibliographic databases; 
identified the profile of the publications; and investigated some of the underlying 
reasons leading to different patterns of Iran’s research publication growth. The 
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findings of the first three studies of my PhD led to several policy recommendations for 
improvement of HRS performance. To utilise the findings, I implemented one of the 
recommendations that, according to the existing empirical evidence and the generated 
knowledge in my PhD, seemed essential and effective in improving different functions 
of Iran’s HRS while being appropriate for the study’s context, too. 
In this thesis, after presenting the background and the context of this PhD, and 
reviewing different methods that could be used for this thesis in Chapter 1, I will 
outline the aims and objectives in Chapter 2. Then, in Chapter 3, the evolution of Iran’s 
HRS over a period of five decades will be described. This overall description will be 
obtained by reviewing the existing literature and using an established conceptual 
framework. After that, Chapter 4 illustrates the landscape of Iran’s health research 
publications, identifies the major contributors to the growth, and provides an 
understanding of the profile of the publications, while Chapter 5 identifies the profile 
of the most-cited publications that are retrieved in Chapter 4. Chapter 6 aims to assist 
Iran to move forward, by considering its context, as described in Chapter 1, and the 
strengths and limitations of its HRS that are identified in chapters 3 to 5. It will present 
a health research priority-setting exercise that will set national-level priorities in Iran 
by involving a multi-disciplinary group of prominent Iranian researchers, health 
research funders and policymakers, and stakeholders from the wider society. Evidence 
shows that HRSs in LMICs often share many similar constraints. Hence, the 
recommendations raised from the findings of this thesis should provide lessons to other 
LMICs, too. Notably, the priority-setting study provides a model on how to implement 
a systematic and inclusive method towards improving health research governance at 
the national level. 
Chapter 7 of this thesis, firstly, interprets the findings of the four studies in the context 
of the existing literature. It then integrates and discusses the key findings of the thesis, 
which provides new insights, summarises the main learning points, and makes 
recommendations for policymakers and organisations seeking to improve HRSs in 
LMICs. Lastly, Chapter 8, will reflect on the strengths and limitations of this PhD, 
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draws out the key conclusions, and highlights the data gaps that should be addressed 
in future research. 
1.2 Overview of the Introduction  
This introductory chapter provides the background to the thesis, opening with an 
overview of the definition and the value of health research in the context of global 
health, and then, summarising evidence from the literature showing the global inequity 
in health research investments. The goal is to show the relevance of the national-level 
studies presented in this thesis to global health. After that, systems approach to health 
research will be explained, and the World Health Organization (WHO) framework for 
operationalising this approach will be introduced. Then, the main purposes of research 
assessment practices will be briefly presented. This will be followed by summarising 
the initiatives that have attempted to address the uneven global health research 
investments, and their outcomes. Thereafter, using evidence from the literature, the 
status of HRS in selected LMICs and the contribution of LMICs to global scientific 
output will be described while the importance of studying Iran’s HRS as an emerging 
scientific nation will be introduced. After that, to assist the reader to better grasp the 
studies provided in this thesis, the context in which this PhD took place will be 
described. This introductory chapter closes with a review of the literature that I have 
conducted on the methods used in chapters 4 and 5, followed by explaining the choice 
of the priority-setting method which is employed in Chapter 6. 
1.3 Definition and value of health research 
Health research involves many different types of research (15). It could include studies 
from biomedical, clinical, epidemiological research to health systems and policy 
research, socioeconomic and behavioural research, and surveillance and programme 
evaluations that are relevant to activities of health systems (15). In the report of the 
Commission on Health Research for Development published in 1990 (1), entitled 
‘Health Research: Essential Link to Equity in Development’, health research was 
defined rather broadly, as being:  
‘the generation of new knowledge using the scientific method 
to identify and deal with health problems’ (1). 
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The report had added that health research is both global and local in nature, concluding 
that both are essential for effective actions for health (1). While the generated 
knowledge from research with global indications sets the basis on which new tools, 
strategies, or approaches possibly applicable to many countries are developed, local 
knowledge—i.e. specific to the circumstances of one country or even one 
community—can address the important questions within its particular context (1, 16). 
The broad definition proposed in the Commission’s report was later used by the WHO, 
too (15, 17). 
The Global Forum for Health Research (GFHR)—which was an independent, 
international organisation committed to demonstrating the essential role of research 
and innovation for health and health equity (18)—had defined health research as 
follows: 
‘research undertaken in any discipline or combination of 
disciplines that seeks to: understand the health impact of 
policies, programmes, processes, actions or events originating 
in any sector – including, but not limited to the health sector 
itself and encompassing biological, economic, environmental, 
political, social and other determinants of health; assist in 
developing interventions that will help prevent or mitigate that 
impact; contribute to the achievements of health equity and 
better health for all’ (18).  
A shorter definition was proposed by the Child Health and Nutrition Research 
Initiative of GFHR, explaining that, 
‘health research should be regarded as a process that begins 
with a research question and undertaken to generate new 
knowledge that will eventually be translated and/or 
implemented to reduce the existing disease burden (or other 
health–related problem) in the population’ (19).  
Health research generates evidence that can inform policies and contribute to the 
performance of health systems, leading to improved population health (15); hence, it 
is a key pillar of the health system (15, 20). It is argued that health systems and health 
research systems should ideally be mutually dependent (15, 17). Meaning that, on the 
one hand, a well-functioning health system is crucial to utilise the evidence (e.g. 
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interventions) that affect public health and health outcomes, while on the other hand, 
a strong health research system should be in place for effective and efficient 
performance of the health system (15, 17).  
The WHO Report 2013 entitled ‘Research for Universal Health Coverage’ presented 
12 case studies (16), ranging from the new diagnostics for tuberculosis to the provision 
of healthcare to ageing populations, all of which exemplified how research could lead 
to universal health coverage (UHC). The presented case studies addressed a diverse 
range of questions and applied various research methods—from observational and 
case-control studies to randomised clinical trials, systematic reviews, and meta-
analyses (16). The examples highlighted the benefits of having health-related evidence 
from multiple sources, while they also showed how health research contributes to 
policy and practice (16).  
Finally, health research is increasingly regarded as an essential tool for achieving 
development goals in LMICs and for reducing global inequity (16, 21). Research helps 
to understand the root causes of health disparities, for which it can then develop, test, 
and refine solutions (18). Given the key role that health research plays as a tool for 
development, clearly, it is essential for LMICs to be active producers and users of 
health research (1). The contribution of LMICs to the global health research will be 
further described in the following sections. 
1.4 Uneven global investment in health research 
In 1987, an independent international initiative—called Commission on Health 
Research for Development—was formed aiming to improve health of the people in 
developing countries by focusing on research based on the belief that research plays a 
huge but too often neglected role to accomplish development and population health 
(1). This was perhaps one of the earliest international initiatives that aimed to support 
and coordinate health research globally (22). During three years of intense data 
collection and analysis, the Commission surveyed the research that was being 
undertaken on the health problems of the developing countries, identified the strengths 
and weaknesses, and provided recommendations for improvement (1).  
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The Commission’s report was published in 1990 (1), carrying a striking message: it 
revealed that 93% of the world’s health problems, which overwhelmingly originated 
in the developing countries, were receiving only 5% of the global health research funds 
(1). It was indicated that fields such as epidemiology, policy and social sciences, and 
management were particularly underfunded, although even in biomedical and clinical 
research which were somehow better funded, significant capacity-building in 
developing countries was needed (1). The reported mismatch in the allocation of global 
health research funds that was later known as the ‘10/90 gap’ triggered initiation of 
multiple efforts towards reducing the gap (20, 22), some of which are described in 
section 1.7. 
1.5 Systems approach to health research 
The literature recommends that for assessment of health research, a systems approach 
should be taken; this section aims to explain why and how.  
The report of Commission on Health Research for Development which revealed the 
10/90 gap, had stated that ‘research is a system involving people, institutions and 
processes’ (1). Nevertheless, until the early 2000s, not much formal efforts were made 
to articulate and define the boundaries, goals, and functions of this ‘system’ (15). The 
growing interest of governments and funding agencies in evaluating the cost and 
benefits of their investments in health research brought renewed attention to the 
concept of HRS (15). A paper published in 2003, entitled ‘Knowledge for better health 
– a conceptual framework and foundation for health research systems’ (15), clearly 
described the need for a systems perspective to health research, and proposed a 
framework including the main functions and operational components of a HRS. The 
framework and systems approach to health research were further explained a year later, 
in the WHO Report 2004, ‘World Report on Knowledge for Better Health – 
Strengthening Health Systems’ (17). 
A systems approach to health research recognises that a comprehensive, integrated, 
and coordinated approach is needed to understand and guide the production and the 
utilisation of research to improve health outcomes and to decrease inequities in health 
(2, 15). Such an approach should address many of the problems of health research 
Describing the evolution of Iran’s health research system, understanding the profile of its publications 
over 50 years, and setting the national health research priorities  
 7 
activities, such as that health researchers often work with minimal effective 
communication with both the researchers in other disciplines, and the users of health 
research (i.e. the policymakers, health professionals, and the community) (23). In fact, 
not much communication exists among researchers within one discipline either, since 
research has become a highly competitive activity (15).  
To achieve a definition for HRS, firstly, a broad definition of health research was used, 
as described in section 1.3. Then, a ‘system’ was defined as ‘a group of elements 
operating together to achieve a common goal’ (15). Hence, HRS was defined as 
follows:  
‘the people, institutions, and activities whose primary purpose 
is to generate and apply high-quality knowledge that can be 
used to promote, restore and/or maintain the health status of 
populations’ (15).  
Arguably, a HRS has two fundamental goals: (i) the advancement of scientific 
knowledge; and (ii) the utilisation of knowledge to improve health and health equity 
(15). Therefore, a health research system exists at the intersection of two larger, 
complex systems: the health system and the broader research system, making the 
health research system a subset of the both (Figure 1) (15).  
HRS captures the generated health-related knowledge which, when used appropriately, 
can lead to health impact (15). Clearly, HRS also fits into health policy and systems 
research (HPSR). HPSR has been described by the Alliance for Health Policy and 
Figure 1 Locating the health research system at the intersection of the health system and the 
research system. Figure adapted from reference number (15) 
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Systems Research as a field that: ‘seeks to understand and improve how societies 
organise themselves in achieving collective health goals, and how different actors 
interact in the policy and implementation processes to contribute to policy outcomes. 
By nature, it is interdisciplinary, a blend of economics, sociology, anthropology, 
political science, public health and epidemiology that together draw a comprehensive 
picture of how health systems respond and adapt to health policies, and how health 
policies can shape − and be shaped by − health systems and the broader determinants 
of health (20).’ 
From an evaluation point of view, the systems perspective addresses the limitations of 
methods that had always been used for evaluation of health research activities, which 
had often seen research process as linear, with an input (e.g. financial and human 
resources) and output (e.g. publications); an approach which neglected the outcomes 
of health research, e.g. improved population health (6, 15, 23).  
1.5.1 World Health Organization’s health research system 
framework 
Understanding the need for a systems approach to health research led the WHO to 
develop a conceptual framework that values both the generation of knowledge through 
research and the use of the produced evidence, while provides a platform for effective 
communication and interaction between all the players and stakeholders in health 
research (15).  
The process of developing the conceptual basis of the framework comprised a 
comprehensive literature review and an extensive consultation process—ten 
consultations and forums held between 2001 and 2003, involving more than 100 
individuals from over 40 countries (15). The group of participants was very diverse, 
in terms of expertise and the sector they worked in, and the majority came from LMICs 
(15). The framework was primarily developed to serve as a base for evaluations, to 
allow benchmarking, identification of best practices, and lessons to exchange, within 
and across countries, aiming to lead to improved function of HRSs (15); something 
that would particularly benefit developing countries.  
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The framework proposed four main functions for an effective HRS including: (i) 
stewardship, (ii) financing, (iii) creating and sustaining resources, and (iv) producing 
and using research (15). Each function is defined by several key operational 
components as described in Table 1.  
Table 1 Summary of the functions and components of the WHO health research system framework. 
Table adapted from reference number (15) 
1.6 Importance of research assessment practices 
In the light of growing attention of governments and funding agencies to research, 
there is an increasing global demand for assessment of research activities for several 
purposes, including (i) accountability, (ii) improvement, (iii) advocacy, and (iv) 
learning (24-26). In addition to these purposes, there exist other reasons to perform 
research evaluation, particularly in relation to ‘selection processes’, which are out of 
the scope of this thesis (25). Examples are evaluations to provide research grants or 
competitions over publishing in prestigious journals (27). 
Evaluation of accountability is often performed by funding agencies to assess whether 
the outcome of their investment has fulfilled its expected aims, e.g. leading to certain 
health impacts (26). In terms of improvement purposes, two examples could be 
mentioned: (i) journal peer review practices to improve the quality of manuscripts 
through the process of critical appraisal and subsequent revisions by the author(s) (27); 
Function Operational component 
Stewardship 
• Define and articulate vision for a national health research 
system (HRS) 
• Identify appropriate health research priorities and coordinate 
adherence to them 
• Set and monitor ethical standards for health research and 
research partnerships 
• Monitor and evaluate the HRS 
Financing Secure research funds and allocate them accountably 
Creating and 
sustaining resources 
Build, strengthen, and sustain the human and physical capacity 
to conduct, absorb, and utilise health research 
Producing and using 
research 
• Produce scientifically valid research outputs 
• Translate and communicate research to inform health policy, 
strategies, practices, and public opinion  
• Promote the use of research to develop new tools (drugs, 
vaccines, devices, and other applications) to improve health 
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and (ii) evaluation of research units with a view of improving them, rather than only 
scoring them (25). Research evaluation for advocacy aims to publicise achievements 
of a research unit in order to encourage further support (26), while evaluation for 
learning purposes identifies cases of success or failure to understand opportunities and 
limitations in research units (26). The focus of assessment of research practices in this 
thesis is on ‘advocacy’ and ‘learning’ purposes.  
1.7 Initiatives to address the 10/90 gap 
• 1990 - Essential National Health Research (ENHR) 
The report published by the Commission on Health Research for Development in 1990 
made it clear that any research seeking to contribute to development of LMICs should 
be based on the local priorities rather than being driven by funders (1). Consequently, 
to address the ‘10/90 gap’ (as described in section 1.4) and to operationalise ‘health 
research for development’, the Commission prepared a step-by-step guide for setting 
national research priorities called ‘the Essential National Health Research’ (ENHR) 
(1). Back then, LMICs were strongly encouraged to undertake the ENHR to define 
their health research agendas (1, 22).  
ENHR focuses on equity in health and development, inclusiveness in participation, 
and consultations at different levels (5, 28). Participants include researchers, decision-
makers, health service providers, and communities (5). The research areas are 
identified by evidence-based situation analysis, e.g. by looking at the health status, and 
then, research ideas are collected from different stakeholders, and consensus is built 
using methods such as brainstorming, multi–voting, nominal group technique, and 
round–table (5). The criteria that are used for ranking ideas are initially proposed by 
brainstorming, and are adjusted to the level of each exercise, e.g. global, national, sub-
national (5).  
• 1993 - Council on Health Research and Development (COHRED) 
Council on Health Research and Development (COHRED) was founded in 1993 to 
take forward the actions towards addressing the 10/90 gap and, since then, has 
supported countries in setting national priorities for health research (22).  
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• 1994 - Ad Hoc Committee (AHC) on Health Research Relating to Future 
Intervention Options 
In 1994, a rather similar initiative was formed by the WHO, known as the ‘Ad Hoc 
Committee (AHC) on Health Research Relating to Future Intervention Options’ (22). 
The Committee’s mission was to identify: (i) priorities for health research and 
development, (ii) prospects for funding, and (iii) institutional changes that could 
improve the output of ongoing research and development investments at that time (22). 
In 1996, the AHC presented a report entitled ‘Investing in Health Research and 
Development’ which provided clear arguments for better alignment of research 
priorities with the global disease burden and building capacity for research, 
particularly in LMICs (22, 29). The report proposed a five-step process to inform 
research and development resource allocation: (i) how big is the health problem?; (ii) 
why does the disease burden persist?; (iii) is enough known about the problem now to 
consider possible interventions?; (iv) how cost-effective will these interventions be?; 
and (v) how much is already being done about the problem? (22, 29).  
• 1998 - Global Forum for Health Research (GFHR) – 17 Best Buyers 
In 1998, the Global Forum for Health Research (GFHR) was established as an 
international foundation headquartered in Geneva, Switzerland, again with the aim of 
addressing the ‘10/90 gap’ through promoting financial and technical support for 
research on the problems of developing countries and monitoring the progress (18, 22). 
The forum held annual conferences where experts could share ideas and strategies to 
address the global health investment inequity (22). GFHR identified 17 research and 
development priorities—the so-called 17 Best Buyers—and categorised them into 
three groups of ‘strategic research’, ‘package development and evaluation’ or ‘new 
tool or intervention development’ (22).  
• 2000 - Bangkok, Thailand Conference on Health Research for Development 
In 2000, an international conference on health research for development was held in 
Bangkok, Thailand (22). The conference was chaired by an international organising 
committee formed by the representatives of WHO, the World Bank, GFHR and 
COHRED (22). COHRED presented a review of experiences of ENHR from 
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developing countries. The issues addressed during the conference were systematically 
categorised into the processes and methods for priority-setting; assessing the results of 
ENHR; defining who sets priorities and how to get participants involved; the potential 
functions, roles, and responsibilities of various stakeholders; information and criteria 
for setting priorities; strategies for implementation; and indicators for evaluation (22).  
• 2003 - ‘The Grand Challenges’, World Economic Forum, Call by the Bill and 
Melinda Gates Foundation 
Another big step at the global level was taken in 2003 during the World Economic 
Forum, held in Davos, Switzerland, where Bill and Melinda Gates Foundation 
(BMGF) announced the allocation of US$ 200 million to support the initiative of ‘The 
Grand Challenges’ in global health research. ‘Grand Challenge’ was defined as ‘a call 
for a specific scientific or technological innovation that would remove a critical 
barrier to solving an important health problem in the developing world with a high 
likelihood of global impact and feasibility’ (22). The identification of ‘Grand 
Challenges’ was achieved with financial support from BMGF and the National 
Institutes of Health (22). The initiative gathered a scientific board, including 20 
scientists and public health experts from 13 countries—some from developing 
countries—and made a call for submissions that resulted in 1,000 submissions from 
scientists and institutions across 75 countries (22). The scientific board reviewed all 
the ideas, and selected 14 of them which were declared as ‘Grand Challenges’. Grants 
of up to a total of $20 million were then made available by BMGF to overcome these 
major challenges to progress against diseases that disproportionately affect the 
developing world (30). 
All of the identified ‘Grand Challenges’ fell into 7 broad categories, as follows: (i) 
improving childhood vaccines; (ii) creating new vaccines; (iii) controlling insects that 
transmit agents of disease; (iv) improving nutrition to promote health; (v) improving 
drug treatment of infectious diseases; (vi) curing latent and chronic infections; and 
(vii) measuring disease and health status accurately and economically in poor countries 
(30). Some of these ‘14 Grand Challenges’ addressed very similar problems that the 
‘17 Best Buyers’ in 1998 addressed (22). The main difference was that the ‘Grand 
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Challenges’ were defined more broadly than the ‘17 Best Buys’, thus they could target 
several diseases and conditions (22). 
• 2004 - Combined Approach Matrix (CAM) 
In 2004, GFHR developed the first specific priority-setting tool: the Combined 
Approach Matrix known as CAM (28). The aim was to bring together economic and 
institutional dimensions into an analytical tool with the actors and factors that play a 
key role in health status of a population (31). CAM tool: (i) helps with classifying, 
organising, and presenting a large body of information which enters into the priority-
setting process; (ii) recognises gaps in health research; and (iii) based on the identified 
gaps, sets the health research priorities through a process which should include the 
main stakeholders in health research (31).  
• 2004 - James Lind Alliance 
The James Lind Alliance is a British non-profit initiative that was founded in 2004, 
not only for health research priority-setting, but more broadly to ensure that those who 
fund health research or decide on health interventions are aware of what matters to 
patients, carers, and clinicians (32). The method uses a mixture of data collection, 
quantitative, and qualitative analyses to generate research priorities in areas of 
treatment uncertainty (32). Participants are identified through Priority Setting 
Partnerships (PSPs) which brings patients, carers, and clinicians together to reach 
consensus (32). Treatment uncertainties are defined as situations that either there are 
no updated and reliable systematic reviews addressing treatment uncertainty, or there 
are systematic reviews that show such uncertainty exists (32). In the first step, 
recommendations by PSPs, or through looking at existing literature, creates a list of 
uncertainties (32). Then, to ensure that they are uncertainties, systematic reviews of 
databases using Cochrane, DARE, NICE, and Sign will be conducted. Once a reported 
confidence interval in a systematic review does not cross the line of effect or line of 
unity, it would be considered as uncertainty (32). Finally, a virtual interim priority 
ranking, and a final priority-setting workshop will be done to reach consensus on 10 
prioritised uncertainties (32). 
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• 2006 - Child Health Nutrition Research Initiative (CHNRI) 
During the late 1990s and the 2000s, while GFHR continued advocating research by 
promoting the five-step process proposed by the WHO AHC, it also facilitated the 
creation of some specific research initiatives (29). One of these initiatives was the 
Child Health and Nutrition Research Initiative (CNHRI), which was created under 
GFHR in 1999, and became a Swiss foundation in 2006 (29). The vision of the CHNRI 
was to improve child health and nutrition in LMICs through research (19). To address 
the gaps in the then existing research priority-setting methods, CHNRI developed a 
systematic and inclusive methodology for health research priority-setting, which was 
introduced in 2007 (19, 33). 
CHNRI methodology uses the principle of ‘wisdom of the crowds’ to score ideas 
against a pre-defined set of criteria (19). In this method, the research ideas are 
generated, and scored independently and often through online submission, by 
researchers (34). The researchers are identified by a management team based on their 
expertise, e.g. the number of publications, experience in implementation research and 
programmes (34). After collecting the research ideas, removing the overlapping ones, 
and improving the clarity of the questions, a compiled list of research ideas will be 
sent back to the researchers for scoring against a set of criteria (34). The following five 
standard criteria are often used: (i) answerability; (ii) equity; (iii) impact on burden; 
(iv) deliverability; and (v) effectiveness, although the criteria could be adjusted based 
on the context of each exercise (19). Researchers would independently score each 
research question against each criterion, on a scale of 0, 0.5, and 1 or on a scale of 0 
to 100 (34). Different stakeholders, e.g frontline healthcare professionals, patients, 
caregivers, could also be engaged by being invited to assign weights to the scoring 
criteria (35). 
• 2007 - The Lancet Series to improve maternal and child survival 
Another attempt towards setting health research priorities has been the engagement of 
The Lancet journal into advocacy of international health issues through publication of 
several series of papers focusing on main priority areas in international health (22). In 
2007, The Lancet even conducted a Delphi process similar to the one that had led to 
Describing the evolution of Iran’s health research system, understanding the profile of its publications 
over 50 years, and setting the national health research priorities  
 15 
the ‘Grand Challenges’ among a wide range of academics and professionals who had 
work experience in developing countries (22). The coordinators of the process ranked 
a limited number of very broad research themes in child health, maternal health, health 
systems, and community development, based on their perceived importance (22).  
• Use of other methods – Delphi process 
In addition to the efforts for introducing initiatives or tools to set health research 
priorities to ensure the alignment of research investments with the real needs, some 
already-existing methods were adopted for health research priority-setting (28). Delphi 
process, developed in the 1950s, is an interactive and systematic forecasting method 
which uses questionnaires and a panel of experts (28). The participants of a Delphi 
process should have a relevant background and experience on the target topic, be able 
to contribute to the process, and be willing to revise their initial judgements in order 
to achieve consensus (28). The researchers identify and invite participants, ideally 
through a nomination process, or selection from potential leaders or authors through 
publication (28). In the first round of the Delphi, an open–ended questionnaire is sent 
to collect information (28). Investigators will then turn the responses into a well–
structured questionnaire to be used as a survey for data collection (28). Through four 
rounds, experts answer questionnaires; the facilitator summarises anonymously the 
forecast after the first round and the experts are then asked to revise their earlier 
answer, thereby decreasing the range of answers and converging towards the correct 
answer; up to four iterations can be used (28). 
1.7.1 Outcome of initiatives to address the 10/90 gap 
As described in section 1.7, over the last nearly three decades, several initiatives have 
attempted to improve the governance of global health research. Some of the attempts 
have resulted in development of specific tools that can set health research priorities at 
global, national, sub-national, or institutional levels (28, 36). However, it is yet not 
clear to what extent the 10/90 gap has been addressed since 1990. 
What is clear is that investments in global health research has been growing over the 
last three decades although the rise has not happened in a coordinated way (37). Over 
25 years, the funding available for health research has increased from US$ 50 billion 
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in 1993 to US$ 240 billion in 2009, and financial contributions to international 
Development Assistance for Health (DAH) has increased from US$ 5.6 billion to US$ 
28.1 billion between 1990 and 2012 (38).  
There have been several attempts to track and monitor the funding for health research 
(37), yet, estimates are considerably varied, reflecting methodological challenges in 
categorising how the money is spent (37, 38). One challenge is in distinguishing 
research funding from broader development assistance for health (38). Further, there 
is no agreement on whether the funding invested in high–income countries for studying 
health problems that could also be relevant to LMICs should be included (37). 
Example of such research areas are non-communicable diseases, e.g. cardiovascular 
diseases and cancer, which their burden in LMICs is rapidly on the rise (38). 
In terms of priority-setting exercises, despite important steps that have been taken 
globally towards setting health research priorities, still most LMICs lack systematic 
and transparent priority-setting exercises (36, 39). A systematic review of all health 
research prioritisation studies in LMICs, between 1966 and 2014 (36), identified a total 
of 91 studies, 46% of  which had been run at the global level without focusing on 
LMICs nor on low- and middle-income regions (36). It has also been reported that the 
majority of health research priority-setting exercises in LMICs have failed in engaging 
the key stakeholders (e.g. the community) in the processes, and they have heavily 
relied on the input from the researchers and the representatives from the governments 
(36, 40). Also, the majority of exercises lack mechanisms for publicising and 
translating the results, hence most of the exercises have failed in the implementation 
phase (36, 40). In 2004, WHO surveyed 550 policymakers and 1,900 researchers in 13 
LMICs; one third of the participants responded that either there was no rational health 
research priority-setting process in their country, or if there was, they were unaware of 
how priorities were being set (17).  
Among the methods that have been used and/or developed, a review of 230 health 
research priority-setting exercises which had been coordinated by the WHO between 
2005 and 2010 reported that, at that point in time, there was still no ‘gold standard’ 
approach for setting health research priorities (41). In 2010, the WHO’s Department 
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for Research Policy and Cooperation held a consultation between experts in 
developing methodology to identify optimal characteristics of priority–setting 
methods that could be applicable at the national level (40). The following three 
methods were recommended: (i) the CAM, (ii) the COHRED, and (iii) the CHNRI 
(40).  
In 2014, a systematic review of the peer-reviewed and non-peer-reviewed studies of 
health research priority-setting exercises in LMICs (36) reported that the most widely 
used health research prioritisation process had been holding a workshop or a 
conference, without any clear specification of established methods (24%) (36). This 
was followed by the CHNRI method (18%) and a stepwise process that includes 
literature review, in-depth interviews, and consultation (18%) (36). A review of health 
research prioritisation studies which were indexed in PubMed database during 2001–
2014 found a total of 165 papers (28). The most frequently used tool was CHNRI 
method (26%), followed by Delphi (24%), James Lind Alliance method (8%), the 
CAM (2%) and the ENHR (<1%) (28). A further 19% had used a combination of 
expert panel interview and focus group discussions (consultation), without providing 
the details, (28). Nine percent had used a combination of literature review and 
questionnaire to identify research ideas among the participating experts (28).  
It is evident that the CHNRI method has received a wide recognition over the last 
decade (28, 41). The CHNRI method uses the principle of ‘wisdom of the crowds’ to 
score ideas against a pre-defined set of criteria (42). This enables funders and 
policymakers to view the strengths, the weaknesses, and relative ranking of each 
proposed research idea based on submitted opinions of a larger number of experts (19). 
This method allows researchers to independently generate and score research 
questions, thus limits the influence of individuals on the rest of the group (19). 
Furthermore, it engages the funders and policymakers from an early stage of the 
process, ensuring their ownership of the final results (43). CHNRI method also 
provides the essential tools for involving stakeholders from the wider society in the 
process and receiving their perspectives (35). Other recognised advantages of the 
CHNRI method include its systematic nature, transparency and replicability, clearly 
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defined context and criteria, a structured way of obtaining information, informative 
and intuitive quantitative outputs, and studying the level of agreement over each 
proposed research idea (19, 28, 42).  
In the first years after the CHNRI method was introduced, it was primarily used for 
setting priorities aiming to reduce global child mortality (42). However, since 2012, 
this method has been applied across various topics (42). It has now been implemented 
in more than 50 studies led by multilateral organisations (e.g. WHO, UNICEF), 
national governments, and funders (e.g. The Gates Foundation) to set research 
priorities in areas ranging from dementia or disability to the efficient execution of 
national health plans (e.g. in China) (4, 42). While the majority of CHNRI studies have 
been conducted at the global level, although with a focus on the problems of LMICs 
(42), national-level CHNRI exercise are on the rise, too (42). They have been 
conducted in South Africa (44), India (45), Brazil (46), China (47), and one study that 
included Malawi, Nigeria, and Zimbabwe (42).   
1.8 Status of health research system in selected low- 
and middle-income countries 
As discussed in section 1.5, a well-functioning health research system is essential for 
all countries. Even if every country does not generate research on all health topics, 
every country needs the capacity to adapt and apply research results to address health 
challenges (2). This section reviews the literature on the status of HRS in selected 
LMICs.  
An assessment of the state of health research systems across the WHO Eastern 
Mediterranean Region (EMR) based on publicly available literature and data sources 
was published in 2013 (6). The review found that – while there have been 
improvements in terms of research output in the EMR since the early 1990s – the 
overall research performance remains poor, with critical deficits in system 
stewardship, research training and human resource development, and data surveillance 
(6). In terms of use of research, the main barriers to translation of research into policy 
and practice were reported as weak institutional and financial incentives, and concerns 
over the political sensitivity of research findings (6). The constraints were mainly 
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linked to the limited expenditure in R&D and the lack of a political will to invest in 
research (6). It was also highlighted that the publicly available data on research 
systems in the EMR was very poor, which made meaningful performance assessments 
of the countries across the region difficult (6). The assessment had called for urgent 
efforts towards improving the understanding of HRS across the EMR (6).  
A recent qualitative study (7, 48, 49) has investigated the strengths and limitations of 
the HRS in Palestine (conducted in the West Bank and Gaza Strip of the Palestinian 
territories), through 52 in-depth interviews and six focus group discussions including 
a total of 104 policymakers, academics, and experts. Moreover, the study has examined 
the participants’ satisfaction with the overall performance of Palestinian HRS (7), in 
addition to investigating their perceptions about macro-level attention to health 
research (7). Their analyses have reported that the level of understanding of HRS 
among health experts in Palestine is inadequate and not sufficiently conceptualised for 
its application (7). It has also revealed that the HRS in Palestine is remarkably 
underperforming (7), and the participants perceived the system as ineffective and 
inefficient, poorly managed, and lacking mechanisms for systematic assessments (7). 
The reasons behind the under-performance were identified as: (i) an unstructured 
system which lacks a research culture and a governing body; (ii) health research being 
regarded as an individualistic activity, not towards development targets, and rarely 
used in policy decisions; and (iii) significant lack of essential resources, and 
uncoordinated use of them (7). The latter problem reflected inadequate political 
support of health research (7).  
A review of 28 case studies that had described or analysed health research systems in 
26 LMICs was published in 2006 (2). The reviewed studies were sponsored either by 
the COHRED (including, Cameroon, Egypt, Ethiopia, Hungary, Jordan, Kazakhstan, 
Lebanon, Lithuania, Mauritius, Oman, Pakistan, Romania, Russia, South Africa, 
Uzbekistan, and Zambia) or the South-East Asia Regional Office of the WHO 
(including, Bangladesh, Bhutan, India, Indonesia, Maldives, Myanmar, Nepal, Sri 
Lanka, and Thailand) or were country monographs of Bangladesh, South Africa, and 
Uganda (2). Several common challenges facing national health research systems were 
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identified among these countries that were compounded by some fundamental system 
constraints (2). The main identified challenges facing HRSs included: (i) lack of 
coordination between research institutions; (ii) inadequate participation of 
stakeholders in research, policy, and implementation processes; (iii) lack of demand 
for research; and (iv) inadequate accessibility of research findings (2). The main 
fundamental system constraints included limited financial, human, and institutional 
resources and inadequate reliable data (2).  
1.9 Status of research publications in low- and 
middle-income countries and emergence of new 
scientific nations 
In section 1.4, the global disparity in health research investments, which is a key 
component of one of the main functions of a HRS, was described. The present section 
informs the reader about the global disparity in the quantity of health research 
publications, i.e. another component of a HRS.  
In recent decades, the number of scientific publications worldwide has substantially 
grown (9, 50) due to several reasons. One is that the global expenditure on R&D has 
significantly increased (8), while the number of researchers has risen, too (51). In 
2015, there were 7.8 million researchers worldwide, which was 21% more than the 
figures for 2007 (51). Furthermore, with the emergence and popularity of electronic 
publishing of journals, online submitting, and online indexing of documents, the 
quantity and the visibility of publications have grown (50). Consequently, globally, 
more research is being funded, carried out, and published (51). 
Nevertheless, data from international bibliographic databases shows that the overall 
contribution of LMICs to this large and growing scientific output is still limited (18, 
52). The world regions comprising mainly high-income countries, e.g. Western Europe 
and North America, continue to publish far more than regions including mostly 
LMICs, e.g. Africa and the EMR (8).  
However, in recent decades, a number of LMICs have managed to greatly enhance 
their research outputs, defined here as the number of peer-reviewed publications in 
international databases (9). For instance, it has been shown that the BRICS (i.e. Brazil, 
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Russia, India, China and South Africa) have made a considerable scientific progress 
between 2002 and 2007, while the number of original health research papers from 
India has also doubled, from 4,494 to 9,066 (38). There is also evidence that the growth 
has not been restricted to the quantity but also the citation impact of research in some 
LMICs, e.g. in China and South Africa, has been improving (38).  
The literature proposes various factors that could have promoted growth of research 
publication in different regions or countries, e.g. in Asia (53), China (54), Africa (55) 
South Africa (56), Brazil (57) and Turkey (58, 59). Overall, the contributing factors 
included: increased gross domestic expenditure on R&D (GERD) (53-55, 60); 
increased number of universities and domestic journals that are abstracted in 
international databases (53-55, 57, 58); establishment of competitive research funding 
mechanisms which distribute funds among and within universities based on 
publication counts (54, 55, 57, 58, 60-62); and incentivising publication in journals 
that are abstracted in international databases (54, 58, 59). In sum, the suggested factors 
seemed to be mainly a result of the national or institutional policies, particularly 
policies with direct impact on the higher education capacity and/or the national 
research capacity, the national budget allocation strategies, and/or research 
performance assessment systems.  
It is argued that the recognition of the role of science in driving social and economic 
development and in addressing local and global sustainability has led to increased 
research activity in some LMICs (8). In this regard, the Royal Society Report on 
Global Scientific Collaborations in 21st Century (published in 2011) quotes Paul 
Kagame, President of Rwanda, who has been a strong advocate for science for 
development, as saying: 
‘We in Africa must either begin to build our scientific and 
technological training capabilities or remain an impoverished 
appendage to the global economy’ (8). 
Among the emerging scientific nations from the LMICs, the rise of China has been 
particularly remarkable, becoming the second highest producer of research output in 
the world, just after the US (8, 63). Some have associated China’s publications’ growth 
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to the exponential increase in GERD; along the significant growth of GDP in China, 
the proportion of GDP dedicated to R&D has continuously increased (54). It was also 
reported that since 1997, the contribution of businesses to R&D expenditure has 
enhanced, and at the same time, China’s rapid and sustained economic development 
has encouraged some of its overseas scholars to return to China (54). Furthermore, the 
Chinese Government has developed several policies to motivate its overseas scholars 
to go back home and contribute to development of a knowledge-based economy (54). 
Another incentive for publishing has reported to be that many Chinese universities, 
started to add a considerable bonus to academics’ salaries once they publish in journals 
which are indexed in Science Citation Index (54). 
In general, several macro-level decisions have contributed to China’s scientific growth 
(54). One example is in the area of nanotechnology where the national support has 
begun by declaring nanotechnology an important R&D priority in the China’s 
Guidance for National Development in 2001, and issuing of the Compendium of 
National Nanotechnology Development, which was jointly issued by the Chinese 
Ministry of Science and Technology, the National Development and Reform 
Commission, the Ministry of Education, the Chinese Academy of Sciences, and the 
National Natural Science Foundation (54). Following these, China started publishing 
two new English-language journals in the field of nanotechnology, which substantially 
contributed to the global output in nanotechnology research (54).  
Turkey is another middle-income country that has improved its scientific output at a 
pace almost competing that of China (8). Turkey’s publication count in Scopus 
database in 2013 was nearly quadrupled compared to 1996 (64). In the 1990s, the 
Turkish Government declared research as a public priority and ever since increased its 
investment on R&D (8). Between 1995 and 2007, Turkey’s GERD increased from 
0.28% to 0.72% and its number of researchers grew by 43% (8). However, on account 
of the ongoing reorganisation of higher education in Turkey, led by its President Recep 
Tayyip Erdoğan, the future of education and research in Turkey is unclear –Turkey’s 
annual number of publications based on the data from Scopus citation database has 
already declined since 2016 (65). 
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Önder and colleagues investigated the role of institutional changes in the growth of 
Turkey’s number of publications in social sciences since the 1990s (58). They reported 
that the old funding schemes in Turkey were exclusively sponsored by the government, 
which distributed funds among universities based on their general size, defined as the 
number of students, whereas the new competitive schemes distribute funds according 
to the research performance scores that each institution earns (58). Another reported 
change was the increase in the number of funding organisations, which resulted in a 
competition between institutions and academics to apply for research grants (58). In 
sum, they had hypothesised that the improvement of the scientific output in Turkey 
was associated with the institutional changes in Turkish higher education system (58).  
Brazil’s rank in terms of the number of research documents indexed in Scopus has 
improved from 21st in 1996 to 13th in 2014 (64). Similar to China and Turkey, the use 
of bibliometrics (e.g. looking into the number of publications) has become popular 
among Brazilian funding agencies in evaluating research grant applications, and 
likewise, they have started to consider publications in journals indexed in leading 
international databases as the main indicator of scientific productivity (57). Some have 
criticised the rapid growth of the Brazilian research output, as finding it only a result 
of the increased number of Brazilian journals abstracted in international databases, the 
promotion of peer pressure among academics for publishing, and the requirement from 
the funders’ side (62).  
Meo and colleagues conducted a study to investigate some of the predictors of the 
success in research publishing among forty Asian countries between 1996 and 2011 
(53). They investigated the correlations between GDP per capita, GERD, the total 
number of universities, and the total number of journals indexed in Web of Science 
Core Collection, with three bibliometric indicators, including the total number of 
research publications, citation counts per document, and h-index (53). The 
bibliometric information was retrieved from SCImago which uses Scopus data. The 
analyses of their study found a positive correlation between GERD, the total number 
of universities and journals indexed in WoS Core Collection, with the investigated 
bibliometric indicators in various fields of science and social sciences; no correlation 
was found with GDP per capita (53).  
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Another study quantitatively explored determinants of health research publication 
counts in the WHO African Region between 2000 and 2014 (55). Publications were 
retrieved from PubMed database and correlations between the number of publications 
in each country and the following variables was investigated: GDP, adult literacy rate, 
number of physicians per 100,000 population, the total expenditure on health, private 
expenditure on health, R&D expenditure and human development index. The only 
significant predictor of the number of publications was found to be the GDP (55).  
1.9.1 Emergence of Iran as a scientific middle-income country 
Among all the emerging low- and middle-income scientific nations, Iran has been 
reported to have had the fastest growth rate of research publications in recent decades 
(11). The annual number of scientific publications from Iran has increased from only 
736 in 1996 to 13,238 in 2008, based on the data retrieved from Web of Science 
bibliographic database (9). A similar significant increase is evident in other databases, 
for instance, in Scopus, where the number of Iran’s research documents per year in 
medicine has risen from 151 in 1996 to nearly 9,000 in 2014 (64).  
The improvements in the ranking of Iran in scientific publishing confirms that Iran’s 
growth in research publication output has been higher than the world average. For 
example, Iran’s world rank in the production of research articles in medicine has 
improved from 58th in 1996 to 19th in 2014 (64). Likewise, Iran’s contribution to 
global research output has considerably increased (64). For instance, Iran’s 
contribution to the global production of research articles in pharmacology, toxicology 
and pharmaceutical sciences has multiplied by 20 times between 1996 and 2014—
increasing from 0.1% to more than 2% (64). While Iran had very few research 
publications in most fields of medical sciences until only 30 years ago, from 2004, it 
has become a leading producer of research publications in medicine among countries 
in the EMR (64). Although this PhD focuses on studying health research system in 
Iran, it should be noted that the growth of research publications in Iran has not been 
restricted to health-related fields, but has happened across several scientific areas, such 
as engineering, material sciences, and chemistry (9, 11).  
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The substantial growth of Iran’s health research publications that are indexed in 
international bibliographic databases has occurred throughout the times of economic, 
social, and political instability in this country, which are further explained in the 
section 1.10. It is expected that such instability would lead to reduced resources and 
less coordination of research activities. Therefore, it is of much interest to firstly, 
obtain a better understanding of the changes in Iran’s health research system over the 
years that this growth has taken place, and secondly, obtain an overall landscape of the 
growth and the possible contributory factors to it. Furthermore, some criticise this 
rapid quantitative growth of Iran’s health research publications, arguing that it may 
have resulted in a decline in citation-based indicators (66, 67). It is essential to 
investigate whether the growth had been limited to the number of publications or it 
may have led to improvements based on citation-based metrics, too.  
1.10 Study context 
1.10.1 Introduction 
In this section, the context in which this PhD was conducted will be described. Firstly, 
having an insight into Iran’s context over the years that its health research publications 
have witnessed a significant growth would assist the reader to better grasp the findings 
of the bibliometric analyses, provided in chapters 4 and 5. Secondly, knowing the 
political system and the key decision-making bodies in Iran would answer the 
following two questions that are further discussed in section 1.12.2 and in the Chapters 
7 and 8: 
i. Among the problems of Iran’s HRS that need to be addressed according to the 
study that will be presented in Chapter 3, why did I choose to run a health 
research priority-setting exercise for improving Iran’s HRS? 
ii. Why is the CHNRI health research priority-setting method appropriate for the 
context of Iran? 
Finally, having a picture of Iran’s current and projected challenges would help with 
better understanding of the findings of the prioritisation exercise, presented in Chapter 
6.  
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1.10.2 General context 
Based on the WHO categorisation, Iran is in the Eastern Mediterranean Region. It has 
a surface area of 1,648,195 km2, six times the size of the UK, and had a population of 
80.6 million in 2017 (68), distributed across 31 provinces (69). The country has great 
oil and gas reserves, estimated as the 4th and the 2nd largest in the world, respectively 
(70), in addition to considerable minerals and other natural resources (70). 
Nonetheless, Iran lacks adequate water resources and has been facing serious water 
problems since a few years back, i.e. evident by drying lakes and wetlands, frequent 
dust storms, and water quality deterioration (71). 
Iran has witnessed a significant demographic change over the last four decades as a 
result of a high growth rate between 1976 and 1986 (3.9%), and a substantial decline 
in fertility rate during its following decade: decreasing from 6.2 births per woman in 
1986 to 2.5 in 1996 (72-75). Consequently, today’s population of Iran is predominantly 
composed of working-age adults, for whom the state has failed to create enough jobs 
(68). The unemployment rate was 11.9% in 2017 (68), and the rate is significantly 
higher in women and in university graduates: approximately 48% of the female 
university graduates and 29% of the male ones are unemployed (76, 77). Further 
information about Iran’s demographic transition is provided in section 1.10.5. 
The majority of Iran’s population has become urban over the last few decades (78). 
While in 1950, 70% of Iranians lived in rural areas and 30% in urban, the pattern has 
now reversed (78). This significant urbanisation coupled with insufficient 
infrastructure has contributed to a rise in the development of informal settlements 
(slums) in many cities, with more than 10 million population, according to unofficial 
reports (79). 
1.10.3 Geopolitical and economic context 
Geopolitically, Iran is part of the Middle East. Unlike many of the countries in this 
region, Iran is not involved with armed conflicts on its land although it is involved 
with wars outside its territories, e.g. in Syria. It also hosts over one million refugees, 
primarily from Afghanistan (80). The last armed conflict within Iranian territories has 
been the Iran-Iraq war, which began with the invasion of Iraqi military forces in 1980, 
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and led to an eight-year destructive war in which Iraq was supported by the West (81). 
The war left behind almost one million Iranians killed and or injured, and destroyed 
much of the country’s infrastructure (82).  
Iran’s international relations have been rather challenging over the last 40 years (83, 
84). Since 1979, Iran has continuously been under international sanctions; initially 
imposed by the US, following the hostage taking of American diplomats in Tehran 
(83, 84). Over the years, the target sectors of the imposed sanctions and the countries 
who participate in imposing them on Iran have changed (84). The sanctions were most 
intensified between 2008 and 2013 as a result of the concerns of the United Nations 
(UN) Security Council, the US, and the European Union (EU) over Iran’s nuclear 
programme, which Iran insisted it was entirely peaceful (70, 84). The sanctions 
excluded Iran from the international payments system, restricted imports and export 
of many items, and isolated the country from global markets (70).  
In 2015, following two years of continuous negotiations, an agreement was signed 
between Iran and the P5+1 (the five permanent members of the UN Security Council—
China, France, Russia, UK, US—plus Germany) and the EU, entitled the ‘Joint 
Comprehensive Plan of Action’ (JCPOA), commonly known as Iran Deal (85). Under 
the accord, Iran agreed to limit its nuclear activities and allow in international 
inspectors in return for the lifting of some of the economic sanctions (85). While the 
International Atomic Energy Agency (IAEA) has reported that Iran was complying 
with the terms of the agreement (86), in May 2018, the US President, Donald Trump, 
announced the withdrawal of the US from the agreement (87). Thus far, this decision 
has been followed by many non-American companies, too. 
A recent systematic review (88) has shown that the imposed sanctions had resulted in 
a decline in Iran’s revenues, devaluation of its national currency, and increased 
inflation and unemployment rates (88). All of these have contributed to deterioration 
of the overall welfare of the Iranian population and have reduced their ability to afford 
the necessities of a healthy life, such as nutritious food, healthcare, and medicine (88). 
Also, the sanctions on financial system and shipment had led to shortage of essential 
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medicines (88, 89). Vulnerable groups, such as the low-income families, patients, 
women, and children were reported to have been the most affected (88, 89).  
Iran is categorised as a higher middle-income country by the World Bank, with a GDP 
exceeding $432.5 billion in 2017, and a GDP per capita of approximately $5,452 (68). 
Iran’s industrial sector has grown both in scope and diversity in recent decades, 
although most of these industries still highly rely on the import of raw material and 
devices (51).  
Iran’s economy is rather fragile because of uncertain international relations in addition 
to social and political instability inside the country, which both increase demand for 
foreign currency (90). One recent example of the impact of national and international 
instability on Iran’s economy is the devaluation of its currency (i.e. rial) to nearly one 
fourth since January 2018 (90). The rise in the rial’s exchange rate against the US 
dollar started following some street protests in a number of Iranian cities, which were 
triggered by economic concerns in the end of December 2017 (90), and the exchange 
rate was significantly deteriorated following the announcement of the US President 
regarding the return of the economic sanctions to Iran. 
1.10.4 Iran’s political system 
Since 1979, following the fall of Pahlavi dynasty, the political system in Iran has 
become a constitutional Islamic republic wherein the position who holds the highest 
political power is the Supreme Leader (Ali Khamenei, since 1989) (83). The Supreme 
Leader, who is elected by an Assembly of Experts, is responsible for formulating the 
general policies, which provide the guidelines for socio-economic, technological, 
diplomatic, and cultural affairs of the nation (91). The General Health Policies 
(Appendix 1) are examples of such (91). 
As illustrated in Figure 2, the Supreme Leader supervises the three independent 
branches of power in Iran: the legislative (i.e. the Parliament, consisting of 290 
members), executive, and the judicial systems (83). The main responsibility of the 
Parliament is to evaluate the new proposed legislations that are submitted for 
ratification (91). Whatever new legislation that is passed by the Parliament should also 
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be evaluated by the Guardian Council (91). The Guardian Council, consisting of six 
clergymen and six jurists - none of whom is appointed through elections - is a 
supervisory body which should ensure the conformity of legislations both to the 
Islamic Law and the constitution of the Islamic Republic of Iran (91). In case of a 
disagreement between the Guardian Council and the Parliament, the ultimate decision 
would be made by the Expediency Discernment Council, whose 44 members are 
appointed by the Supreme Leader (91). It should be noted that the President of the 
country, members of the Parliament, and members of the Assembly of Experts are 
appointed through elections. However, since 1991, the eligibility of all the candidates 
who want to run in the elections, should be first approved by the Guardian Council 
(83). 
The executive branch, headed by the President and consisting of 18 ministries 
(including Ministry of Health and Medical Education) and several other organisations 
(e.g. the Plan and Budget Organisation) is responsible for implementing the ratified 
legislations (91). The executive branch should also propose the national budget plan 
(i.e. a document where the annual funding for national and provincial agencies is laid 
out) to the Parliament and allocate the budget once it is approved (91). Additionally, 
the executive branch is vested with the duty of devising the five-year socio-economic 
development plans (91). Once the development plan is approved by the Parliament and 
the Guardian Council, the President would be responsible for its implementation (91).  
Iran’s education and research system is highly centralised and the government plays a 
significant role in running it (92). A national survey has investigated the views of 
faculty members in medical schools affiliated with MOHME about academic culture 
and values (93). The survey had identified politicisation, conservativeness, 
centralisation, and bureaucracy as the most common features of Iran’s public medical 
schools (93).  
Currently, three ministries of the executive branch are responsible for education and 
research in Iran: the Ministry of Education, i.e. responsible for the 12 years of school 
education; the Ministry of Science, Research, and Technology, for non-medical higher 
education and research; and MOHME for medical and health-related disciplines (70, 
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92). Since 2007, a number of new institutions in relation to funding and policymaking 
for research have been established; which are again, affiliated to the government, e.g. 
the Vice Presidency for Science and Technology (70).  
It should be noted that an organisation, called the Supreme Council of the Cultural 
Revolution (SCCR) holds the ultimate authority in formulating policies, decision-
making, and provision of guidance on the matters of culture, education, and research 
in Iran (Figure 2) (91). Furthermore, all the plans and policies that are passed by the 
science and technology policymaking institutions, including MOHME, should be 
approved by the SCCR before implementation (91). The SCCR was established in 
1980 by the order of Ruhollah Khomeini, the leader of the 1979 Islamic Revolution 
(91). 
As described in section 1.5, and shown in Figure 1, HRS is a subset of both the health 
system and the broader research system. Therefore, in the following sections, I will 
describe some of the key changes that both of these systems in Iran have witnessed 
over the past few decades. 
  
Describing the evolution of Iran’s health research system, understanding the profile of its publications over 50 years, and setting the national health research priorities  
 31 
Figure 2 Institutional mapping of Iran's health and health research systems – NIMAD: National Institute for Medical Research Development; NIHR: Iran National Institute of Health Research  
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1.10.5 Changes in Iran’s health system and population 
health 
• Changes in Iran’s population health over the recent decades 
Since recovery from the Iran-Iraq war, Iran has achieved substantial health gains, such 
as reduction of under-5 mortality from 67.4 deaths per 1,000 live births in 1990 to 18.8 
in 2015, and halving maternal mortality within the same period (94). Life expectancy 
has improved by 8 years since 1990, reaching 78 in women and 72 in men in 2016 
(95). Similar to other parts of the developing world, the major causes of death and 
disability in Iran in the 20th century were communicable diseases (96, 97). 
Nonetheless, changes such as the improvements in children nutrition, access to clean 
water and sanitation, improved heating systems, access to oral rehydration solutions, 
and national vaccination programmes have contributed to reducing the burden of 
infectious diseases over the past few decades (98-104).  
Consequently, Iran’s population health problems have transited from being 
predominantly communicable diseases to non-communicable diseases (NCDs) and the 
types and the profile of risk factors have changed, too (105). In 2015, NCDs 
contributed to 74% of disability adjusted life years (DALYs) in Iran (106). The 
observed leading causes of death were cardiovascular diseases (41.9%), neoplasms 
(14.9%), and road traffic injuries (7.4%) (105). The leading risk factors were high 
blood pressure, dietary risks, and high fasting plasma glucose (105). 
• Development of formal structures for the health system in Iran 
Iran’s health system has undergone several changes over the last decades (107). After 
a brief review of the development of formal structures for governance of health system 
in Iran, the main changes will be reviewed in this section.  
In 1920, with the aim of managing the public health and medical affairs, the ‘Ministry 
of Health and Charity Affairs’ was founded in Iran; two decades later, charity activities 
were separated, leading to the establishment of the ‘Ministry of Health’ (108). In 1975, 
the ‘Ministry of Health’ was merged with the ‘Ministry of Social Welfare’ creating the 
‘Ministry of Health and Welfare’ (109, 110). During all those years, training of the 
healthcare professionals was the responsibility of the ‘Ministry of Higher Education’ 
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(111), and back then, Iran severely suffered from a shortage of healthcare professionals 
(112). In some parts of the country, there was only one physician to provide services 
to a population of over 18,000 (112).  
A major institutional reform of Iran’s health system after the 1979 revolution was the 
integration of ‘medical education and research’ into ‘health services’ in 1985, leading 
to the establishment of the ‘Ministry of Health and Medical Education’ (111, 113). 
The integration had three main aims as follows (111, 113): to (i) increase the number 
of admitted students to the universities of medical sciences; (ii) improve the quality of 
curriculum and training by shifting the approach to being more community-oriented; 
and (iii) pass more responsibility in service provision to medical universities which 
were being founded all across the country. Since the establishment of MOHME, all of 
the national-level decisions regarding strategic planning and resource allocation for 
healthcare and health-related education and research are made by MOHME (114); 
indeed, decision that are aligned with the parliamentary legislations and approved by 
higher level entities, as discussed in section 1.10.4 (91). 
This organisational reform eventually resulted in that the universities in the provinces 
take over all the activities related to medical education, research, and provision of 
health services in the capital of each province, its urban, and rural areas (113). The 
chancellor of the university in each province became responsible for these activities 
(113) (as shown in Figure 2). The outcome of the integration and its impact on health 
research will be further discussed in section 3.5.2.  
• Iran’s family planning programme 
One of the most successful programmes implicated by MOHME has been the family 
planning programme. This national programme had started in 1966, as a health and 
social policy, but following the 1979 revolution, the authorities renounced the 
programme for several years (72). It was argued by the religious leaders that use of 
contraception was inconsistent with Islamic tenets, while instead, family formation 
was strongly promoted (115). Moreover, the legal minimum age at marriage was 
declined to only 9 years old for girls and 12 for boys, and married couples were 
provided with financial incentives by the government to have more children (115). 
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Further, the Iran-Iraq war (1980-1988) created a nationalistic and pro-birth atmosphere 
in the country (115). All of this, led to a substantial population growth rate in the 
1980s: Iran’s population rose from 34 million in 1976 to nearly 50 million in 1986 (72, 
116).  
The post-war economy and social challenges led the authorities to accept the proposal 
of MOHME regarding resuming the implementation of the family planning 
programme (117), and finally, the family planning Act was passed by the Parliament 
in 1994 (118). Thereafter, using the vast network of primary health care centres all 
across Iran, MOHME successfully implemented the programme. Population growth 
reduced dramatically to 1.6% in 2004, (74) and to around 1.2% in 2015; the figure was 
nearly 4% in 1986 (119). Over the past decade, Iran’s population has paced toward an 
older age structure (75). 
• Primary health care programme 
A significant health system reform in Iran’s health system has been the establishment 
of the so-called ‘National Health Network’ in 1983 (i.e. a primary health care system 
- PHC) (120). This network was mainly based on the principles of ‘Health for All’ as 
introduced in the conference of Alma-Ata in 1978 (107). In this programme, local 
‘Health Houses’, as shown in Figure 2, were established in rural areas all across the 
country (120). These local ‘Health Houses’ are staffed with community health workers 
who receive two years of training in medical universities (120). During the training, 
they learn how to provide a range of individual- and population-level primary health 
services (121). After completing the training, they provide primary-level services to a 
population of around 1,000 to 1,500 (120, 122). Once required, the community health 
workers refer patients to the ‘Rural Health Centres’, where a family physician is 
present (123). The PHC programme has significantly improved health indicators in 
rural areas, but it is no longer sufficient to meet the emerging health needs of the whole 
population in Iran, primarily because of the growing urbanisation (107, 124).  
• Health Transformation Plan 
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To address the emerging problems described in the previous section, and other issues 
in the performance of Iran’s health system—e.g. a high out-of-pocket payment—since 
the early 2000s, there have been initiatives for a healthcare system reform (107). The 
first attempts started in 2002 by a joint project between Iran and the WHO, which led 
to allocation of funds to start research about the health system reform, and this was 
followed in 2004, by a joint project with the World Bank, which resulted in an in-depth 
situation analysis of Iran’s health system, as well as planning for implementing the 
reform (125). The results of these programmes were included in the 3rd and the 5th 
national 5-year development plans of Iran (126). In 2014, the General Health Policies 
(Appendix 1) were announced by Iran’s Supreme Leader, drawing the health 
framework of Iran’s Vision by 2025 (127). Finally, in the same year, the Health 
Transformation Plan towards UHC was launched with the support of the President of 
the 11th government of the Islamic Republic of Iran (107). The transformation plan is 
still ongoing and thus far has had successes and challenges (107); there is yet no 
comprehensive evaluation of its impact.  
1.10.6 Changes in Iran’s research system 
Most analyses of the status of science in Iran highlight the rich heritage of the ‘Golden 
Age’ of Islamic civilisation and then, compare and contrast it with the current status 
(11). However, it should be noted that the majority of the famous Iranian scientists, 
e.g. Avicenna (the author of Canon of Medicine) or Zakariya al-Razi (who discovered 
alcohol) lived during only a period between the 9th and 12th centuries (128). According 
to the literature, this ‘Golden Age’ was followed by two centuries of decline in 
scientific activities in Iran and nearly six centuries of ‘ignorance’ between the 14th and 
20th centuries (128). In fact, the history of modern science in Iran is fairly 
contemporary (128, 129).  
Although the first higher education institution in Iran (Jondi-Shahpour medical 
school), was founded in 271 CE, the first modern higher education institution in Iran, 
‘Dar al-Fonun’ (meaning House of Technologies) was established in 1851 (92, 130, 
131). Even that institute was not founded for the purpose of contributing to science, 
and instead, was only to train new students (129, 132). During the reign of 
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Mohammad-Reza Shah Pahlavi, in the late 1960s and the 1970s, new universities, e.g. 
Pahlavi University (renamed to Shiraz University after the 1979 revolution) were 
established based on American standards (132). The majority of their faculty members 
were American and some European, but still, not much scientific contribution was 
made back then (132).  
The first years following the 1979 revolution were catastrophic for scientific activities 
in Iran (132). A process aiming to bring the education system in line with Islamic 
principles went on during the early 1980s, so-called ‘Cultural Revolution’, which had 
different aspects (92, 132). ‘Cultural Revolution’ caused the expulsion of a large 
number of faculty members, leading to a huge wave of brain drain during the 1980s 
(92, 132). Also, all of the universities were closed for three years - two years for 
medical universities - after which, the power was given to Islamic societies of the 
universities to monitor activities of academics and students to ensure their conformity 
with the principles of the Islamic Revolution (132). After the re-opening of the 
universities, many academics were forced to work in areas irrelevant to their specialty 
(10). Such events led to a substantial regression in scientific activities in Iran. This 
regression was further deteriorated by the consequences of the war with Iraq (1980-
1988) (10), as it shifted resources from academia towards the more immediate needs 
of a country in war (10). 
On the other hand, it is argued that the Iran–Iraq war and the tight sanctions against 
Iran—both described in section 1.10.2—may have triggered a drive towards a 
knowledge-based economy in Iran and may have created support at the macro level 
for a push towards ‘self-reliance’ by using nationally-produced science and technology 
(10, 51). It is argued that the war made Iranian policymakers realise that scientists, 
such as physicists and mathematicians were needed for developing military technical 
requirements, which the West supplied to Iraq, but not to Iran (51, 81).  
At the same time, since the 1979 revolution was a movement towards egalitarianism, 
at least in its early years (10), the government sought to improve the healthcare 
services in rural and deprived areas (111). This required training more healthcare 
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professionals, which was made possible by establishing new medical universities and 
schools, and recruiting more students (111). 
Serious attention to science development in Iran started since 2001, when for the first 
time, a specific chapter of the 5-year Development Plan was devoted to science and 
technology (S&T) policies (70, 133). Since then, until 2015, over 50 policies for S&T 
development, e.g. laws and national documents, have been adopted in Iran (133). As 
will be described below, three distinguishable periods of S&T policy formulation in 
Iran since the 1979 revolution have been proposed in the literature (133).  
The first period is 1979–1988, when the state significantly invested in development of 
public elementary education (133). A policy was passed that made elementary 
education for children tuition-free and mandatory (133). Also, an initiative known as 
the ‘Literacy Movement’ was promoted under the order of the then Supreme Leader 
aiming to provide free education to illiterate adults (133). This resulted in a substantial 
increase in literacy rate as well as closing the literacy gap between men and women, 
and between urban and rural populations (92, 133). Between 1955 and 2015, the 
literacy rate in women and men rose from 10% and 30% to more than 84% and 91%, 
respectively (133). However, secondary school attendance was still nearly 75% in 
2015 (134). 
The second period of S&T policy-making in Iran is attributed to the years between 
1989 and 2001, when the emphasis was placed on expanding the capacity of higher 
education (70, 133). Consequently, the number of public universities and the schools 
within each university increased while also a large number of private universities were 
established all across the country (70, 133). This resulted in a 10-fold increase in the 
number of universities and other institutions of higher education (133). In 2015, Iran 
had 58 public universities of medical sciences, affiliated with MOHME; 154 public 
universities affiliated with the Ministry of Science, Research, and Technology; 567 
semi-private; and 354 non-profit private universities (70).  
The policies during the third period, 2005–2015, focused on increasing the number of 
post-graduate programmes and promoting basic and applied research (133). The 
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number of post-graduate students within this period increased by five times (69). 
Policies to promote research activities in the emerging fields and technologies and the 
establishment of advanced technological initiatives were among other activities during 
that period (133). 
Different reasons are proposed in the literature to explain the intentions behind 
formulating policies for expansion of higher education in Iran. One hypothesis argues 
that the expansion of higher education has been done with the aim of controlling the 
high unemployment rate among the youth who had completed high school (135). 
These young people were the baby-boomers of the late 1970s and the 1980s, as 
described in section 1.10.5. Another suggested purpose of expanding higher education 
has been to provide equal opportunities for all; this was in line with the egalitarian 
values of the 1979 revolution (10). Other proposed reasons were to: respond to the 
demand of: (i) a generally credential society (92); (ii) a large number of young women 
who were willing to pursue higher education for gaining a better social status (92); and 
(iii) young men whose aim for pursuing higher education was to delay recruitment for 
the 2-year mandatory military service by remaining a ‘student’ (135). Some also 
suggest that since the early 1990s, the universities in Iran were commercialised, 
meaning private and semi-private universities were established only for the purpose of 
earning money (135). 
These S&T policies in Iran have resulted in a large number of educated Iranians, either 
in Iran or among the diaspora (10, 70). There is even some empirical evidence for the 
birth of a scientific community in Iran, although Iranian leading scientists have 
paradoxical opinion about this (10). Some believe that Iran’s scientific achievements 
over the last few decades have solely been products of personal endeavours, while 
others believe that a scientific community, although a fragile one, exists (10). This 
PhD will further look into the changes in Iran’s health research system during the past 
five decades. The following section would provide a review of the literature about the 
methods that will be used for assessment of different patterns of the growth that has 
occurred in the number of Iran’s health research publications.  
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1.11 Different methods for research assessment 
Considering different purposes of research assessment, as described in section 1.6, it 
is clear that the ways by which research is assessed is a key matter for a wide range of 
stakeholders, e.g. policymakers and funders, heads of academic institutions, and 
individual researchers (25). Research assessment includes evaluation of research 
quality and measuring research inputs, outputs, and impacts (25). It embraces both 
qualitative and quantitative methods, including the application of peer review 
judgements, bibliometrics, and alternative indicators (24, 25). These methods are 
further described in the following sub-sections.  
1.11.1 Peer review 
Peer review is a process that is used in various research evaluation contexts and 
responds to different purposes that were summarised in section 1.6. In general, peer 
review—i.e. peer evaluation in research—is a process in which a jury of equals active 
in a given research field gather to assess the conduct of a scientific activity or its 
outcomes (27). The result of the process is often a summarised judgment about 
suitability for publication or funding, accompanied with comments (27). The prime 
strengths of peer review are that it is based on specialised knowledge of the subject 
and methodology, and that relevant literature is available for making evidence-based 
decisions (24).  
The International Committee of Medical Journal Editors (ICMJE) defines peer review 
as: ‘the critical assessment of manuscripts submitted to journals by experts who are 
not part of the editorial staff’ (136). Indeed, peer review has several contemporary 
applications in addition to the critical appraisal of papers. Some of its common uses 
are: (i) assessment of books by publishers; (ii) review of scientific data in the context 
of publication decisions or data repositories; (iii) measurement of the performance of 
researchers or research groups in the context of national and international research 
assessment exercises or awarding scholarly prizes; (iv) assessing fellowship applicants 
and grant proposals; and (v) evaluations in the context of future studies and the 
development of national or international research agendas (24, 27, 137). Peer review 
is increasingly being used for national research assessment exercises (24). Particularly, 
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countries who intend to assess research impact in addition to assessment of research 
output highly rely on peer review approach; examples are the UK, Italy, France, and 
Belgium (24).  
Despite peer review’s strengths and wide use, it has several limitations too, being 
summarised as follows (24, 27, 138-141): (i) the process is slow, expensive and 
inefficient; (ii) human judgment is basically subjective; (iii) most of the peer review 
processes are not transparent; (iv) it is not a consistent process and the lack of inter-
rater reliability is reported repeatedly; (v) the process is highly prone to bias, e.g. 
gender bias regarding career decisions or even publication, bias against publishing 
negative results, bias in favour of prestigious institutions/countries and vice versa; (vi) 
the process is vulnerable to be abused, e.g. to block competitors or even insert abusive 
comments; (vii) it is not very effective at detecting mistakes or even in identifying 
fraudulent data; (viii) it cannot evaluate the complete research output of a country; (ix) 
it cannot provide information about the productivity and efficiency of a large research 
system; and (x) finding peer reviewers is a difficult task, because of potential conflict 
of interest, lack of experts in emerging and interdisciplinary fields, etc. 
Some major areas of improvements of peer review suggested in the literature are  to 
(24, 140): (i) make the process single- or double-blind to overcome potential biases; 
(ii) replace pre-publication review with post-publication review; (iii) provide open 
peer review to solve the risk of abuse and to increase accountability; (iv) provide 
trainings for reviewers to improve the quality of their reviews; and (v) develop new 
types of peer review, e.g. being more focused on methodology rather than substantive 
quality criteria as developed by PloS ONE in journals. Pre-prints and post-publication 
peer reviews are also among the major developments which have become possible 
with the advent of online networks (142-144). One great advantage of preprints is the 
ability to disseminate research findings rapidly once the project is complete (143). 
Faculty1000Research is another novel approach known as post-publication peer 
review, which provides transparent peer review after publication for materials in life 
sciences (144).  
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Two of the disadvantages of peer review that are particularly important in analyses at 
larger scales are being time-consuming and expensive, which can eventually result in 
a drop in its quality. For instance, in the 2008 UK research assessment exercise (RAE), 
each of the members of the review panel for biological sciences had to assess almost 
1,000 papers within a few months, and in the fields of social sciences and humanities 
each member had to review 100 books (24). Clearly, with peer review approach, not 
all of the submitted research could be reviewed in depth for large-scale research 
assessments. Furthermore, using peer review for national-level research assessment is 
very expensive, too. For example, running the UK Research Excellence Framework 
(REF) exercise in 2014 is estimated to have cost £246 million, comprising almost £232 
million in costs to the higher education community and around £14 million in costs for 
funding bodies (145).  
1.11.2 Evolution of research assessment methods 
Recognition of the limitations of peer review has encouraged endeavours to replace 
and or complement it with quantitative metrics, such as bibliometrics and/or 
Altmetrics. Bibliometrics is further described in the following sub-sections. Altmetrics 
is ‘the study and use of scholarly impact measures based on activity in online tools and 
environments’ (146). The term Altmetrics was proposed in 2010, originating from 
altmetrics hashtag (#altmetrics), which proposed metrics as alternative or 
complementary to more traditional metrics, e.g. journal impact factor or h-index (146). 
Examples of the tools and environments using which Altmetrics tracks research impact 
are: (i) social media, e.g. Twitter and Facebook; (ii) online reference managers, e.g. 
Mendeley, CiteULike; (iii) collaborative encyclopaedias, e.g. Wikipedia; (iv) blogs; 
and (v) scholarly social networks; e.g. ResearchGate (24, 146-150). For instance, 
counting the number of page/article views, downloads, number of ‘retweets’ on 
Twitter or ‘shares’ on other social networks and any mentions in policy documents or 
mainstream news outlets could be counted by Altmetrics (146, 148, 149). Such metrics 
are increasingly gaining attention, particularly on micro levels of assessment, e.g. 
individual assessment or article evaluation (147).  
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Another major development that could influence the way citation impact is assessed is 
in relation to the rise in Open Access publishing (151), meaning publication of journals 
which provide the full-text versions of articles free of charge (151). The availability of 
full-texts, and not only the bibliographic information, enables the construction of more 
advanced citation impact metrics, e.g. indicators that take into account the number of 
times a publication is referenced in a citing publication, the location where a 
publication is referenced in a citing document (e.g. introduction, methods, results, or 
discussion) or even the context in which a publication is referenced (i.e. the sentences 
in a citing document about the reference to a cited publication) (148, 152). Such new 
sources of data might be used in the future for obtaining more sophisticated 
measurements of citation impact (152). 
1.11.3 Bibliometric methods 
Introduction 
As a result of the increased attention to assessment of research performance, 
bibliometrics has evolved from being an almost obscure statistical sub-field of 
information science to playing a substantial role within the social and political 
processes of scientific activities in academia (147, 148, 153). This section first reviews 
the history of the development of the field bibliometrics. This would help us 
understand how this field has evolved from formulas and theories to influencing 
policy, how this contemporary use of bibliometrics can pose problems, and how the 
limitations can be minimised. Then, different citation databases and bibliometric tools 
will be introduced, which is followed by a section that compares peer review approach 
and bibliometrics. Finally, some applications of bibliometrics in large-scale research 
assessment practices will be reviewed.  
History and basic concepts in bibliometrics 
Today, the terms bibliometrics and scientometrics are used interchangeably (154) and 
this section begins with a brief review of their origins. Both terms were introduced and 
defined in 1969 (154, 155). The term bibliometrics was defined as, ‘the application of 
mathematical and statistical methods to books and other media of communication’ 
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(148), while scientometrics was first defined as ‘the quantitative methods of the 
research on the development of science viewed as an information process’ (148).  
However, over the past thirty years, the blurry line between these two specialties has 
almost been disappeared (154). Today, the originally broader field of bibliometrics is 
replaced by informetrics, while scientometrics and bibliometrics provide equal 
meanings (154, 156). Therefore, informetrics is like an umbrella that covers 
scientometrics/bibliometrics as well as the younger related fields, such as altmetrics 
(156, 157).  
The basis of the field of scientometrics or bibliometrics has older origins though, 
perhaps going back to 1896 when Pareto’s principle was introduced (158-160). 
Pareto’s principle stated that for many events, approximately 80% of the effects come 
from only 20% of the causes (159). Pareto’s principle that was initially proposed in 
economy to describe income distribution was later applied in analysis of citation 
behaviours in science (153, 158, 160). In 1934, Bradford published his important study 
on the frequency distribution of papers across journals (154, 155), which showed that 
if scientific journals would be ranked in terms of their number of articles on a particular 
subject, there will be a core of journals that publish most of the articles in that subject 
(148). Bradford’s hypothesis was quite similar to Pareto’s proposed pattern. Around 
the same time, a citation-based study was published which had assessed 3,633 citations 
from 1,926 volumes of the Journal of American Chemical Society (161) to help 
deciding which chemistry periodicals were better for purchasing by small libraries 
(154, 155).  
A new chapter was opened in practical scientometrics when Eugene Garfield proposed 
the idea of citation indices for science (162) and officially founded the Science Citation 
Index (SCI®) at the Institute for Scientific Information (ISI) in 1964 (163). The SCI® 
was first proposed as a tool for facilitating the dissemination and retrieval of scientific 
literature (164).  
Another historic highlight in development of scientometrics field was  the Derek J. de 
Solla Price 1963 book entitled ‘Little Science, Big Science’ (165), in which the first 
Describing the evolution of Iran’s health research system, understanding the profile of its publications 
over 50 years, and setting the national health research priorities  
 44 
quantitative data on the growth of scientific publication covering 1650 to 1950 was 
provided (165). The book had reported a growth rate of 5.6% per year in the number 
of journals, and an annual growth rate of 7% for science (165). By analysing the recent 
systems of science communication of his time, Price established the foundation of 
modern research evaluation methods (154).  
A theory characterising processes of scientific communication was the principle of 
cumulative advantage proposed by Price (166), which is also known as ‘success seems 
to breed success’ (148). Price explained that a paper that has been cited many times is 
more likely to be cited again. Similarly, an author of many papers is more likely to 
publish again than one who has been less prolific.  
This idea was initially introduced in 1968 as ‘Matthew Effect’ by Robert K. Merton 
(167), who had shown how certain psychosocial processes can influence the allocation 
of rewards among scientists—an allocation that in return influenced the flow of ideas 
and findings through scientific communication networks (167). Merton had also been 
one of the first people who proposed the idea of citations being a reflection of 
recognition or acknowledgement of a piece of work among peers—i.e. an indicator of 
the impact of the work on a community of peers (137). He once wrote that ‘if one’s 
work is not being noticed and used by others in the system of science, doubts of its 
value are apt to rise’ (168).  
In 1972, Eugene Garfield developed a measure for evaluating and ranking journals—
the journal impact factor (IF), which still is in use despite being widely criticised for 
its flaws (169). In 1978, ‘scientometrics’ developed as a discipline with the publication 
of the journal Scientometrics—the first journal specialised in this field (148, 154, 155). 
Around the same time, the first links between bibliometrics and research evaluation 
and the use of citation analyses in policymaking took place (148). For instance, the ISI 
data was included in the US National Science Board’s Science Indicators Reports in 
1972 and was applied by the Organization for Economic Cooperation and 
Development (OECD) (148).  
• Levels of aggregation in bibliometrics 
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In bibliometric analyses three levels of aggregation are often used. These levels are: 
(i) micro, e.g. publication output of one author or research groups; (ii) meso, e.g. 
publication output of institutions, journals, or research fields; and (iii) macro, e.g. 
publication output of countries, regions, or the world (153, 154). In the literature, micro 
is considered as the lowest and macro as the highest level of aggregation (154). In 
performing analyses on any level of aggregation, information about names of the 
authors, institutions, countries, etc are often obtained from the sections on a 
publication that include authors’ names and affiliations (170).  
• Data quality in bibliometric analyses 
Arguably, the quality of data in bibliometric studies requires significant attention. That 
is why choosing an appropriate database and cleaning the data is essential (153). 
Names of authors, institutions, and some countries often have many variations; they 
may contain spelling errors; or the names might change over time (153, 154, 171). 
Furthermore, attention should be paid to possible synonyms and homonyms (153). 
Synonyms are when more than one name exists for one entity—e.g. an author whose 
name is spelled differently on different publications—while homonym is when one 
name refers to more than one entity—e.g. different authors who share the same initial 
and surname (153, 154). Disambiguation and cleaning the names of authors, 
institutions and even countries is fundamental to performing meaningful bibliometric 
analyses, particularly in research assessments on micro levels (137, 153, 154, 171).  
One strategy to correct identification and disambiguation of authors and institutes in 
order to improve scientometric analyses on the micro and meso levels is to promote 
the use of online registries where each researcher can obtain a unique identifier, and 
link it to his/her publications. In this way, the publications linked to each author could 
be tracked using their registered identifiers—i.e. IDs (171). This could solve the issues 
with synonyms and homonyms of authors. Examples of such author ID registries are 
ORCID (Open Researcher and Contributor ID) and ReseacherID (171). They are both 
freely available (172), but yet, not widely used for bibliometric analyses. Because 
firstly, their coverage is still limited and secondly, they are sensitive to human errors, 
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because authors should regularly update their list of publications and maintain 
publication assignment to their IDs (171).  
• Research area assignment 
Several bibliometric analyses investigate the publication activity in certain research 
areas. Publications in bibliographic databases are often allocated to research areas, 
either by subject headings, or based on journals’ classification (154). A good example 
of assignment based on subject headings is the MeSH (Medical Subject Headings) in 
PubMed (173). PubMed is a bibliographic database for biomedical literature and 
assigns subjects to documents with a document-based vocabulary thesaurus called 
MeSH (173). A MeSH term is one of the main topics that is discussed in a document 
and is assigned to each document based on the decision of subject specialist staff (173). 
Moreover, these specialists continually revise and update the MeSH vocabulary and 
may add new major MeSH terms if an important emerging new field is missing (174).  
Unfortunately, the main citation databases, i.e. Web of Science and Scopus, allocate 
research areas to the documents using journal classification (154), meaning they 
determine the subject of each individual document based on the scope of the journal 
where the document is published (154). As journals are often not devoted solely to one 
single topic, the allocation of research fields based on journal assignment is less precise 
than being based on the subject headings of individual documents (154). In addition, 
the journal-based subject assignment approach fails regarding the subjects allocated to 
the documents that are published in multidisciplinary journals such as Nature and 
Science (154) or in general medical journals, e.g. The Lancet.  
Citation databases 
Successful quantitative analysis of citations requires accurate and comprehensive 
bibliographic data sources. There are currently three indexing databases that provide 
citation information: Web of Science (WoS), Scopus, and Google Scholar (GS) (152). 
This sections describes and compares these databases with each other. It should be 
noted that various features of these databases are in constant development. Hence, this 
review is only valid at this time. 
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• Web of Science (WoS) 
Web of Science™ (WoS) citation database was first created at the ISI by Eugene 
Garfield (163), and since 2016, has been owned by Clarivate Analytics Company 
(Philadelphia, United States of America) (175). WoS comprises several citation 
indexes, it is a subscription-based database, and its coverage varies based on the type 
of subscription (152). Its most famous database—WoS Core Collection—includes 
Science Citation Index Expanded (covering 8,500 journals), Social Sciences Citation 
Index (indexing over 3,000 journals), Arts & Humanities Citation Index (full coverage 
of 1,700 journals) and several other indices, e.g. the Conference Proceedings and Book 
Citation Indexes, both in science and in social sciences and humanities (148, 176). A 
more recent addition has been the Emerging Sources Citation, which aims to include 
scientific literature of regional importance and in emerging  fields (152). 
• Scopus 
In 2004, Elsevier introduced Scopus (152), which is another subscription-based 
citation database rather similar to WoS, covering 21,500 journal titles from 5,000 
publishers, over 360 trade publications, over 530 book series, more than 7.2 million 
conference papers, 116,000 books, and more than 27 million patent records (177). 
Being younger than WoS, the characteristics of Scopus have been studied less 
extensively than those of WoS, but there is still a lot of literature comparing these two 
databases from various aspects, some of which are reviewed in the following sub-
sections. 
• Google Scholar (GS) 
In 2004, Google Company launched Google Scholar (GS) as a simple and free-of-
charge academic search engine (152); it uses automated software to extract citations 
from the digital publications that it finds online or that are provided by publishers (148, 
152). GS indexes literally any scholarly literature that is available on the web; little is 
known about its exact coverage (152).  
• Comparing WoS, Scopus, and GS 
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Several comparisons of the coverage of WoS and Scopus has been conducted, some 
of which have reported that Scopus has a better coverage than WoS in various field, 
although it is suggested that Scopus seems to be covering journals with lower impact 
factors (178). An analysis of researchers in the field of human-computer interaction 
showed that Scopus had a better coverage of conference proceedings than WoS (179). 
An investigation of the overlap of journal titles in Scopus and WoS found the coverage 
of Scopus to be superior, particularly in science, technology, and medicine (180). 
However, a study analysed the coverage of publications of two Portuguese universities 
in WoS and Scopus and concluded that about two third of the documents indexed in 
any of these databases can be found in both databases, and one third is only indexed 
in one or the other (181). Furthermore, an analysis of journals in the field of oncology 
indicated that the journals that are covered by Scopus, but not covered by WoS, tend 
to have a lower citation impact and are likely to be more nationally oriented (178). The 
issue of Scopus covering journals with a relatively lower impact was observed in 
another study, too (182).  
Several studies have compared GS against WoS and Scopus to investigate its 
suitability for research evaluation purposes. A number of studies have reported that 
GS outperforms WoS and Scopus in terms of coverage of different types of 
publications (152). For example, it has been observed that GS has a broader coverage 
of conference proceedings and non-English language journals in the field of library 
and information science (183). Similarly, GS covers more publications than WoS in 
the fields of business and management. The mean citation of the research papers of 
three UK business and management schools in GS were seen to be nearly double the 
figure for WoS (184). Studies from computer sciences (185) and psychology (186) 
have also shown broader coverage of GS than WoS. GS might also be a better option 
for research assessment exercises in the fields where publishing books is more 
common than publishing journal articles (24). A study compared the citations to 1,000 
books submitted to the 2008 UK RAE across seven book-based disciplines and found 
that both the numbers and medians of GS citations to books were three times as high 
as Scopus citations (187).  
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Having said that, GS does not necessarily have a better coverage than WoS and Scopus 
in all fields. For instance, an analysis documented that coverage of GS compared with 
WoS and Scopus in the field of energy physics was poor (188). Another study from 
the field of chemistry reported a lack of convergent validity of the citation analysis 
based on the GS data and recommended WoS and Scopus as more suitable databases 
for research assessment in chemistry (189). It should be noted that, some studies have 
found none of these three databases to be consistently better than the other two in terms 
of coverage. A comparison of WoS, Scopus, and GS in the fields of oncology and 
condensed matter physics with the data from 1993 and 2003 indicated that none of 
these databases consistently outperforms the others (190). A similar conclusion was 
derived from an analysis of publications in general medical journals (191). 
Additionally, a comparison of WoS and GS in the field of earth sciences presented a 
lack of consistent outperformance (192). 
GS may be useful for assessment of units that contain a substantial amount of non-
English documents, and when pre-prints and or publications in non-conventional 
platforms must be included (148). However, for a number of reasons, GS should be 
avoided as the first citation database of choice in undertaking bibliometric analyses. 
Firstly, GS does not provide transparent information regarding its indexed sources  
(193). Secondly, GS has no clear quality control over its indexed content (148). It 
contains many inaccuracies and errors leading to incorrect citation counts (194). Some 
concerns have also been raised regarding the possibility of manipulating citation 
counts in GS (195, 196). Finally, cleaning the data from GS could be extremely time-
consuming (183). 
• Which citation database to choose? 
In terms of the sensitivity of citation analyses, to choose between WoS and Scopus, 
suggestions in the available literature are quite mixed. One study ranked different 
departments of the University of Navarra in Spain based on citation counts from WoS 
and Scopus and found that they both eventually provided similar rankings (197). Two 
other studies have indicated that in analysis of small entities—e.g. journals, conference 
proceedings, or institutions—citation results retrieved from WoS and Scopus are 
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significantly different, whereas for larger entities—e.g. research fields or countries— 
the yielded figures from two databases could be very similar (198, 199).  
The general agreement at this time is that bibliometric data either from WoS or Scopus 
is sufficient to perform research evaluations in the natural and other sciences where 
the coverage of publications is high—i.e. excluding social sciences, arts and 
humanities (24, 148). Particularly, bibliometric analyses in WoS and Scopus on higher 
levels of aggregation—e.g. national or global levels—seem to yield similar results 
(199).  
The coverage of these three databases has substantially improved over the last recent 
years, which necessitates further updated comparative studies (24, 200). In particular, 
WoS has been increasingly expanding the indices that includes, especially in different 
languages (200). A recent longitudinal comparison of the rate of growth of 
publications and citations in these databases between 2013 and 2015 found a consistent 
quarterly growth across all three databases and suggested that all three provide 
adequate stability of coverage (201).  
Bibliometric indicators 
Traditionally, the findings of original research are communicated through 
publications, particularly in certain fields, e.g. biomedical and natural sciences, 
publishing journal articles is the main way of dissemination of findings (153). Hence 
publications could be considered as proxies of scientific output of research units (e.g. 
researchers, institutions, countries) (148, 152, 153). Furthermore, it is assumed that a 
citation to a document in subsequent articles represent the scholarly impact of the cited 
document (153, 168). In this way, the number of received citations by a document 
would somehow reflect scientific impact of that document (137). Consequently, 
although bibliometrics can, and somehow do, study different aspects of the dynamics 
of science, in practice, this field has mainly developed around the notion of citations 
(148, 153), and the majority of indicators developed in bibliometrics focus on citations. 
Several indicators based on citation counts are available for measuring research 
impact, which are described in the following sub-sections. 
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• General categories of citation impact indicators 
Two main characteristics of citation-based indicators are about: (i) being size-
dependent or size-independent (152); and (ii) being normalised or not (153). Size-
dependent indicators, aim to provide an overall picture of the performance of one 
research unit (152), while size-independent indicators aim to provide an average 
performance measure per publication (152). Example of a size-dependent indicator is 
the total citations received within a year by publications of an academic institution. 
This could be helpful for providing an overview of the research performance over time. 
Indeed, comparing the total citation counts to publications of a large institution with 
the figures for a small institution is not fair; that is where size-independent indicators, 
e.g. the average citations per publication come useful. Another well-known example 
of size-independent indicators is the journal impact factor that aims to calculate the 
average citation counts to each publication of a journal (24).  
In terms of normalising the indicators, the goal is to correct the effect of variables that 
may influence the outcomes of citation analyses (24). Citation indicators can be 
normalised by research fields; because of the substantial differences among fields in 
citation density, i.e. the average citation counts per publication (153, 202). For 
instance, molecular biology articles have been reported to have ten times as much as 
citations than publications in computer sciences (203). Also, citation counts should be 
normalised by the year of publication if they are used for comparison of research units 
with different ages (152), because an older publication has had more time to get cited 
than a recent publication (204). Some believe that citation counts should also be 
normalised by the document type (152), i.e. original article, review article, letter, etc. 
An analytical tool offered by Clarivate Analytics Company that normalises the number 
of citations by research field and the year of publication is Essential Science 
IndicatorsSM (ESI), which enables the assessment of researchers, institutions and 
publications within a given research field and publication year (24, 205). Moreover, 
InCite is another research evaluation tool provided by the same company that allows 
assessment of the productivity and citation impact of different research units. One of 
the metrics in InCite that is normalised by subject category and the year of 
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publication—Percentile in Subject Area—has shown a high correlation with 
Faculty1000 (i.e. based on peer judgements) ratings (206).  
• General citation impact indicators 
A large number of citation impact indicators have been proposed in the literature, most 
of which can be seen as variants or extensions of a limited set of indicators that are 
introduced in the following sub-sections (152). Five main citation impact indicators 
are the: (i) total number of citations; (ii) average number of citations to publications of 
a research unit; (iii) number of highly-cited publications; (iv) proportion of the highly-
cited publications; and (v) h-index. While the first indicator is self-explanatory, the 
other four citation-based indicators are described in the following text. 
• Average number of citations 
Average number of citations of a research unit is the average of citation counts to 
publications of a research unit. Journal IF that calculates the average number of 
citations received by publications in a journal is perhaps the most commonly used 
indicator based on the idea of average number of citations (169). Although average-
based metrics are routinely in use, they are widely criticised. The critics rise from the 
possible skewness of citation distribution in any research publication unit (153). 
Meaning that the average number of citations of a set of publications can substantially 
increase by only one or few highly-cited publications, and vice versa (152). Similar to 
early theories discussed in section 1.11.2, 80% of citations are received by 20% of 
documents; many publications are even never cited (207). The limitation of average-
based metrics on account of unequal distributions has been reported on the level of 
countries (208), universities (209), and repeatedly on the level of journals (157, 210). 
Therefore, it is strongly recommended to replace or complement indicators that are 
based on the average number of citations by other metrics (152). The median has been 
suggested to be a more robust alternative (211), but as median disregards the highly-
cited ones, it also cannot fully represent the citation impact of a research unit (153). 
Providing the standard deviation with the mean seems more appropriate (153). The 
following indicators are other examples of alternative metrics for average-based 
indicators.  
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• Number of highly-cited publications 
To calculate this indicator in a research publication unit, firstly, a threshold should be 
chosen to define the number of citations that are required to call a document ‘highly-
cited’ and then, the highly-cited publications will be identified (24). In recent decades, 
a number of studies have suggested the use of ‘number of highly-cited publications’ 
in research evaluations (212-215). GS and WoS have started using this indicator; GS 
reports ‘i10-index’ for authors, which represents the number of their publications with 
10 or more citations (24), while WoS offers a tool called ESI, which identifies the 
highly-cited publications (205). ESI uses WoS data by which identifies a threshold for 
highly-cited papers as the minimum number of citations received by the top 1% of 
papers in each research field and in each year.  
• Proportion of highly-cited publications 
This indicator is the proportion of the publications of a research unit that are identified 
as highly-cited. Citation percentiles, such as the top-5 or the top-1% highly-cited 
documents have been reported to be appropriate measures of excellence (206, 216).  
• H-index 
In 2005, a more complex indicator was introduced by a physicist called Jorge E. Hirsch 
to somehow address the limitations of older citation indicators (217). This new metric, 
the h-index (or Hirsch index) was defined as follows: ‘A research unit has index h if h 
of its publications each has at least h citations and the other publications each has no 
more than h citations’ (217). 
H-index was the first indicator which—to some extent—intended to capture both the 
quantity and the citation impact of an individual’s research unit in a single number 
(217). It is now automatically calculated in all three main citation databases (152, 188). 
H-index can be applied at different levels of aggregation, e.g. authors, institutions, 
countries (148). Another advantage of h-index is that it disregards the lower down 
publications, thus it is robust to poor quality data that can be an issue while using GS 
(148).  
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However, h-index has several limitations and some of them are inherent limitations of 
citation indicators, e.g. the problem of using h-index to compare research units in 
different disciplines with different citation density (148, 203). Two other important 
limitations of h-index that have provoked many studies for improving this indicator is 
that h-index is insensitive to firstly, the total number of publications, and, secondly, to 
the actual number of citations received by the documents included in the h-index—i.e. 
the h-core. Therefore, research units, e.g. two authors with entirely different number 
of publications and/or citations could have equal h-indices as long as they both have 
published h papers, each with h citations (153). It is also important to mention that, 
since the maximum of the h-index is the number of publication in the research unit, 
the h-index is more strongly formed by the number of publications rather than the 
citation counts (153).  
• Newer variations of h-index 
To overcome the limitations of h-index, a large number of its variants have been 
proposed in the literature, of which the g-index (218) is probably the one that is best 
known. G-index, introduced in 2006 by Egghe, was defined as, ‘a set of papers has a 
g-index of g if g is the highest rank such that the top g papers have, together, at least 
g2 citations’ (218).  
The basic idea is that the papers that contribute to h-index—i.e. the h-core—must have 
at least h2 citations between them, although in practice, they might have more. G-index 
attempted to solve the insensitivity of h-index to actual number of citations of the h-
core papers (148). The more citations they have, the larger the g will be and so it will, 
to some extent, reflect the total number of citations. However, the disadvantage of g-
index is that it is less intuitively obvious than h-index (148).  
Another proposed indicator is a-index which is the mean number of citations of the h-
core documents (148). The a-index disadvantages better research units, because 
divides the citation counts by h, which is higher for better research units (148). A 
further proposal to solve this shortcoming was the r-index that is the square root of the 
sum of the citations of h-core documents. The ar-index is another variant of the r-index 
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which also takes into account the age of the papers (148). M-index is another indicator 
which is the median of the citations of h-core documents (148).  
In sum, the use of indicators that are based on the total or average number of citations 
is criticised, because citation distributions are often highly skewed, thus the total or 
the average citation counts in a set of publications could be very much influenced by 
only one or a few outliers. Therefore, mean number of citations cannot provide a valid 
measure of central tendency. Median or providing standard deviations are better 
alternatives. Indicators based on the idea of counting highly-cited documents have 
been reported to be a more robust alternative to metrics based on the total or average 
citation counts. Percentile-based approaches that would determine a threshold and 
count the number of documents reaching that threshold have shown more promising 
results.  Finally, the h-index has become a well-established indicator and compared to 
new generations of its variants, it is much more practical as it is now calculated by all 
main citation databases. However, it is a rather crude simplified indicator to compress 
the information about both productivity and citation impact into one single number.  
Indicators of the citation impact of journals 
The previous sub-sections generally described citation-based indicators. This sub-
section focuses on some of the most well-known citation indicators that are used for 
journals. 
IF is the most famous journal citation impact indicator (152). It is calculated using two 
elements: (i) the numerator, which is the number of citations in the current year to 
documents that were published in the previous two years; and (ii) the denominator, 
which is the number of substantive original and review articles published in the same 
two years (169). In a simple example, if a journal has published a total of 100 
publications in 2013 and 2014 and if these publications were cited 200 times in 2015, 
the IF of this journal equals 200/100 = 2. Therefore, IF seems to be a proxy of the 
average citations to a journal publications in recent years (169). Nevertheless, 
considering its definition, in the numerator of IF, the citations to all of the publications 
(all document types) are counted, whereas in its denominator only publications of 
specific document types—the so-called citable documents—are included (152).  
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It is also worth highlighting that IF was initially developed by Garfield as a tool to aid 
them in selecting the most ‘relevant’ journals among thousands of journals for 
coverage in SCI with a view of improving the cost-effectiveness of their task (153). 
Eugene Garfield and his colleagues in ISI had studied the references of the articles in 
SCI and had shown that the majority of references were citing roughly 500 to 1,000 
journals (153, 169). By 1969, they identified 2,200 journals as ‘the world’s most 
important scientific and technical journals’ and fully indexed them in the SCI (153). 
Today, the historical background of the creation of IF is often overlooked and IF is 
extensively used in research assessment contexts (147, 153). This has caused a lot of 
debate around the use of IF. Part of the debate regarding the IF is not much about the 
indicator itself, but mainly around the way in which it is used for research assessment 
purposes, particularly on micro levels, e.g. in assessing articles based on the IF of the 
journal where they are published or in evaluating researchers based on the IF of the 
journals where they publish (147, 152, 210). 
There is also debate regarding how IF is calculated. Several improvements of and 
alternatives to IF have been suggested in the literature (24). For example, including 
citations belonging to a time period longer than two years has been suggested(152), 
e.g five-year IF which are calculated based on citations to publications in the previous 
five years rather than two years. The Journal Citation Reports (JCR)—a product of 
Clarivate Analytics that calculates IFs for journals indexed in the WoS Core 
Collection—provides both the two-year and the five-year journal impact factors (24).  
Some have recommended the use of median instead of the average number of citations 
of the journal publications (24). Another suggestion is to calculate an h-index for 
journals as a replacement or complement to IF (24). The concern with the use of h-
index for journals is that this indicator unlike most metrics for journals is size-
dependent, thus journals with more publications are likely to obtain a higher h-index 
(152).  
Another approach that has received more attention is to normalise journal citation 
impact metrics for the differences in citation density and citation behaviour among 
different fields (148). One of these approaches is implemented in the ‘Source 
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Normalized Impact per Paper’ (SNIP), which normalises citation impact of journals 
by their subject and provides the possibility of fair comparisons between journals from 
different fields (219, 220).  
It is also important to mention the attempts to improve journal ranking metrics that 
have resulted in the creation of Eigenfactor and SCImago Journal Rank (SJR) (152). 
Eigenfactor that uses the WoS data aims to take into account the prestige of the citing 
journals (152). This means to add more weight if the citation is received from 
documents in highly-reputed journals, such as Nature and Science rather than coming 
from less known journals. SJR, which relies on Scopus database, uses a similar 
prestige-based approach as Eigenfactor, but also adds credit to journals when they are 
cited in sources with a close scientific theme (221, 222). Indeed, determining the 
prestige of journals is a rather subjective decision, with no clear criteria. 
• Use of journals’ citation impact indicators in research assessment contexts 
The IF and other citation impact metrics for journals are very often used not only in 
the assessment of journals, but also in the assessment of individual publications in a 
journal or in assessment of the authors of articles in those journals. The use of journal-
level metrics for evaluating individual publications is rejected by many (24), because 
the distribution of citations over the publications in a journal is highly skewed, which 
means that the IF or any other journal-level metrics are not representative of the 
citation impact of a single document in a journal. 
The San Francisco Declaration on Research Assessment known as DORA (210), 
which strongly argues against the use of IF in the assessment of individual publications 
and their authors was published in 2012, and ever since, has received a lot of support 
from researchers, academic institutions, and even funding bodies (24). Having said 
that, some would argue that indicators of the citation impact of journals can be useful 
in assessing very recent publications—meaning for publications that there has yet been 
no time for them to receive citation (24). 
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Excluding certain types of publications and citations 
In this section, the main issues that are usually considered in selection processes of 
publications and citations are reviewed. While calculating citation impact indicators, 
some of the publications may need to be excluded (152). Usually, only publications 
from a certain time-period are included, thus a selection is made based on the year in 
which the document was published (152). Another selection of publications is done 
according to the types of documents; e.g. original articles, editorials (152). Similarly, 
not all of citations are necessarily included in bibliometric analyses; they could also 
be excluded depending on certain time-periods after the publication of a document. 
This time-period is often called ‘the citation window’ and is discussed further in the 
following sub-sections. Furthermore, the selection process of citations often addresses 
the issue of self-citations that will be further explained in this section.  
• Document types 
One of the inclusion/exclusion criteria in bibliometric analyses is the type of the 
document. In the WoS and Scopus databases, each publication is allocated to a certain 
document type. Some of the main document types for instance are original article, 
review articles, editorial, letter, or proceeding abstracts. The underlying reason for 
excluding certain types of documents from analyses is that usually there is a significant 
difference in the citation density of different document types (152). Once size-
dependant citation indicators are being used, this does not make a huge problem, 
whereas when size-independent metrics are used, e.g. the average number of citations 
per publication, the variation of citation counts across different document types can 
lead to flawed conclusions. 
• Language 
The next selection criterion is the language of documents. Current literature suggests 
that it is better if non-English documents are excluded from citation analyses, 
particularly in global comparisons of citation performance of countries (152). The 
reason is that non-English publications on average receive fewer citations than English 
publications due to the language barrier. Thus, it is argued that including non-English 
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publications can create a bias against countries where researchers publish a lot in their 
own language (152).  
• Self-citations 
There are also suggestions regarding exclusion of certain types of citations, e.g. self-
citations (152). Self-citations can occur on various levels. For example, on journal 
level, i.e. when a document in a journal cites other documents published in the same 
journal or on institutional level, which is when the publications of an institution would 
cite the publications of authors from their own institution. However, the main focus of 
the literature about self-citation is on the author level, i.e. an author citing his/her own 
previous publications. 
Several studies have shown that on the macro level, i.e. national, regional, and global 
analyses, the effect of author self-citations is very insignificant and there is no need to 
exclude author self-citations on higher levels of aggregation (152). On the other hand, 
for analyses below the macro level, some suggest excluding self-citations, while others 
believe it is better to present both, including and excluding author’s self-citations 
(152). On the micro level, there is no agreement about sensitivity of h-index to author 
self-citations and some have found its sensitivity to be limited, whereas others 
recommend reporting both h-indices including and excluding self-citations (152).  
Although there are strong arguments in favour of excluding self-citations on lower 
levels of aggregation, this could have shortcomings as well (152). For instance, it could 
disadvantage highly specialised or emerging fields as well as research groups who are 
leading larger sub-fields (152). Moreover, excluding self-citation is problematic when 
publications have a large number of authors, such as articles in global genomic or 
epidemiologic projects where there may be even more than hundred authors on one 
paper (152).  
• Citation windows 
In the calculation of citation impact indicators, sometimes only citations within a 
specific time-period after the appearance of a publication are taken into account (152). 
This time-period is often referred to as the ‘citation window’ (152). Using a certain 
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citation window may influence the selection process for both publications and citations 
(152). For example, if an analysis aims to include publications with a citation window 
of minimum five years, then recent publications also should be excluded.  
A large number of studies have intended to find an optimum citation window (152). 
The findings are quite mixed, but some points could be highlighted. Several studies 
have investigated the correlation between shorter and longer citation windows and it 
seems that in most fields they are correlated (152). Perhaps in areas such as 
mathematics or the space research (223) longer citation windows provide better results. 
For instance, an analysis showed that except for publications in mathematics a citation 
window of two to three years is adequate for providing robust citation impact 
indicators (224). Another study has suggested that a citation window of at least one 
full year is essential for all fields (202). The most extensive study performed in this 
regard has concluded that there is generally no applicable rule for choosing citation 
windows (152).  
Another issue in this context is delayed recognition of influential publications; delayed 
recognition refers to the lag time before the importance of a publication is recognised 
(152). One argument that was made based on an analysis of all publications indexed 
in WoS in the sciences from 1980 is that this phenomenon does not have much 
influence on citation impact indicators (152). Finally, there is even evidence showing 
that the documents that are published within the first months of the year are luckier in 
receiving more citations. This is particularly important to consider while choosing a 
very short citation window, e.g. a couple of months (225). 
Limitations of bibliometric methods in research assessment 
While bibliometrics can provide very useful tools to be used in research assessment 
exercises (147, 210), their limitations should be considered. In terms of limitations in 
assessment of research output, firstly, bibliometrics heavily rely on information on 
journal publications, and to some extent books and conference proceedings, and do not 
retrieve information from other categories of research output, e.g. policy briefs, 
clinical guidelines, datasets, software, scientific videos (210), particularly if the 
outputs come in languages other than English. 
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In terms of use of bibliometrics in research impact assessment, clearly, bibliometrics 
fail to track the wider impacts of research, such as on population health, policy, and 
economy (24). Even assessment of scholarly impact using citation-based indicators 
has limitations. Firstly, since most journals ask for a limited list of references, the list 
of cited items that appear on a publication is not a complete list of the scientific sources 
that have influenced the work of the author(s). Secondly, some publications may be 
used and cited in academic materials other than journal publications, e.g. teaching 
handouts (24, 147, 210). 
Excessive reliance on bibliometrics could lead to goal displacement (24, 58, 226). 
Meaning, the final goal could change from being a tool of evaluating whether an 
anticipated level of performance has been achieved to solely trying to attain a high 
score in research assessment exercises (24). Another issue is in relation to the task 
reduction (24). Empirical evidence suggests that enforcing publication of certain types 
of articles can eventually lead academics to spend less time and effort on other 
activities, such as teaching and or communicating research with its end-users, while 
only focusing on publishing in English peer-reviewed journals and mainly on certain 
hot topics (24).  
Comparing bibliometrics and peer review in research assessment 
practices 
As discussed in this section so far, there is an intention to use bibliometrics as 
complementary tools for peer review in different research assessment contexts, 
particularly at large-scale studies which are too expensive and time-consuming if they 
rely only on peer review methods. Nevertheless, many concerns have been raised in 
the literature regarding the use of bibliometricsin research assessment contexts, as 
described in this section thus far. Due to the limitations of bibliometric methods, some 
have attempted to investigate the extent to which the results from bibliometric analyses 
correlate with the results from peer review judgements to see if bibliometrics can 
complement peer review processes. This sub-section will show that most of the studies 
have found a positive, but week correlation, although it depends on the level of 
aggregation and the type of study’s indicator (24). A hypothesis for the underlying 
reason of the imperfect correlation is the variation in peer judgements (24). 
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One study analysed the relationship between bibliometric indicators and peer review 
in evaluating the scientific performance of six research groups in economics (227) and 
found that peer judgments and bibliometric results were generally in agreement (227). 
Another study analysed 56 research programmes in condensed matter physics which 
had led to 5,000 publications and nearly 50,000 citations (228). That study found 
mixed correlations between different bibliometric indicators and the outcomes of a 
peer assessment: the strongest correlation between peer judgments and bibliometrics 
was found on the level of research groups, and the correlation for groups doing basic 
research was stronger than those in applied research (228). 
A study of the relationship between citation analysis and peer ratings of books in the 
field of medical history has also found a high degree of agreement about which books 
are the best (229). Another comparison that found a positive, but weak correlation 
between bibliometric indicators and peer review outcomes in a study conducted at a 
Norwegian university argued that the weak correlation could be due to the 
shortcomings of the peers’ assessments and in the limitations of the indicators (230). 
A more recent study based on an evaluation of 147 chemistry research groups in Dutch 
universities covering the work of about 700 senior researchers showed that the h-index 
related in a quite comparable way with peer judgments (231). However, for smaller 
groups in the fields with ‘less heavy citation traffic’, the h-index seemed to be a less 
of an appropriate measure of research performance. 
A paper published in 2011 has reported the analysis of the relationship between peer 
judgment and a range of citation metrics regarding the impact of researchers in six 
fields of public health in Australia and has shown a moderate positive correlation in 
four of the six fields (232). The authors have suggested the reason that there was no or 
even a negative correlation in other two fields was that in those areas researchers are 
assessed based on other criteria than visibility in the literature.  
Some have compared the results from the Italian qualitative research assessment 
exercise (VTR 2006) with bibliometric indicators (224, 233) and have concluded that 
in natural and formal sciences citation-based indicators were better than the VTR 2006 
peer review in evaluating the quality (24). The major reported advantage of 
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bibliometrics over qualitative assessment was its ability to measure all the output (24). 
Also, in national assessments that use bibliometrics, institutes can avoid submitting 
only a subset of documents, which leads to less error and saves time and costs (24). 
The Italian peer-based VTR 2006 assessment had only managed to process 9% of the 
total output of the country (24). While bibliometrics can provide improved robustness 
and validity in national-level assessments, it fails to capture all scientific outputs (233). 
Another study compared the results from informed peer review—i.e. use of peer 
review and quantitative metrics together—with bibliometrics alone in a random 
sample of 12,000 publications in economics, business and statistics (234). It showed 
that informed peer review and bibliometric analysis produced similar evaluations, 
although they mentioned that the influence of bibliometric information on the 
reviewers should not be overlooked (234).  
In sum, bibliometrics provides helpful tools to inform qualitative judgement processes 
in research evaluation (147, 235). Furthermore, implication of bibliometrics in 
evaluating research performance on higher levels of aggregation has opened a wide 
range of opportunities to researchers, funders, and policymakers (8). Bibliometrics 
enable investigating where research capacity needs to be enhanced and also allows 
monitoring the changes in research activities of different units over time (8, 9, 38). 
However, almost all the studies warn about excessive reliance on bibliometrics in 
research assessment, particularly on lower levels of aggregation.   
1.11.4 Uses of bibliometrics in large-scale research 
assessment practices 
As discussed earlier, bibliometrics are very useful tools to perform large-scale research 
performance assessments. The results of large-scale bibliometric analyses can easily 
investigate trendy topics, collaborations, top institutions, and authors, while could 
identify those who are lagging behind and require further investment or capacity-
building (148). By regional and global analyses of research activity, firstly, the 
countries and institutions that require further attention to enhance their research will 
be identified (236), and secondly, countries and institutions which can serve as strong 
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and capable hubs of research will be recognised (38). Then it would be easier to 
legitimately coordinate the investments.  
One of the early examples of the use of bibliometrics for global research assessment 
has perhaps been the 1997 Science journal article by Robert May, entitled ‘The 
Scientific wealth of nations’ (237). May provided comparisons of scientific research 
outputs among several countries. He retrieved publications between 1981 and 1994, 
mainly from the SCI, and reported that the top 15 countries, ranked by their 
contribution to the world’s total scientific publications, accounted for 81.3% of the 
world's papers. The top seven countries were the world’s seven largest economies at 
the time of study including the US (publishing around 35% of the world’s science, 
receiving  nearly 50% of the total citations), the UK, Japan, Germany, France, Canada 
and Italy (237). May had also matched the number of citations per paper with the GDP 
of countries and had reported a correlation between GERD and average citations per 
paper (237). May had also tried to document the changes in the quality of global 
research publications by using citations per publication and had found India and China 
as emerging scientific nations (237). He showed how bibliometric methods can be used 
for exploring the global patterns of change in research publications. For instance, he 
showed within that 14-year period which he analysed, the world’s scientific 
publication output had increased by 3.7% every year (237).  
Another influential global bibliometric analysis was performed by David King, which 
was published in an article entitled ‘The scientific impact of nations’ (238). Using 
bibliometric methods, the article highlighted the global inequalities in scientific 
productivity by showing that only 31 countries accounted for the top 1% of highly-
cited publications; among the 31 countries, South Africa, in 30th place, was the only 
African nation, and Iran, in 31st place, was the only Islamic country (238). 
Such global studies can also be conducted for analysing the research performance in 
specific fields. One of the fields that attracts attention is medical and health research 
where investments are increasingly high (38). In anticipation of the 2012 WHO Report 
‘no health without research’, which was eventually published a year later, under the 
name ‘Research for Universal Health Coverage’, McKee and colleagues tried to find 
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global gaps in health research using bibliometric methods (236). They used the total 
number of publications indexed in Scopus to indicate how much health research has 
been undertaken by each country (236).  
A recent study which has investigated the public health research capacity around the 
world has proposed using h-index instead of the crude total number of publications 
(38). This study in its methodology has considered some adjustments to minimise the 
limitations of h-index. Particularly, since the h-indices in that study is calculated for 
each country within 5-year intervals, to be more careful in choosing an appropriate 
citation window.   
Large-scale bibliometric analyses have also been performed on regional levels: for 
instance, in different continents, such as Africa (55) and Asia (53), or at national levels, 
e.g. Australia (226), Turkey (239) and Iran (11), just to name a few. Some of these 
studies have investigated the patterns of scientific output changes over time only by 
using basic indicators, whereas some have normalised their results by different 
variables, for instance they have normalised the number of publications, citation per 
paper, h-index by population size, GDP, GERD, number of universities, PhD students, 
or postgraduate programmes. Some of these studies were reviewed in section 1.9.  
1.12 Choosing the appropriate priority-setting method 
1.12.1 Introduction 
As discussed in section 1.7, since the release of the report of the Commission on Health 
Research for Development in 1990, several global initiatives have attempted to address 
the so-called ‘10/90 gap’, mainly by proposing tools and methods that would help 
identifying the research areas where the funders should invest in. The use of these 
methods have been promoted among LMICs during the last three decades, although as 
discussed in section 1.7.1, still, appropriate health research prioritisation exercises in 
many LMICs are non-existent.  
In Iran, several priority-setting exercises have been conducted since the early 1990s 
(240). However, evidence shows that research is yet not guided by the priorities (240, 
241), and it has been reported that Iran still lacks a systematic and inclusive mechanism 
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for health research priority setting (241). To choose the most appropriate health 
research priority-setting method for the purpose of this thesis, I considered a 
combination of: (i) evidence from the literature on health research priority-setting 
methods, as described in section 1.7; (ii) context of Iran, as explained in section 1.10; 
and (iii) the barriers to and the facilitators of health research priority-setting in Iran 
(240). The latter is further described in this section. 
1.12.2 The barriers to and the facilitators of health 
research priority-setting in Iran 
A recent qualitative study, including 23 key informant semi-structured interviews, has 
identified the constraints on setting health research priorities in Iran, as well as the 
factors that can facilitate the process (240). In this section, I will justify choosing the 
CHNRI method as an appropriate health research prioritisation method for improving 
HRS in Iran by addressing how it can overcome the barriers against priority-setting 
processes.  
One of the main barriers to initiating health-research prioritisation exercises in Iran 
has been identified as the rapid turnover of people at executive roles, because it makes 
individuals at such rather temporary positions reluctant to engage with complicated 
and time-consuming processes (240). Furthermore, the rapid replacement, encourages 
those at such positions to invest in projects that lead to achievements rather quickly 
(240). It should be noted that firstly, steps of a CHNRI process are very straightforward 
and simple, and each study could be completed within a few months (34). Unlike other 
prioritisation methods, the CHNRI method does not require reviewing the literature 
for identifying the research gaps, while no meeting arrangements is needed in CHNRI 
studies, as in this method, all the input can be collected through e-mail or other online 
platforms (34). A CHNRI prioritisation process, only requires enough time to allow 
the researchers to generate and score research ideas (34). Secondly, the results of 
CHNRI priority-setting exercises are easy to be understood and used by decision-
makers (43). Particularly, since the end-users of the findings, i.e. policymakers and 
funders, are already engaged with the process from an early stage, communicating the 
findings with them would be fairly quick (43). In sum, CHNRI method is suitable to 
use in the context of Iran, where research directors are changed after short periods, 
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because this method is a relatively simple and quick method and its findings are likely 
to lead to impact, too.  
Another raised concern has been that the majority of research directors in Iran are 
unfamiliar with priority-setting methods (240). The advantage of the CHNRI method 
in this regard is that plenty of published information about the application of this 
method consisting of clear guidance is available in open access journals (34, 35, 42, 
43). Research directors with even limited knowledge of priority-setting methods, can 
easily follow the instructions in the already published CHNRI studies, many of which, 
are fairly recent and updated (42).  
It has been mentioned that one main barrier against the utilisation of health research 
priority-setting results in Iran is that the decision-making process in Iran’s HRS is 
highly centralised and top-down (240, 241). Merit of the CHNRI method to address 
this challenge is that it offers specific ways to engage participants from different levels. 
It collects input from the top (i.e. funders and policymakers who would set the scoring 
criteria) and the bottom (i.e. stakeholders from the wider society who assign weight to 
the criteria and the researchers who would generate and score research questions) (19). 
In this way, since the decision-makers are engaged within the CHNRI process from an 
early stage, they would have a sense of ownership of the results, even though the results 
will not be purely their opinion and will also include opinions of researchers and the 
wider society (19). 
The poor stewardship of HRS, including problems such as weak leadership, and 
insufficient interaction between academia and the end-users of health research, has 
been identified as the major barrier to health research prioritisation in Iran (240). 
Priority setting, per se, improves stewardship function of HRSs, as it guides on how to 
efficiently use the resources to achieve the national health goals (15). Furthermore, 
CHNRI exercises tend to engage the end-users of research within the process: end-
users, including funders, policymakers, and representatives from the industry (e.g. 
pharmaceutical companies) (43). This improves interaction between academics and 
the end-users (43).  
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Another obstacle has been described as the lack of incentives for the researchers who 
are invited to participate in health research priority-setting exercises (240). It has been 
argued that most academics in Iran rather investing time and efforts on activities which 
lead to publications, preferably in journals that are abstracted in international citation 
databases (240). To incentivise participation of researchers in CHNRI exercises, one 
recommendation is to provide co-authorship to the researchers who participate in 
scoring of the research questions, in the publications arising from the exercise (34). 
The studies that use the CHNRI method seem to have a good chance of getting 
published in reputable journals. A review of the first 50 applications of the CHNRI 
method has shown that most of the papers had been published in PLoS Medicine 
(20%), BMC Public Health (14%) and The Lancet (12%) (42). Indeed, authorship will 
be given to the researchers only with their permission, and could either take the form 
of equal co–authorship, or listing under the group co–authorship (34). It should be 
noted that although to improve transparency, the scoring sheets collected from all the 
authors would be published as supplementary material of the original articles, the 
scoring sheets would be anonymised to protect confidentiality of the participants 
regarding the input they provide individually (34). 
It has also been highlighted that perhaps not all the resources should be allocated to 
the priorities (240). The CHNRI exercises do not aim to provide an exact list of 
research questions to be used in research grant calls (19). Instead, this methodology 
allows the funders to see the costs and benefits of investing in each research idea, based 
on the collective wisdom of the participants of that process (19). It even shows how 
the research questions are scored against each criterion (19). Therefore, the results of 
CHNRI exercises would help the funders to predict the potential impacts of investing 
in each area or research question (19). 
Another reported problem of health research priorities in Iran was that the identified 
priorities are often too general, which can basically include any research question (240, 
241). One advantage of the CHNRI methodology is that the researchers are invited to 
generate research questions that are clear and answerable within the time frame of the 
study (34). If any generated research ideas/questions fail at these, the researchers 
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would be advised by and assisted with the management team of the study to improve 
the clarity and specificity of their proposed questions (34).  
Another raised concern in the context of Iran was mentioned to be that many 
stakeholders with decision-making positions would attend the meetings of the 
prioritisation process as a formality, without providing actual ‘intellectual input’ (240). 
The advantage of the CHNRI method in addressing this issue is that as mentioned 
earlier, the CHNRI process only relies on ‘intellectual input’ of the participants and 
does not even involve face to face meetings (35, 43). 
Some Iranian key informants about health research priority-setting argue that the 
community is the main stakeholder in health research, thus despite lacking the basic 
knowledge of research, the community should be involved in health research 
prioritisation processes (240). Others believe that instead of directly involving the 
community during the process, the community should be involved in some surveys 
which their findings would be later integrated into the results of the priority-setting 
exercises (240). The CHNRI method provides a creative way of involving the 
community (35). Since lay people from the community do not hold the knowledge and 
expertise about research, they cannot indeed propose research questions (35). 
However, the community would be invited to allocate weight to the criteria, upon 
which the research questions would be scored (35).  
It has been mentioned that in Iran, in certain types of research, such as participatory 
research, the non-governmental organisations (NGOs) are perhaps better than the 
state-run organisations (240), thus the NGOs should certainly engage with priority-
setting exercises (240). However, the raised concern was that, given the political 
circumstances in Iran, representatives from the NGOs may not feel free to express their 
ideas in experts’ meetings (240). In the CHNRI process, representatives from NGOs 
would be invited and involved through individual correspondence and nobody outside 
the management group of the study would know what input they have provided (35). 
If the participants from the NGOs are researchers, they would be invited to generate 
and score research questions, while if they are not researchers, they could participate 
as stakeholders from the wider society, by adding weight to the criteria (35).  
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It was argued that the consensus-based prioritisation methods that rely on a panel of 
experts suffer from the fact that firstly, a louder voice can influence the others, and 
secondly, once there is a ‘powerful’ person on the panel, the more junior participants 
would not feel free to express their opinion (240). As mentioned, the value of CHNRI 
methodology lies in that, although it seeks consensus of the participants, it collects 
individual input, and anonymise them in a way that nobody outside the management 
team of the study, who according to research ethics would keep the information 
confidential, would know about the individual input of participants (34).   
There is general agreement among Iranian health research priority-setting key 
informants that funders and policymakers should be involved within the process, but 
cautiously (240). In terms of the concern regarding the involvement of the funders, it 
was argued that some funders have a ‘special relationship’ with researchers or would 
only fund the research that could lead to findings that are desirable to them (240). In 
terms of involvement of policymakers, it was argued that their decisions could be 
primarily political rather than scientific (240). These concerns have been tried to be 
addressed by the vast majority of CHNRI implementers; it is recommended that the 
funders and policymakers would not be invited to generate nor score research 
questions (34, 43).  
Another recommendation by Iranian key informants has been to create opportunities 
that the findings of the priority-setting exercises could be further discussed and 
improved through feedback from stakeholders (240). It was mentioned earlier that the 
CHNRI results are recommended to be used as a guide rather than a strict list of 
priorities to fund. The results are simple, thus could be easily provided online and 
different stakeholders are encouraged to discuss them among themselves (34). For 
instance, funders are encouraged to calculate new weights for the criteria and re-rank 
the research questions to adjust them to the needs of their specific group of 
stakeholders (35). 
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Chapter 2 Aims and objectives 
2.1.1 Aims 
The overall aim of my PhD was to obtain a better understanding of the growth of health 
research publications in Iran by describing the evolution of Iran’s health research 
system and understanding the profile of its publications and the key trends in the 
growth to provide policy recommendations for Iran and other LMICs.  
2.1.2 Objectives 
My specific objectives of the PhD were to: 
• Conduct a narrative review of the existing literature by using the WHO HRS framework 
to understand the changes in the following main functions of Iran’s HRS over the last 
50 years: (i) stewardship; (ii) financing; (iii) creating and sustaining resources; and (iv) 
producing, disseminating, and using research.  
• Study the annual number of Iran’s clinical, biomedical, and public health publications 
over 50 years across different areas, and characterise some of the major trends 
• Compute the changes in h-index of Iran’s health research publications over 50 years  
• Identify the h-core papers of Iran’s health research publications in the WoS CC, for the 
period 1965-2014 
• Identify the major contributors to the conduct and publishing of the h-core papers and 
the most common document types and research areas 
• Investigate different types of collaborations among the h-core papers and identify the 
papers that had only relied on Iranian resources 
• Identify the profile of the h-core papers that had only authors from Iranian institutions 
and investigate the origin of citations to these papers 
• Identify Iran’s health research priorities for the next five years by adapting the CHNRI 
method 
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Chapter 3 Evolution of Iran’s health research 
system over the past 50 years: a 
narrative review 
3.1 Introduction 
As reviewed in section 1.3, health research is increasingly regarded as an essential tool 
both for improving population health and for development (1-3). Hence, numerous 
efforts at the national, regional, and global levels have attempted to strengthen health 
research capacity in LMICs (2, 4, 5). Still, most LMICs continue to have limited 
capacity for health research (2, 6, 7). Many have remained largely dependent on 
international academic institutions and donors: on the former for research-relevant 
knowledge and expertise, and on the latter, for financial resources (2, 6, 8). Evidence 
shows that many of the barriers impeding improvement of health research capacity are 
shared across LMICs (as described in section 1.8) (2). Thus, studying the approaches 
that each country takes for overcoming some common obstacles could provide 
important lessons to other LMICs. 
As described in section 1.9.1, a substantial growth in the number of Iran’s health 
research that are published in journals indexed in international bibliographic databases 
over the last few decades has intrigued many international scholars (9). There has been 
clearly a significant evolution in the development of Iranian capacity for health research, 
which has occurred throughout the times of economic, social, and political instability in 
this country, as described in section 1.10. There is a need to explore and explain the 
various stakeholders, institutions, policies, the structure, and incentives in the academic 
community, and funding sources that underlie the observed increase in Iran’s health 
research output.  
3.2 Aim 
The aim of this chapter was to review the existing literature that could provide a better 
understanding of the evolution of Iran’s health research system over the period of the 
past five decades to explore and discuss the key factors and events that have contributed 
to the evolution of Iran’s HRS. 
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3.3 Objectives 
The objective of this chapter was to undertake a narrative review of the existing 
literature and use the WHO HRS framework to understand the changes in the main 
functions of Iran’s HRS over the last 50 years. The HRS functions which I looked into 
included: (i) stewardship; (ii) financing; (iii) creating and sustaining resources; and 
(iv) producing, disseminating, and using research.  
3.4 Methods 
Due to the broad scope of the topic and anticipated heterogeneity of the studies to 
review, a narrative review approach was employed, as it provides a rather 
comprehensive coverage (242, 243). Unlike systematic reviews which enjoy 
established guidelines to ensure rigour of the methods, there are no specific guidelines 
for conducting and reporting narrative reviews (243); in fact, being tied up to strict 
rules is somehow against the nature of narrative reviews (242, 243). Having said that, 
there exists some ‘best practice recommendations’ to improve transparency and 
reproducibility of narrative reviews and reducing selection bias (243). This is mainly 
done by employing an effective bibliographic search strategy and reporting it explicitly 
(243).  
The search strategy and categorisation of the retrieved data in the present chapter were 
informed by the WHO HRS, as described in section 1.5.1 (15). As summarised in 
Table 1, the WHO HRS framework proposes four functions for HRS and a number of 
components for each function. 
I conducted the search in April 2018, through PubMed and Google Scholar. PubMed 
was used to search MEDLINE; relevant MeSH terms in conjunction with ‘Iran’ in the 
Title and/or Abstract were used. Since HRS is a broad topic, semantic searchers - both 
through PubMed and Google Scholar - were also conducted to retrieve further relevant 
publications, either from journals or from the grey literature. In Google Scholar, no 
difference was found between the number of search results for ‘Iran’ and ‘Iran’. Hence 
I only used one variant; I used the term ‘Iran’ in conjunction with relevant terms based 
on the four functions of the WHO HRS framework. In PubMed, all the search results 
were included. In Google Scholar, the results were sorted by relevance and the 
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inclusion of the search results was continued until it became clear that the listed results 
were no longer relevant. Full details of the search strategy are provided in Table 2. 
After removing the duplicates, 805 sources of information remained. After scanning 
the titles and abstracts, I found 536 of the records irrelevant and excluded them. Then, 
I scanned the full-text versions of the remaining 269 records. In the end, 204 records 
were retained as relevant to this narrative review which I reviewed in detail. All types 
of documents with available full-texts (either in English or Persian) were included.  
The included 204 records were organised within Endnote (a reference management 
software) into the following categories: (i) financial, human, and infrastructural 
resources; (ii) knowledge networks and collaboration; (iii) 
medical/research/publication ethics; (iv) HRS monitoring and evaluation; (v) research 
priority-setting; (vi) national vision and agendas for health research; (vii) research 
output (general); (viii) bibliometric analyses; (ix) quality of publications; (x) 
disseminating and using research; and (xi) Iranian journals. I made this categorisation 
following my initial familiarisation with the themes covered by each record while 
guided by the HRS framework. After further familiarisation with the data, I categorised 
the reviewed information into groups as described in Table 3.  
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Table 2 Search strategy for the narrative review of Iran’s health research system 
Search through PubMed 
1. (‘Bibliometrics’[Mesh]) AND iran[Title/Abstract]  
2. (‘Ethics, Research’[Mesh]) AND iran[Title/Abstract] 
3. (‘Research’[Mesh]) AND iran[Title/Abstract] 
4. (‘Scientific Misconduct’[Mesh]) AND iran[Affiliation] 
5. (‘Periodicals as Topic’[Mesh]) AND iran[Title/Abstract] 
6. (‘Translational Medical Research’[Mesh]) AND iran[Title/Abstract] 
7. ((‘research system’ OR ‘research policy’)) AND iran[Title/Abstract] 
8. (‘research capacity’) AND iran[Title/Abstract] 
9. ((‘research output’ OR ‘research product’ OR ‘research growth’ OR 
‘scientific growth’ OR ‘scientific output’ OR ‘scientific product’)) AND 
iran[Title/Abstract] 
10. ((‘research evaluation’ OR ‘research assessment’ OR ‘academic assessment’ 
OR ‘academic evaluation’)) AND iran[Title/Abstract] 
11. ((‘research quantity’ OR ‘research quality’ OR ‘research impact’)) AND 
iran[Title/Abstract] 
12. ((‘scientometrics’ OR ‘scientometric’ OR ‘bibliometrics’ OR 
‘bibliometric’)) AND iran[Title/Abstract] 
13. ((‘research network’[Title/Abstract] OR ‘research 
networks’[Title/Abstract])) AND Iran[Affiliation] 
14. (knowledge transfer[Title/Abstract]) AND iran[Affiliation] 
15. ‘plagiarism’ AND ‘Iran’ 
Search through Google Scholar 
1. ‘iran’ AND ‘medical research’ 
    Up to 50 pages 
2. ‘iran’ AND ‘health research’ 
    Up to 15 pages 
3. ‘iran’ AND ‘research assessment’ 
    Up to 10 pages 
4. ‘iran’ AND ‘research evaluation’ 
    Up to 10 pages 
5. ‘iran’ AND ‘research priority’ 
    Up to 12 pages 
6. ‘iran’ AND ‘research capacity’ AND ‘medical’ 
    Up to 11 pages 
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Table 3 The categorisation of the retrieved data on Iran’s health research system 
Stewardship 
• Structure and vision for governing health research 
• Identification of health research priorities and coordinating adherence to them 
• National-level ethical oversight 
• Monitoring and evaluating HRS 
Financing 
• Gross Domestic Expenditure on Research and Development (GERD) 
• % of Research and Development (R&D) allocated to health 
• % of health budget allocated to research 
• Source of the research budget 
• Mechanisms for distributing funds 
• Mechanisms for tracking the investments 
Creating and sustaining resources 
• Figures for human and infrastructural resources 
• Capacity building – outcome and the barriers to research activities 
• Collaboration 
Producing, disseminating, using research 
• Number of research outputs, e.g. research papers, books, patents 
• Figures for Iranian journals 
• Figures for citation-based indicators 
• Underlying reasons for the growth of Iranian research publications 
• Knowledge translation and research impact 
3.5 Results 
In this section, I will present the information which I obtained about different 
components of Iran’s HRS since 1970 from the 204 reviewed documents.  
3.5.1 Stewardship 
Structure and vision for governing health research 
Several organisations in Iran are actively involved with health research policy-making, 
either directly or indirectly (244): (i) The Parliament; (ii) The Supreme Council for 
Cultural Revolution; (iii) The Department of Research and Technology of MOHME; 
and (iv) The Plan and Budget Organisation (i.e. responsible for compilation of the 
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annual budget) (244). The Department of Research and Technology of MOHME, and 
(to a lesser extent) the research departments of the medical universities across Iran, are 
responsible for executive planning of the policies to achieve the national health 
research policies (244).  
A national evaluation of different functions of HRS in Iran, which was published in 
2004 (244), indicated that although an elaborate system existed in Iran to undertake 
the different operational components of the function ‘stewardship’, a clear articulation 
of the vision and the goals of health research was absent (244). Later on, in 2009, a 
panel of Iranian experts drafted a ‘national scientific plan’ for health, which outlined 
Iran’s long-term plan by 2025 (245). The plan was based on the Islamic-Iranian values, 
an agenda known as Iran’s Vision for the year 2025, and the general concepts of the 
National Innovation System (245). This national scientific plan outlined Iran’s national 
vision, goals, monitoring and evaluation indicators, priorities, policies, and strategies 
for health research (245). 
No information was found in the reviewed literature about the extent to which this 
national scientific plan for health had been followed. It was suggested, as a general 
conclusion, that perhaps too often the policies are not well implemented in Iran. This 
may be explained in view of the following constraints (244): (i) inconsistency in 
policies; (ii) instability in administration; (iii) limited alignment of policies and 
available facilities; (iv) lack of communication between researchers and policymakers, 
and (v) the absence of suitable implementers for the policies (244). Regarding the 
latter, many of the people at executive roles who should implement the policies seem 
to lack the necessary skills to fulfil their responsibilities. For example, an assessment 
of individuals in research management positions at 39 Iranian universities of medical 
sciences found that 40% of them lacked adequate research management skills (246).  
Identifying health research priorities and coordinating adherence to 
them 
According to the literature (244), four national-level health research prioritisation 
exercises have been conducted in Iran. The first two, had been undertaken by the then 
National Research Council, one exercise in 1993, and another one on three separate 
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occasions in 1991, 1995, and 1999. The last two exercises, were carried out by the 
Department of Research and Technology of MOHME (in 1996 and 2010-2011) (244). 
The first three exercises had followed the COHRED (244), as COHRED proposes a 
process for national-level exercises to show essential steps for priority-setting 
processes (28). The last exercise had used the ENHR method and had involved all the 
universities of medical sciences affiliated with MOHME (247): local research 
priorities were identified by the universities who had also engaged stakeholders within 
the process. In this last exercise, a total number of 9,607 research ideas were gathered 
from the universities, which after excluding the irrelevant ones were reduced to a list 
of 6,723 ideas as ‘research priorities’. The research ideas were categorised into nine 
main areas, e.g. communicable and non-communicable diseases, basic sciences, and 
health systems research (247, 248).  
In terms of institutional-level priority-setting for health research, 45 Iranian medical 
universities and 53 research centres were surveyed for their status of health research 
priority-setting in 2002 (244). Twenty-eight of the universities had conducted at least 
one exercise (244). Those that had not carried out any had stated that their research 
priorities were the same as the ones identified by MOHME (244). Of the 53 surveyed 
research centres, 21 had never conducted any priority-setting, and 8 had based 
priorities upon the health research system’s problems (244). Fifteen out of 25 
executive departments in the health system had conducted a priority-setting exercise; 
the remaining 10 had indicated that their priorities corresponded to those set by 
MOHME (244). The prioritisation exercises had followed COHRED guidelines with 
some modification (244). Over the last 10 years, several priority-setting exercises had 
been undertaken in Iran in different areas of health research, and on different levels of 
national, institutional, or regional, as summarised in Table 4 in.  
Table 4 Health research priority-setting exercises in Iran over the last 10 years 
Number Year 
Brief description of the retrieved health research priority-setting 
studies 
1 2008 
COHRED approach was used to set research priorities in infectious 
diseases (249). All of the participants were from one university. The 
study identified 99 ‘research priorities’ in 25 areas with HIV/AIDS, 
tuberculosis, and drugs being on top.  
Describing the evolution of Iran’s health research system, understanding the profile of its publications 
over 50 years, and setting the national health research priorities  
 79 
2 2009 
To identify priorities in oncology nursing research, Delphi method was 
used during a regional conference although the study only involved 
Iranian nurses (250). Among the 35 proposed areas, the top-3 priorities 
were as follows: (i) psycho-socio-economic impact of cancer diagnosis 
on family members; (ii) oral care in patients receiving chemotherapy; 
and (iii) nutritional needs of cancer patients.  
3 2010 
A modified version of COHRED was used to set research priorities at 
an institutional level by engaging 610 faculty members and 220 
stakeholders (251). A total of 841 research areas and 1,900 research 
options were identified as ‘priorities’.  
4 2010 
An institutional-level study used COHRED to set priorities in a 
research centre of paediatric surgery (252). It identified 7 areas of 
research and the highest priority was trauma in children, followed by 
paediatric cancers.  
5 2011 
Iran’s research priorities to reduce burden of cancer were identified 
(253) by inviting cancer experts from all across Iran to rank a list of 
topics in cancer research based on the criteria of being necessary, 
appropriate, practical, and yielding in the Iranian societal context. An 
electronic system of communication was developed and all scientists 
were asked to rank each topic from 1 to 5. The results highlighted the 
need for prioritising studies on infrastructure of cancer control 
programmes, cancer registration, service delivery, and patient quality 
of life. 
6 2011 
The research needs of a health insurance organisation was investigated 
through semi-structured interviews with 60 healthcare professionals 
who worked in clinical settings affiliated with the organisation (254). 
Twelve research topics were proposed, among which ‘Designing 
standard treatment protocols’ scored highest.  
7 2011 
A Delphi study was undertaken for setting priorities in Health Systems 
Research at an institutional level for each of the departments of a 
medical university (255). A total of 89 research areas were identified 
in their study which the top priority for each department varied.  
8 2011 
Research priorities in healthcare services were set using semi-
structured interviews with patients who received services at three 
hospitals (256). Thirteen research topics were identified of which 
studying the payment models that vary based on the patients’ income 
and access to services was found as the top-priority.  
9 2012 
Research priorities in medical education for the countries in the EMR, 
including Iran were identified (257). Using Delphi method a list of 20 
research areas was proposed, of which the top area was ‘training 
physicians to be effective teachers’.  
10 2012 
A national-level study used the Delphi method for identifying priorities 
in medical education research (258). A total of 50 research topics were 
ranked in this national-level study of which the topic ‘methods for 
promoting faculty members’ capabilities’ was identified as the top 
priority for further study.  
Describing the evolution of Iran’s health research system, understanding the profile of its publications 
over 50 years, and setting the national health research priorities  
 80 
11 2013 
Iran participated in a research prioritisation exercise, coordinated by 
the WHO Alliance for Health Policy and Systems Research (259). The 
exercise identified research priorities for LMICs in health policy and 
systems research in the areas of access to medicines and used a mix of 
literature review, interviews with stakeholders, and reaching 
consensus. Eighteen research questions were formulated and ranked 
according to four criteria (innovation, impact on health and health 
systems, equity, and lack of research). The top research question was: 
‘In risk protection schemes, which innovations and policies improve 
equitable access to and appropriate use of medicines, sustainability of 
the insurance system, and financial impact on the insured?’.  
12 2014 
Research priorities in the field of patient safety in Iran were identified 
through a Delphi study where 45 research questions were rated and 
grouped (260). 
13 2014 
To identify the institutional-level health research priorities, the 
following methods were used: (i) semi-structured interviews with 
managers at a healthcare centre, (ii) questionnaires; and (iii) analytic 
hierarchy process for ranking the criteria (261). This led to 191 
research titles (as priorities) across seven themes.  
14 2015 
Using COHRED, institutional-level research priorities were identified 
for a research centre and a total of 31 research areas were identified as 
priorities (262). 
15 2015 
Health research priorities were set for one medical university by firstly, 
extracting a list of research areas from the goals and targets listed in 
macro policies, and secondly, inviting eight health research experts to 
rate the research areas based on COHRED criteria (263).  
16 2016 
Nominal Group Technique and Delphi were used to identify research 
priorities in the field of medical education at one medical university: 
Medical Ethics and professionalism gained the highest scores (264).  
17 2016 
A national-level study (265) invited experts to a workshop and asked 
them to list their suggestions for preventing invasive cervical cancer in 
Iran. After merging similar items and removing the duplicates, the 
experts were asked to rank the list of research suggestions. From the 
total of 26 suggestions, priorities were: developing national guidelines 
for cervical screening, and quality control protocol for patients’ follow-
up. 
18 2016 
Another study conducted a systematic review on published 
epidemiologic Iranian studies in HIV/AIDS and reported the 
knowledge gaps as research priorities (266). 
19 2017 
Delphi method was also used to determine health research priorities in 
occupational health in Iran (267). It engaged 22 research centres across 
Iran and proposed that research in musculoskeletal disorders and 
injuries should be prioritised in Iran.  
In 2002, a study commissioned by the WHO (244) attempted to define how research 
priorities were being identified in Iranian medical universities, in their affiliated 
research centres, and executive departments. Moreover, it studied how different 
stakeholders contributed to the processes, what information sources were used, how 
consensus was achieved, and what criteria were applied to set priorities (244). The 
Describing the evolution of Iran’s health research system, understanding the profile of its publications 
over 50 years, and setting the national health research priorities  
 81 
study concluded that ‘qualitative and quantitative techniques have not been used in 
these settings [Iran] and the criteria used were diffuse; the one most frequently used 
was feasibility’ (244). It has also been mentioned that the attempts for setting health 
research priorities in Iran have so far been mainly relying on the opinion of experts 
(246).  
In a qualitative study that investigated the barriers to evidence-based decision-making 
in Iran’s health system in 2012, participants identified the following challenges: (i) 
absence of a systematic prioritisation mechanism; (ii) priorities being set by MOHME 
and not being communicated with academics; and (iii) priorities being too general that 
fail to guide researchers (241). Another paper had looked into research projects that 
were approved between 2005 and 2007 by an Iranian university (Golestan University 
of Medical Sciences) and had found that half of the researchers had chosen the topic 
of their studies according to their ‘personal interest’ (268). Finally, a bibliometric study 
mapped the number of research publications in Iran against the burden of disease in 
the country and found that the publications did not seem to be aligned with the disease 
burden (269). 
I could not find any study that had matched the investments in health research with 
research priorities. However, MOHME had stated in 2013 - drawing on the data 
collected for the annual evaluation of academic performance of medical universities 
in Iran - that 70% of research projects undertaken at universities were in line with their 
institutional-level priorities (270). It was also reported that the topic of 60% of the 
projects conducted in 2007 in Iranian medical universities was aligned with their 
institutional priorities (271). Nonetheless, adherence to the priorities would matter 
only once the priorities are identified through systematic, inclusive, and transparent 
processes. 
National-level ethical oversight 
In terms of introducing guidelines and regulations regarding medical and biomedical 
research ethics, Iran has made significant progress over the last 25 years (some major 
activities are summarised in Table 5). While until the mid-1990s, not much attention 
was directed towards ethical aspects of medical research in Iran, in the late 1990s, a 
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paradigm shift seemed to have happened (272); some reasons to explain this were 
suggested, and they will be presented in further text. 
Shortly after the release of the first revision of the Declaration of Helsinki (in 1975), 
Iran went into a turbulent decade: the Islamic Revolution took place in 1979, followed 
by the Iran-Iraq war (1980-1988) (272). The urgent challenges that Iran was facing 
during the 1980s and the early 1990s did not allow implementation of the 
recommendations of the Helsinki Declaration (272). Additionally, following the war 
in which Iraq seemed to be backed by the West against Iran, a period of hostility 
between Iran and the West began, which resulted in Iran’s isolation, even from the 
international scientific community (273). It is suggested that this could be a reason that 
the Iranian academics who were trained during that period became rather unfamiliar 
with the international research standards (273). This meant that, until the mid-1990s, 
not only had Iran lacked essential resources to move towards improving research 
conduct but also there may not have been a sufficient interest in this progress. It is 
even argued that perhaps the long history of medical sciences in Iran, along with the 
stress placed on cultural values and religious beliefs in the country, had undervalued 
the need for a new set of ethical standards (244, 274). 
However, when Iran began to publish its research output in international journals, the 
need for aligning activities with international research standards became lot more 
apparent (272). For instance, international journals requested Iranian authors to 
provide information about the ethical considerations of their research upon submitting 
manuscripts for publication (272). Furthermore, addressing ethical issues became 
particularly important in biomedical research, where some new areas, e.g. stem cell 
research, were emerging in which Iran could potentially pioneer (272, 275).  
Finally, in the late 1990s, some leading medical researchers in Iran called for an urgent 
action towards addressing ethical aspects of health research in Iran. In their 1999 paper 
(272), the need for attention to medical research ethics was highlighted by focusing on 
the poor status of ethics in clinical trials. The study (272) had assessed 51 clinical trials 
conducted in Tehran University of Medical Sciences (TUMS), i.e. the leading Iranian 
medical university—presumably having a better performance than the rest—between 
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1995 and 1998. Only one had mentioned ‘ethical considerations’ in its proposal and/or 
final report; in only six of the 51, human subjects were informed that they were 
participating in a research. Obtaining informed consent was mentioned in only four of 
the reports; 13 of the trials had used placebo while in 10 of them the participants were 
imposed to some risks without having been informed that they might receive placebo. 
In more than 80% of the trials, the participants had even paid for the intervention, 
because they thought those were part of their treatment (272). 
As evidence of the progress that has taken place since then, a survey of ethics 
committees of the Iranian medical universities reported that in 2011 all the universities 
had ethics committees (with 5 to 11 members each); 95% of the committees had a 
template consent form to provide to the researchers; all would have reviewed research 
that involved human participants; and in half of the universities, non-compliance with 
the regulations would have led to penalties (276). Another study reviewed grant 
applications that had been approved at one university (Urmia University of Medical 
Sciences) during 2003-2008 (277). Eighty percent of applications for conducting 
clinical trials had included informed consent. Of the total 324 applications (including 
all types of research), 85.5% had addressed ethical considerations (277). 
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Table 5 Activities for promoting medical ethics, including medical and biomedical research ethics in 
Iran 
Year Major activities for promotion of medical ethics 
1993 
MOHME supported the establishment of a research centre focused on 
medical ethics: Medical Ethics Research Center—MEHRC. In the same year, 
the centre held the first international conference on medical ethics in Tehran, 
which saw the collection, organisation, and categorisation of a number of 
scientific publications on medical ethics, and the publication of proceedings 
of the conference (244, 278). Over the following years, MEHRC continued 
promoting medical ethics by holding numerous seminars and courses for 
health care professionals and academics (244, 278). The centre has published 
several books, including a comprehensive textbook of medical ethics that is 
used in Iranian medical schools (244).  
1997-1998 
National Committee of Ethics in Medical Research was formed in MOHME 
to: (i) apply Islamic, legal, and moral principles to medical research; (ii) 
guard human rights and legally protect the participants, the researchers, and 
the institutions involved; and (iii) promote mandatory inclusion of advisors 
on ethical issues in all research projects at universities, private research 
foundations, and industries (279).  
1999 
Committees of Ethics in Medical Research were formed at the institutional 
level to monitor the alignment of research that is conducted at universities of 
medical sciences and biomedical research centres with the national and 
international ethics principles (244, 248). The committees were asked to 
follow a uniform guideline, which was written by the Department of 
Research at MOHME (280). Also, research ethics courses have been held 
periodically to train the ethics committee members at the universities (281). 
2000 
MEHRC took the initiative to enact a code of medical research ethics (244). 
Preparation of these codes was done through a 1.5-year project consisting 46 
national ethics committee meetings at MOHME through: (i) a comprehensive 
review of international codes of ethics, e.g. the Helsinki Declaration and 
documents of the Council for International Organizations of Medical 
Sciences (CIOMS); and (ii) customising the international standards for the 
context of Iran (278, 282). To better understand the context of the Iranian 
society regarding research ethics, a national survey was conducted, and also 
the relevant codes in religious laws in Shia (the official religion in Iran) were 
further reviewed (274, 280). Finally, a code of practice of 26 principles was 
established for research that involves human subjects (244). Examples of the 
codes were requirement of informed consent; the need to review the risks and 
benefits of each study; protection of participants’ rights; confidentiality of 
participants’ information; compensation for injury; and preservation of the 
rights of foetus, prisoners, and individuals with mental illnesses (274). 
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2002 
The Department of Research and Technology of MOHME initiated 
compiling a strategic plan for medical ethics activities in Iran (278). The plan 
covered areas from management, regulations, education, and training to 
monitoring and assessment of medical ethics activities at the national level 
(278). The year 2002 was particularly crucial for biomedical research in Iran, 
because in that year, Iran’s Supreme Leader, Ayatollah Ali Khamenei, 
released a religious decree (fatwa) in which experiments using human 
embryonic stem (hES) cells were permitted under special circumstances 
(283). Finally, because in the 26-item codes of medical research, the ethics 
codes for genetic studies were minimal, some Iranian researchers in 2002 
initiated reviewing of the world literature about ethical standards for genetic 
studies to investigate how they could be adapted for the Iranian context (280).  
2005-2006 
After rigorous reviewing of relevant literature both on ethics and religious 
principles, Specific National Ethical Guidelines for Biomedical Research 
were drafted jointly by (i) MEHRC, (ii) Department of Research and 
Technology of MOHME, and (iii) the Endocrinology and Metabolism 
Research Center of TUMS (278). The draft was revised by a group of experts 
in law, ethics, and medicine as well as the religious authorities (281). Then, 
the revised guidelines were reviewed, approved, and ratified by the Iranian 
Parliament and the Guardian Council of the Constitution, and were delivered 
to all the medical universities and research centres (281, 284). The guideline 
included 22 items, addressing clinical trials; research involving vulnerable 
groups; genetic research; research on gamete and embryo; transplantation 
research; and research on animals (278). It prohibited production of human 
embryos for research purposes or production of human-animal hybrids, and 
eugenics (283). 
It is of much interest to understand how the processes that have led to the compilation 
of guidelines in medical and biomedical research ethics in Iran had been facilitated. 
The literature primarily highlights the pivotal role of one person in this regard: 
Professor Bagher Larijani, one of the former chancellors of TUMS who also founded 
MEHRC (272). It is argued that the reason why Professor Larijani was able to initiate 
and successfully lead discussions surrounding ethics in medical and biomedical 
research, which is a potentially sensitive issue in most countries (280, 285), is that not 
only he is a prominent medical practitioner and leading researcher in Iran but also he 
came from a highly religious and politically influential family; his father was a 
religious authority and his brothers have always held important decision-making 
positions in the Islamic Republic of Iran (272). Therefore, Larijani could use the 
confidence that Iranian authorities had in him as an opportunity (272) and he played a 
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crucial role in (i) developing medical ethics guidelines in Iran; and (ii) promoting the 
activities of MEHRC both among the policymakers in the health system and among 
the Islamic scholars (284). Another facilitator of the improvements was suggested to 
have been the support of political and religious leaders (281). It was assumed that this 
support could have had partly originated in their interest in advancing Iran’s 
international rank based on science and technology indicators (284).  
In terms of the advances, the literature shows that not only Iran has significantly 
progressed in terms of the development of national medical and biomedical research 
ethics guidelines and has promoted their use through trainings and by introducing 
regulations but also research ethics of a diverse range of specific issues have been 
discussed by Iranian scholars over the past years. For example, ethical aspects of 
involving Iranian female participants (274); ethical evaluation of research projects that 
are funded by international organisations (286); ethical issues in clinical trials (287); 
or research on laboratory animals (288, 289) are all discussed in the literature.  
Steps have also been taken towards promoting integrity in research publications. It was 
mentioned in 2012 that the number of Iranians who were members of the Committee 
on Publication Ethics (COPE), World Association of Medical Journal Editors 
(WAME), and or European Association of Science Editors (EASE) has substantially 
increased (11). Even a survey of 27 Iranian medical journal editors in 2001 had 
indicated that the majority had an average to high knowledge of the Uniform 
Requirements for Manuscripts Submitted to Biomedical Journals (290). Moreover, it 
had been pointed out that in 2011 the first scientific congress of the Iranian Society of 
Medical Editors was held in Iran, in collaboration with COPE and with a focus on 
‘publication ethics’ (291).  
In addition to this, several Iranian journals have been trying to raise awareness among 
academics about research integrity and publication ethics in recent years (292-295). 
For example, a paper depicted several examples of good practice (e.g. obtaining 
permission before reproducing figures protected by copyright) and examples of 
research and/or publishing misconduct (e.g. data fabrication, ghost and guest 
authorship) followed by relevant recommendations based on COPE guidelines (296). 
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The examples were from papers authored by faculty members of a large Iranian 
university (Mashhad University of Medical Sciences) that had been published in the 
journals owned by the same university (296). Finally, some universities, e.g. Shiraz 
University of Medical Sciences, had not only been providing short courses on 
publication ethics but also had been offering a MS programme on medical journalism 
since 2008 (297).  
Despite such efforts, the literature still calls for greater attention towards research 
integrity and publication ethics in Iran. In 2008 and 2009, the journal Nature reported 
several cases of retraction of publications by Iranian senior officials, albeit outside 
medical fields, due to evident plagiarism (298). A recent paper has identified the 
retracted papers from Open Access Journals in MEDLINE and has indicated that the 
majority of the retracted publications were authored by researchers affiliated with 
institutions in China (n = 199), India (n = 83), US (n = 75), and Iran (n = 50) (299). It 
was reported that in 2016, 28 retractions from Iranian authors were the result of 
compromising the peer-review process, plagiarism, and authorship disputes (299). An 
investigation of the prevalence of publication misconduct in the papers published in 
Iranian journals indexed in Scopus database during 2009-2011 reported guest 
authorship (18.10%) and falsification of the methodology (12.65%) as the most 
common types of misconduct (300). Another study reported that nearly 26% of 
postgraduate students who graduated from one of the medical schools in Iran in 2015 
had done some sort of research misconduct (including plagiarism, fabrication, or 
falsification of data) in their theses (301). In 2009, an Iranian medical journal studied 
a sample of 80 of the manuscripts received by their journal and found that 55% of the 
manuscripts had at least one plagiarised sentence (294).  
The findings of a survey in 2012 described the knowledge of medical students at 
TUMS about plagiarism and self-plagiarism as very low (302). It was reported in 
another survey that nearly 10% of students at TUMS were not even aware that using a 
copied paragraph from a textbook or a web page in their academic writing is 
unacceptable (303). As for postgraduates, a recent study has analysed the curricula of 
125 postgraduate programmes in medical sciences in Iran and has found that only 53 
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programmes (42%) contained ethics training, of which only 17 had specific courses on 
research ethics, and even that was an elective subject in 25% of the programmes (304). 
Although it had been thought that medical ethics education had been improved by the 
launch of MPH (Master of Public Health) courses in 2004 as the programme includes 
medical ethics subject (278), an assessment of the knowledge of plagiarism did not 
find a significant difference between the students who were only doing medicine with 
those who had also been enrolled in MPH courses (303). It is likely that the course 
does not sufficiently address ‘publication ethics’. A survey of 198 students found that 
medical interns (medical students during the last two years of their studies) seemed to 
know more about plagiarism than the sub-specialty residents (305).  
Several reasons for the emergence of publications containing research/publication 
misconduct were proposed in the literature as follows: (i) inadequate knowledge of 
plagiarism and of the regulations in place to deal with cases of plagiarism (273, 294, 
302, 303, 305, 306); (ii) poor English language skills and limited writing skills that 
could lead to plagiarism (273, 297, 303, 306); (iii) requiring faculty members to have 
publications for academic promotion (67, 273, 294); (iv) requiring PhD students to 
have publications before graduation (67, 273); (v) requesting certain academic degrees 
from people who apply for political positions (307, 308); (vi) installing powerful 
people as the heads of research centres may have led to guest authorships (309); (vii) 
limited budget that cannot cover all research costs (67); (viii) as a result of the rapid 
development of postgraduate programmes, some individuals have quickly become 
faculty members, without having been properly trained to mentor students in research 
(273); (ix) replacement of competent academics in Iranian universities by less 
qualified faculty members who were unaware of research activities and ethical 
regulations (307); and (x) limited interaction between the academics and other sectors, 
leading to insufficient awareness of academics about the final goal of research, i.e. 
filling the knowledge gaps to address the problems, rather than solely leading to 
publications (273).  
Monitor and evaluate health research system 
In 2000, the Department of Research and Technology of MOHME initiated an annual 
evaluation of research activities of all the universities and research centres affiliated 
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with MOHME (271); currently including 58 universities of medical sciences and 736 
research centres (310). The results of the evaluation of each institution used to be 
reported to them as a written feedback, while since four years ago, the results have 
been sharing online (248). The strengths and the weaknesses of the academic 
performance at the levels of national and institutional are summarised through these 
evaluations which become the evidence to inform decision making at MOHME and at 
the institutions towards improving health-related research activities (311). 
In this evaluation system that was initially designed based on the WHO HRS 
framework, research activities are assessed and scored against indicators across three 
domains: (i) capacity building; (ii) knowledge production; and (iii) stewardship (in 
recent years, this domain has been renamed to ‘leadership’) (270, 271, 312). Although 
the indicators are revised every year based upon the feedback received from research 
directors of the universities and research centres (311), they generally continue to 
include the following points described below. 
For the assessment of capacity building in each institution, the indicators include the 
number of: (i) research training courses provided to the academic staff; (ii) national 
and international organised conferences; (iii) awards that had been achieved by the 
staff/students at science festivals; (iv) status of the amount and the visibility of the 
institution’s Web contents; and (v) the status of Student Research Committees (SRCs) 
(313). The second domain, i.e. Knowledge production, is evaluated by the number of: 
(i) journal publications (the scores allocated to the publications vary according to the 
databases where the publications are abstracted, e.g. in Scopus, Web of Science Core 
Collection); (ii) abstracts presented at national and/or international conferences; (iii) 
published books; (iv) patents; (v) completed research projects that their results had 
been applied in the health system; and (vi) citations to the published papers in 
textbooks and peer-reviewed journals (271). Stewardship domain includes the 
following: (i) having had identified institutional-level research priorities and the status 
of adherence to them; (ii) having a 5-year strategic plan; and (iii) having an active 
ethics committee (270). 
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The universities have been categorised into three groups, and they are ranked within 
each group based on the total score they receive from the three domains mentioned 
above (271). The criteria for grouping the universities were not clearly defined in the 
literature, although it seems to be according to the universities’ general size, without 
further definition (312). In the first years since the evaluation was introduced, the 
scores used to be adjusted by the amount of core funding and the number of academic 
staff at each university (271, 312). In recent reports, the scores do not seem to be 
adjusted anymore (271, 312). Furthermore, according to the literature, institutions used 
to receive scores for collaborative research with industry and/or the governmental 
organisations and for multi-centre projects (244); these seem to have been removed in 
the recent evaluations, although international collaboration still contributes with 
additional points (270, 311). Several citation-based indicators had been added to the 
assessment of ‘knowledge production’ domain in recent years, e.g. citation counts per 
paper, h-index of institutions, or impact factor of the journals where the papers had 
been published (312).  
Although this system has allowed the annual evaluation of health-related research 
activities in Iran, it has been criticised for its over-reliance on quantitative indicators; 
lacking qualitative evaluation by a panel of experts (314); and minimal attention to 
research outcome and impact (315). A pilot study in 2015 (315) attempted to include 
assessment of the impact and the quality of research activities in the evaluation of 
research centres. It evaluated research activities of 5 biomedical and 3 clinical research 
centres using a peer-review approach (315). Indicators were designed for four 
domains: governance and leadership, structure, knowledge production, and research 
impact. The implementers of that pilot study concluded that peer-review model would 
work for the evaluation of research output, outcome, and impact of medical research 
centres in Iran (315).  
3.5.2 Financing 
The reviewed literature generally suggests that investing in health research has not 
been a priority in Iran. This is reflected in Iran’s Gross Domestic Expenditure on 
Research and Development (GERD). Iran’s GERD for nine specific calendar years 
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were found in the reviewed literature: it ranged between 0.31% (in 2011 and 2014) 
(316) and 0.75% (in 2007) (6, 314, 317). Although GERD has remained limited, the 
annual budget that MOHME had been allocating per research centre had increased 
more than 80 times between 2001 and 2014 (from 4.8 million to 387.5 million Iranian 
rials per centre) (318). It was also reported that the amount of research budget per 
academic member in institutions affiliated to the government had increased by five 
times between 2002 and 2010 (270). However, these two reports of the increase should 
be considered cautiously as the amount of investments was not adjusted by the annual 
inflation rate. 
It is also important to note what proportion of GERD is allocated to health research. 
This figure had decreased from 8.9% in 1999 to 7.6% in 2001 (244). Another 
publication in 2001 had reported that 5% of GERD was invested in health research 
(317). Regarding the proportion of GDP that is allocated to health research, the figures 
ranged between 0.01% to 0.05% between 1991 and 2001 (17), while funding for health 
research as a proportion of the total health care budget was 0.9% and 2.5% in 1991 
and 2001 (244).  
No information from the recent years was found in the reviewed documents. It was 
suggested that the integration of medical education and health research with health 
care services, which took place in 1985 (as described in section 1.10.5), may have 
shifted resources away from research to service provision (113). In the short term, the 
integration has led to the training of a substantial number of healthcare professionals 
and development of health services across various parts of the country, particularly in 
deprived areas (114). However, evidence shows that the curriculum of the programmes 
provided in the universities of medical sciences have not become oriented around the 
needs of the nation (319, 320). Moreover, in the long term, the integration has 
increased the universities’ workload and responsibilities. It is reported that universities 
now invest more time and resources on providing service than on research and 
education (113). 
Some minor progress has been made in financial aspects of health research in Iran. For 
instance, since 1996, GERD began to be specified in Iran’s annual national budget 
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plan, which has relatively improved transparency in financing and has allowed 
monitoring the investments in research (317). Furthermore, several papers have 
reported that, in recent years, some major macro-policy documents had set targets for 
substantial rises in R&D expenditure, although the targets were not eventually met 
(316, 321). An apparent example of failure was the target of increasing GERD to 2.5% 
by 2015, whereas the last retrieved GERD was only 0.3% (in 2014) (316). It was 
suggested that the failure in increasing expenditure in R&D is in policymakers' lack of 
belief in the return of investment in research (321). Finally, it was mentioned that 
insufficient financial resources for health research have led, at times, to the complete 
exclusion or underfunding of specific areas in national-level studies, such as mental 
health research (322). 
Transparent information on the mechanisms of distribution of health research funds 
was absent in the retrieved documents. It was mentioned that, in 2011 (316), more than 
80% of GERD was distributed through the universities and institutions affiliated to 
MOHME but also to the Ministry of Science, Research and Technology; Ministry of 
Defence; Ministry of Industry; Ministry of Agriculture; Science and Technology 
Parks; and institutions affiliated to the Vice-Presidency for Science and Technology. 
The latter is a group of research councils under the supervision of the Presidential 
Office (316). Firstly, no information to estimate the share of each of these entities of 
the total funds was provided. Secondly, the sustainability of funding decisions within 
this model of distribution—which is predominantly through the governmental 
organisations—was criticisd for being vulnerable to the opinion of politicians who are 
changed every few years in Iran (66).  
In yet another example of insufficient information on how the funds are distributed, in 
2015, there were 36 medical research centres earmarked in the national budget plan 
for receiving funds directly from the public budget (318), but no information regarding 
the criteria upon which the research centres would be earmarked was provided. Also, 
it was implied from the reviewed literature that health research funds are somehow 
distributed equally among academics who work in the institutions affiliated to 
MOHME (270). Finally, it was reported that in 2013, 40% of health research budget 
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was invested in ‘research projects’, 70% of which were in line with the institutional-
level research priorities (270). It was unclear what the authors meant by investment in 
‘research projects’ and it was not mentioned where the remaining 60% of the health 
research budget was invested. For the period 1997-2001, it was reported that 5.76% of 
the total public funding for health research had been allocated to research priorities in 
the health system (244). In sum, a system for tracking research investments seemed to 
exist, although its function was not described.  
In terms of the source of the research budget, the public sector has remained the 
primary source of research funds in all fields in Iran, including health (244, 316, 323). 
In a 2004 report by the WHO, the share of non-governmental sources (i.e. private 
companies, scientific associations, and NGOs) was estimated to amount to 3-6% of the 
total funds for health research in Iran, and the figure had decreased from 5.9% in 1991 
to 2.7% in 2001 (244). Some have reported that, in recent years, the contribution of 
the private sector to research investment has increased. For instance, in 1998, less than 
1% of investments in R&D was from non-governmental sources (316, 317), whereas 
in 2009, nearly 31% was the contribution of the private sector (316). Nevertheless, it 
was reported in 2016 that public funds still constituted 98.5% of the research budget 
of medical research centres in Iran (318). A paper investigated the status of 
collaborations in research projects that were conducted between 2005 and 2007 in one 
of Iran’s universities (Golestan University of Medical Sciences) and found that among 
the 102 included studies, only 12 of them (11.8%) had been co-funded by organisations 
outside the university (268). 
3.5.3 Creating and sustaining resources 
Over the last five decades, Iran has largely developed its higher education capacity in 
medical sciences. This is reflected in the substantial increase in the figures for physical 
(infrastructural) resources (e.g. the number of schools of medicine) and human 
resources. The efforts towards expanding the capacity of medical education primarily 
aimed to increase the number of health care professionals across the country to address 
the shortage of physicians. However, this already existing human capital was later 
enabled and encouraged to engage with research activities, too.  
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Changes in the figures for human and infrastructural resources 
While there was inconsistency in the figures across the reviewed documents, all the 
retrieved data reported a significant rise in the number of academic staff and students 
at the universities of medical sciences affiliated to MOHME, at different levels of 
education and training (i.e. primary qualifications, specialty, sub-specialty, and 
postgraduate programmes) (112, 316, 317). Graph 1 highlights that the literature 
lacked data on human resources in most years while indicates the significant rise that 
has occurred in the number of both the students (during 1970-2008) and academic staff 
(during 1985-2014). The substantial increase in the number of students in disciplines 
related to medical and health sciences started in the late 1980s (112) and had 
continued, reaching 56,131 in 2014 (270, 316). It was also mentioned that over the last 
few decades, the proportion of female students in higher education has greatly 
increased; for instance, the percentage of female students increased from 42% in 1990 
to 68% in 2013 (316).  
Investigating the number of faculty members in different years was rather confusing. 
Certain terms, e.g. ‘teaching staff’, ‘academic researchers’, or ‘non-academic 
researchers’, were used without being defined (316). Moreover, it was often unclear 
whether the reported figures for faculty members included or excluded the academic 
staff of medical universities that are not affiliated with MOHME, e.g. the academics 
employed by private universities or medical schools affiliated to military 
organisations. The information summarised here are from the sources that had 
appropriately described the figures. The number of faculty members in the universities 
and/or research centres affiliated with MOHME had increased from 3,153 in 1985 
(287) to 8,625 in 1999 (317), 11,324 in 2007 (271), and over 13,200 by 2014 (316). It 
was mentioned that in 1999, there were also 1,158 faculty members in the universities 
outside the structure of MOHME (317). It was also noted that a new type of academic 
position was introduced in 2010 as ‘research-focused faculty member’, meaning some 
academic staff were recruited for positions which did not involve any teaching; in 
2010, 289 of them were recruited (270).  
The increases in the number of specialty, sub-specialty, and PhD programmes were 
also highlighted in the literature. Until 1980, Iranian medical universities offered only 
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a few specialty programmes, no sub-specialty, nor PhD programmes (112). It had been 
reported that between 1975 and 2008, the annual number of admissions to specialty 
programmes increased from 401 to 1,732 students, and from zero to 268 in sub-
specialty programmes (112). A significant increase in the number of students enrolled 
in masters and PhD programmes in all disciplines was reported between 1998 and 
2013: the first one had increased from 23,303 to 454,978 and the latter from 3,771 to 
60,900 (more than 16-fold increase) (316). While the figures for the programmes 
relevant to health sciences were not specified in that paper, another report showed the 
rise in the total number of students admitted in doctorate and masters programmes with 
a health research component for the period 1997–2001 from 44 to 216 (244). 
In 2010, MOHME launched a new scheme of PhD programmes, so-called ‘PhD-by-
research’ (316). In 2017, 616 students were enrolled in these PhD programmes across 
188 research centres affiliated to MOHME (316). Unlike the conventional type of PhD 
programmes in Iran, where students are awarded positions only after excellent 
performance at an annual national entry exam that relies on multiple-choice questions, 
‘PhD-by-research’ students are assessed, recruited, and supervised by faculty members 
whose eligibility is approved by MOHME (324). Also, while one of the criteria for 
being offered a ‘PhD-by-research’ position is having a certain number of publications 
in international bibliographic databases, graduation from these programmes is also by 
publication (324).  
It was reported that because of the significant increase in university admissions in the 
1980s, initially, the ratio of students to faculty members had increased (112). Later on, 
consequent to the development of postgraduate programmes, the number of 
individuals who were qualified as faculty members also increased, so that the ratio 
relatively improved (112, 287): from 17.1 students per faculty member (in 1985) to 8 
in more recent years (112, 317). Finally, the number of employed researchers in 
research centres affiliated to MOHME has risen from 637 in 2001, then 3,828 in 2010, 
to reach 5,736 in 2014. This translated to an average of 10 researchers per research 
centre (318) (although the definition of ‘researcher’ was not fully explained).  
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Regarding infrastructural resources, the number of academic medical institutions 
affiliated to MOHME has substantially increased (310, 317, 318). This includes the 
increase in the number of universities of medical sciences from 34 in 1996 to 58 in 
2017 (310). Also, between 1970 and 2008, the number of schools of medicine had 
increased from 7 to 36; and schools of dentistry and pharmacy from 3 each to 15 and 
11, respectively (112). Likewise, the number of schools of nutrition, public health, 
nursing, midwifery, and several paramedical disciplines has significantly increased 
(112). Over the last two decades, a substantial increase has taken place in the number 
of research centres in areas related to medical sciences: from only one centre in 1992 
to 53 in 2001, 359 in 2010, and 736 in 2016 (310, 317, 318). The majority of medical 
research centres are reported to be in the areas relevant to internal medicine, 
pharmaceutical sciences, and cellular biology (112). Research centre was defined as 
‘a facility or building dedicated to research, commonly with the focus on a specific 
area’ with no further requirements (310). It was reported that the increase in the 
number of research centres between 2010 and 2016 occurred without sufficient 
oversight and led to some challenges (310). 
Capacity building 
Short-term and long-term strategies have been adopted to build capacity in Iranian 
academics in areas related to health research. First, many students have obtained 
research-relevant training during postgraduate studies. Then, numerous training 
courses relevant to research have been offered since 1990 by the MOHME’s affiliated 
universities and research centres (17). The number and diversity of these courses - 
from basic research methods to statistics, academic writing, and research methods that 
are used in specific fields, e.g. in mental health - have been increasing over the last 
decades (110, 322, 325). The figures had increased from 458 in 2000 to 1,097 in 2007 
(271). A survey in 2004 showed that the majority of participants were satisfied with 
the quality of the courses that had been provided since the early 2000s (244). More 
recently, research centres have been increasingly providing similar courses; the 
number of workshops organised by medical research centres increased from 92 in 2001 
to 625 in 2014 (318). Furthermore, some research hubs that have achieved a reasonable 
capacity for research in specific areas are now building capacity in their peer 
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institutions. For instance, Royan, a leading Iranian stem cell research centre, now 
provides courses related to research in stem cell and tissue engineering (283). 
The role of Student Research Committees (SRCs) was also noted in the literature in 
developing research capacity. SRCs are run by students and they promote research 
among the students of medical sciences primarily by: (i) offering research methods 
training; (ii) conducting research; (iii) writing papers; and (iv) presenting at 
conferences (271). Some SRCs even raise funds to sponsor travels of the committee 
members to international conferences (326). Finally, SRC members try to acquire 
other essential skills for research, e.g. communication, management, and teamwork 
(327). The first SRC was established in TUMS in 1993 by a group of enthusiastic 
undergraduate students who aimed to create a supportive and enabling research 
environment at universities (327). Later on, under the supervision of the Department 
of Research and Technology of MOHME, SRCs were formed in all universities (271, 
326). 
It was reported that a significant capacity has been built in certain disciplines, such as 
gastroenterology and hepatology, which have advanced substantially in educating and 
training clinical and research fellows (112). It was suggested that such success could 
be related to the hard work and the determination of some devoted academics in those 
fields, who were also supported and provided with resources both by the governmental 
and non-governmental entities (112).  
Barriers to research activities 
Despite efforts to improve the capacity of Iranian academics in research and 
publishing, the number of skilled researchers in the country is still limited (17). An 
assessment of the knowledge, attitude, and practice of 436 students in an Iranian 
university of medical sciences in 2013 found that students' skills in using research 
methods were considered moderate; the majority had no positive attitude towards 
research activities; and their research performance was graded as weak (328). Several 
papers have touched on the possible reasons. One hypothesis is that many motivated 
young graduates who have acquired research skills by attending courses and/or 
through working in SRCs during undergraduate studies would immigrate to developed 
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countries soon after publishing a few papers and improving their academic CV (6, 85). 
Another proposed reason is that the students who join SRCs, or the faculty members 
who attend research-related courses, are likely to be already willing to improve their 
research skills (303). Hence, research capacity in those with less interest in research 
may never improve much because research methods are not included in the core 
curriculum of programmes in medical sciences and are only offered as optional courses 
(327). 
Furthermore, the literature highlighted that the education curriculum in Iran does not 
equip graduates with the necessary skills for research. The medical education 
curriculum was particularly criticised for being too oriented towards the students 
passively learning facts (329), rather than looking for critical thinking or creative 
problem-solving. The model of admittance to Iranian universities was criticised, too, 
for being largely dependent on the performance of applicants on a competitive 
multiple-choice annual exam, which trains students to memorize facts instead of being 
critical thinkers (246).It was also emphasised that students in Iran’s higher education 
programmes do not receive training to develop skills in communication, writing, 
management, or teamwork, which are requisite for becoming a competent researcher 
(246, 329).  
Another critical barrier to more enthusiasm for research are lower financial incentives 
for research compared to teaching or clinical activities. In an assessment of 186 
academics from one Iranian university (Guilan University of Medical Sciences), 70% 
reported limited financial reward as a major constraint on doing research (246). On the 
other hand, the extra payment that academics receive for additional teaching hours is 
often higher than earnings from their time invested in research (246). Importantly, 
since in Iran, medical education and research are merged with health care services 
provision, many of the academics in the universities affiliated with MOHME are 
clinicians too. These clinical academics are paid greater salaries by working in 
teaching hospitals (246). They even receive extra payment per patient that they visit in 
university clinics (246). Therefore, they can have a much higher income through 
providing clinical services instead of investing in research activities (246). A 
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Commentary had suggested that many Iranian clinical academics still think of research 
as a luxury good while considering clinical activities as a necessity good. Thus, they 
engage with research only to get academic promotion, rather than contributing to the 
society or to the industry (330). Also, one of the reported constraints cited the 
researchers’ own low expectation that their findings would be applied in practice 
(244).  
Other constraints reported in a number of studies are summarised as follows: inability 
or unwillingness for collaborative work; lack of essential means and facilities to 
conduct research; restrictive administrative regulations; lack of university autonomy; 
limited organisational support and poor cooperation between executive offices within 
the universities; weak project management skills; inadequate number of qualified 
senior researchers to provide effective supervision; and limited number of qualified 
librarians (244, 331-333). On the individual level, heavy workload and limited time 
for research; poor knowledge of research methods and statistics; insufficient 
incentives; and inadequate support for academics with family commitments were 
mentioned as some of the barriers to medical and health sciences researchers in Iran 
(331, 333). 
Some literature argue that the international trade sanctions against Iran, which aimed 
to restrict Iran's nuclear programme by targeting its oil and gas export, banking, and 
financial sectors, had posed another constraint on research activities of Iranians (85, 
334-336). The reasons behind this argument are that the sanctions had (i) restricted 
exchange of Iranian students and faculty members with international academic 
institutions; (ii) made purchase of laboratory equipment and material difficult; (iii) 
negatively affected international collaboration; and (iv) at times led to the outright 
rejection of Iranian research papers by some journals (85, 334-336). In terms of the 
last one, in April 2013, Elsevier advised its US editors against handling any papers 
authored by employees of the Iranian government, which could include any academic 
working at the universities affiliated with MOHME, and this ‘advice’ was followed by 
some journal editors (335, 336). 
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On the other hand, although sanctions must have had made it harder for Iranians to 
conduct research and to partake in the international scientific community, data 
retrieved from international bibliographic databases show that the quantitative growth 
of Iran’s research publications had continued during the sanctions (85). Also, as for 
publishing research papers with international collaborators, between 2005 and 2014 
(i.e. during tight trade sanctions), the rate of the growth of international collaboration 
in Iran was similar to that in Egypt and Israel, and higher than that in Turkey, 
suggesting that sanctions against Iran did not much affect its international scientific 
collaborations (337). Likewise, the number of collaborations with the UN agencies 
showed no significant change during this period (318). It was explained that the 
development of Iranian journals might have alleviated some of the consequences of 
sanctions on Iranian research publications (337). Also, The Lancet editors claim that, 
as one of the main actors of the international health research community, their support 
may have had a positive impact on reducing consequences of sanctions (337). 
Finally, it was argued that one barrier against innovative and high-quality original 
research in Iran is that higher education opportunities are still not equally provided to 
all Iranians (338). As an example of inequality, it was mentioned that in Iran women 
are banned from studying 77 disciplines (without providing the list) and that equal 
opportunities may not be provided to all religious minorities (338). 
Collaboration 
Collaborations and coordinated activities are key to sustaining and strengthening 
research resources (6). In the early 2000s, the Department of Research and Technology 
of MOHME introduced several initiatives to promote collaboration in research. One 
initiative was that, between 2001 and 2011, MOHME signed official memorandums 
for collaboration between Iran and academic institutions in Sweden, Germany, South 
Africa, Belarus, Malaysia, Indonesia, and the Eastern Mediterranean Regional Office 
of the WHO (339). These memorandums led to the joint training of 20 students; 18 
collaborative projects; 26 publications; and co-organising 17 workshops (339). The 
second initiative, beginning in 2001, was for expansion of collaboration between 
researchers and the community (244, 340). This initiative was implemented through 
the establishment of community-based participatory research centres in several 
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medical universities across Iran. These centres supported the conducting of projects 
that could lead to capacity-building in the community, so that the community’s 
knowledge could be used for addressing health problems, particularly those regarding 
the social determinants of health (340). 
The third initiative of MOHME towards promoting collaboration was the development 
of knowledge networks, aiming to organise, lead, empower and coordinate efforts 
made by health researchers and key stakeholders to: firstly, prevent repetitive and/or 
parallel health research in Iran; and secondly, strengthen knowledge translation (244, 
341, 342). By 2012, Iran had 27 knowledge networks in medical and health sciences 
(342). However, it was shown that the approaches used in the management of those 
networks was not very transparent, and that the majority lacked clearly defined goals 
and faced multiple administrative problems (341). Still, according to the literature, 
some networks - e.g. Iranian Osteoporosis Research Network (IORN) and Iranian 
National Diabetes Research Network (INDIRAN), both established in 2002 - made 
significant contributions. IORN, by 2008, had linked 21 Iranian universities and 
research centres and had: established osteoporosis clinics; initiated a multi-centre 
osteoporosis study and a hip fracture registry project; and run education and prevention 
programmes (343). By that time, INDIRAN had also completed and/or initiated 
multiple projects, e.g. estimating the prevalence and the burden of diabetes in Iran; 
evaluation of the quality of life in diabetic patients; and running diabetes education 
and prevention programmes (344). It was mentioned that, despite accomplishments of 
INDIRAN, a number of provinces still required research facilities, trained researchers 
or research centres in diabetes that could collaborate on national projects (344).  
To further promote collaborative research, the Department of Research and 
Technology of MOHME that runs a national, annual academic assessment, by which 
it ranks the Iranian medical universities and their affiliated research centres, allocated 
points to collaborative research projects that engaged several institutions (246). 
However, the regulations that were in place for evaluation of academics still provided 
more points to single-authored papers; this obviously discouraged collaboration. The 
regulations for academic promotion requirements are made by a different organisation. 
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This conflict in regulations suggests that further coordination is required for the 
success of initiatives that promote collaboration (246).  
Despite the abovementioned efforts, the literature suggests that the status of research 
collaboration is not satisfactory. A paper investigated the status of collaborations in 
research projects that were approved between 2005 and 2007 by an Iranian medical 
university (Golestan University of Medical Sciences) (268). Among the 102 assessed 
studies, only 10 projects (9.8%) had been performed in collaboration with other 
organisations; only one project was commissioned by a non-governmental 
organisation; and half of the researchers had chosen the research topic according to 
their personal interest (268). Another study showed that of the 208 research projects 
conducted in TUMS in 2004, only 2.2% had a collaborator from non-academic 
organisations and 51 researchers (24.5%)  stated the users had not contributed to any 
stage of the research (345). A qualitative study in 2004 investigated the status of 
collaboration between universities of medical sciences and their affiliated research 
centres with either the community or the executive organisations and found the 
following: 20% of the academic institutions had no link with the private sector, while 
collaboration with the community as well as with executive entities was weak too, 
particularly in knowledge utilization and identification of research priorities (346).   
3.5.4 Producing, disseminating, and using research 
Producing and disseminating research 
A substantial rise over the last few decades has been reported in the number of Iranian 
health-related research papers in international bibliographic databases (313, 316). For 
instance, it was reported that the number of Iranian documents in MEDLINE had 
increased from only 273 in 2000 to 14,511 in 2014 (316). This review retrieved 34 
papers that had reported the quantitative growth of Iranian publications in different 
biomedical, clinical, and/or public health research areas (Summarised in Table 6). It 
was also noted that the rise in research output had occurred regardless of the population 
growth. For instance, the number of publications per million Iranian inhabitants had 
increased from 155 in 2008 to 326 in 2014 (12, 316), while the number of publications 
per academic has risen too (271). The growth had also been observed in the figures for 
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the Iranian papers in Persian (a 30-fold rise between 1979 and 2003) (112), and the 
number of Iranian books that have used the findings of national research had increased 
as well (313). 
In terms of citation-based indicators, the reports are paradoxical. While some have 
reported a decline in the average number of citations per document (67), it has been 
shown that the number of citations that Iranian research papers have been receiving in 
medical textbooks (313) and the citation counts per academic have increased (316). 
Also, Iranian papers are being published in journals with higher IFs than before (112, 
244).  
Likewise, the number of Iranian medical journals, both national and international, has 
increased over the last few decades (271). Only between 1990 and 2010, 155 new 
medical journals were approved by Iran’s MOHME and many of them have found 
their way into international bibliographic databases (66). Improvements have also been 
reported in the citation-based indicators of the Iranian medical journals that are 
indexed in the WoS Core Collection: e.g. between 2012 and 2014, their average IF had 
increased from 0.40 to 0.68 and the average number of citations that each of the 
documents in these journals has been receiving from international authors had risen 
from 0.19 to 0.49 (347). However, Iranian journals have been criticised for being 
predominantly published by the universities; it was argued that this closeness of 
journals to where the research originates could have been negatively affecting the 
independence of peer review processes (66, 348). 
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Table 6 A summary of the reported increase in the number of Iran’s research publications in various research areas, using different data sources, and within different 
periods 
Rank  Area Data source(s) Time period(s) 
1 Medical education (325) Index Medicus 1982-1998 
2 Transplantation research (349) Data from 91 Iranian journals abstracted in IranMedex 1993-2003 
3 Nephrology  (350) Medline and IranMedex 1997-2007 
4 Nephrology and urology (351) PubMed 1993-2013 
5 Psychiatric disorders (352, 353) The national mental health data bank (IranPsych) 1973-2002 
6 Substance use and addiction (354) Web of Science, Medline, Scopus, SID, and Iranmedex 2008-2012 
7 Epilepsy (355) Scopus 2000-2014 
8 Dental research (356) Data from electronically accessible national journals and also through PubMed 1982-2006 
9 Dental research (357) Medline and IranMedex 1990-2009 
10 Dentistry (358) Web of Science 1993-2012 
11 Dental research (359) PubMed 2005-2014 
12 Endodontic (360, 361) Pubmed 1992-2011 
13 Orthodontic research (362) PubMed, IranMedex, and SID 1997-2012 
14 Mineral trioxide aggregate (363) Pubmed 1993-2012 
15 Trauma (364) Using the database of one of the largest trauma centres in Iran (Sina Trauma Data Bank) 2000-2006 
16 Ophthalmology (365) MEDLINE/PubMed 1981-2010 
17 Paediatrics (366) PubMed 2002-2007 
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Rank Area Data source(s) Time period(s) 
18 Rationale use of medicine  (367) 
PubMed, Web of Science, Google Scholar, CINAHL, Proquest, International 
Pharmaceutical Abstract and Persian databases including SID, Iran Medex and MagIran 
1975-2012 
19 Neuroscience (368) Science Citation Index Expanded (SCIE) via Web of Science database 2005-2008 
20 Parasitology (369) Web of Science 2002-2010 
21 Stem cell (370) Science Citation Index (SCI) Expanded 1996-2012 
22 Stem cell (283) Web of Science 2004-2010 
23 Stem cell (371) Web of Science 1996-2013 
24 Health policy (372) Web of Science 1898-2013 
25 Cardiovascular diseases (373) Medline 2003-2012 
26 Obesity/overweight (374) Scopus 1990-2013 
27 
Health impacts of mustard gas 
exposure in Iran-Iraq war (375) 
Scopus, Medline, and Web of Science 1988-2012 
28 Diabetes (376) Scopus, Medline, and Web of Science 1990-2012 
29 Diabetes (377) Scopus 1968-2014 
30 Reproductive health (378) Scopus 2010-2014 
31 Public health (379) Web of Science and PubMed 1975-2014 
32 Hepatitis (380) Web of Science 2005-2014 
33 Breast cancer (381) Scopus 1991-2015 
34 Neurosurgical research (382) 
PubMed and IranMedex were searched for the publications of all Iranian neurosurgeons 
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While the increasing number of Iranian journals that are indexed in international 
databases has significantly improved the visibility of Iranian publications (11), the 
publications in the national journals do not yet seem to be very applicable by the 
international readers (383). An assessment of the web-based databases where Iranian 
journals were indexed has found that none had a complete coverage of Iranian journals; 
the search features were sub-optimal; English translation of the titles of the Persian 
papers, authors’ names, keywords, and abstracts were not aligned with standard 
formatting styles; there were numerous typos in the English content; and some 
websites did not even provide English abstracts (383). This assessment had included 
the following websites: IranDoc; IranMedex; MagIran; Scientific Information 
Database (SID); and Shiraz Regional Library of Sciences and Technology (383).  
In terms of the substantial growth of Iranian health-related research publications, 
although no explanatory study had investigated the national-level contributors to the 
growth, several possible reasons were hypothesised in the reviewed papers as follows: 
(i) increased investment of the government in R&D (11, 12, 311) and increased 
investment in the health sector (246); (ii) increased number of research centres and 
medical universities (12, 246, 308); (iii) increased number of faculty members (11, 
246); (iv) providing academics and students with training courses in research and 
publishing (311); (v) introduction of regulations that required faculty members to have 
papers for academic promotion (66, 297, 330); (vi) increased number of students (11); 
(vii) the large number of young and talented researchers who mostly publish papers to 
improve their academic CVs (85); (viii) introduction of regulations that required PhD 
students to have papers abstracted in international bibliographic databases (11, 273); 
(ix) improved quality of Iranian journals and increased number of Iranian journals that 
are indexed in international citation databases, e.g. Scopus (11); and (x) increased 
international collaboration, which may have been for bypassing the international 
sanctions (308, 337).  
Regarding the institutional-level underlying reasons for the growth, one paper in 2014 
studied the success of implemented policies in one major Iranian university (Shahid 
Beheshti University of Medical Sciences) towards promoting research and publication 
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among its academics (384). They found the following interventions that seemed to 
have had contributed to improving the quantity, the quality, and utilization of research 
(384): (i) providing research courses for administrative staff so that they could speed 
up the research grants’ allocation processes; (ii) expanding subscription to 
international journals and bibliographic databases; (iii) equipping a laboratory with 
facilities to run PCR (i.e. polymerase chain reaction) tests and do MRI on lab animals;  
(iv) establishing a centre to serve as an intermediary between the departments of 
pharmacy and pharmaceutical manufacturers to help with knowledge translation and 
raising research funds from the industry; (v) replacing the paper-based administrative 
processes of research with online forms; (vi) identifying research priorities and 
encouraging adherence to them; (vii) increasing (more than doubling) the number of 
research centres of the university; (viii) introducing grant schemes specific to prolific 
authors (the amount of the awarded grants was dependent on the indexing and the IF 
of the journal where the previous papers of the academics had been published); and 
(ix) introducing a regulation that research publications were requisite for remuneration 
(384). 
Regarding the quality of research, the literature suggests that still most of the output is 
not of high quality (17) although in most cases the quality was only assessed by 
citation-based indicators (67), a practice which is widely criticised (147, 210, 385). A 
quality assessment of 509 Iranian clinical trials published during 2008-2010 in national 
journals reported that the adherence of 43.8% of the publications to the standard 
CONSORT checklist was inadequate (386). Nonetheless, regarding reporting, an 
analysis of 795 clinical and/or health systems research articles published between 2001 
and 2006 that had included Iranian populations on maternal care, diabetes and 
tuberculosis (indexed in national and international databases) found that 98.5% of the 
papers contained a clear message (387). One study used two standard tools for quality 
evaluation of the methodology and reporting in Iranian papers in medical education 
research (2003-2008) that were abstracted in MEDLINE, and/or SID (388). The study 
suggested that the quality of publications was suboptimal, particularly the validity of 
research methods and the reporting of study limitations (388). 
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Using research 
In terms of knowledge translation (KT), according to the literature, several steps have 
been taken in Iran over the last recent decades which seem to have been effective in 
the promotion of KT. The activities could be grouped into the categories of Supply of 
knowledge that is relevant to the users; Demand for knowledge; and Exchange—which 
includes the interaction between knowledge producers and users (6, 323). In the Supply 
category, while capacity has been built in academia to increase needs-based research, 
KT activities had also been incentivized (323). Regarding capacity building, 
representatives from almost all Iranian medical universities participated in a KT 
training course in 2009 that was organised by the WHO EMR Office; the course 
covered topics from the basics of KT to the passive and active KT strategies (323). In 
terms of incentives, the annual evaluation of academic institutions that is undertaken 
by MOHME allocates points to the implementation of research findings (271) and—
likewise—according to the 2008 revision of the regulations for academic promotion, 
medical universities’ faculty members could receive points by KT activities (323). 
In the Demand category, although some assume that the integration of medical 
education and research into the health care services has closed the gap between the 
knowledge producers and users in Iran’s health system provision (6, 244), evidence 
suggests that this model has not much succeeded in this regard (Further details in 
section 3.5.2) (113). On the other hand, an attempt that seems to have been successful 
is that in recent years, the executive departments of medical universities were asked to 
allocate nearly 2% of their budget to ‘applied research’(244, 323). Hence, the 
university executive departments commission the academics and provide them with 
funds to address the needs of the executive departments through research (244, 323). 
Moreover, since 2005, MOHME has been calling for applied research grants, e.g. in 
Health Systems Research. Finally, great efforts have been made to promote using the 
findings of systematic reviews and clinical trials and, in general, ‘evidence-based 
decision-making and practice’ among service providers and policymakers (287, 323). 
Another attempt that improved Demand in KT was the development of the Iranian 
Registry of Clinical Trials (IRCT) in 2008 which increased the public accessibility to 
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the ongoing and/or the findings of completed clinical trials in Iran (287). The number 
of registered clinical trials in IRCT rapidly increased. It was more than quadrupled 
between 2009 and 2010 (rising from 181 to 772), presumably as a result of the 
regulations introduced by the Iranian medical journals that requested authors to include 
IRCT codes in their submitted manuscripts (389). This regulation indeed led to a 
substantial number of trials getting registered retrospectively, particularly after 
completing the recruitment of participants; 62% of the registered trials in 2011 had 
been submitted after the end of patients’ recruitment (389).  
In the Exchange category of KT activities, significant efforts have been made to 
identify health research priorities at the national and institutional levels with the 
engagement of the academics and the key stakeholders (323). Further information on 
this subject is provided in section 3.5.1 and Table 4. Also, as described in section 3.5.3, 
in the sub-section of Collaboration, community-based participatory research centres 
were established to facilitate interaction of the academics and the community in the 
process of research (323). A major attempt in the Exchange category has been the 
establishment of ‘incubation centres’ where researchers could present their ideas 
and/or findings that have a potential of commercialisation to the businesses and could 
receive seed funding to further develop their work (316, 323). Moreover, establishing 
Science and Technology Parks and supporting young graduates to found knowledge 
enterprises have been among the strategies towards improving Exchange in KT (316, 
323). 
Between 2010 and 2013, the number of incubation centres increased from 98 to 148, 
while the figures for knowledge enterprises had also risen from 2,169 to 3,400, and the 
number of Science and Technology Parks had reached 33, from 28 (316). The figures 
for research staff of the parks had increased from 16,139 to 22,000 within the same 
period (316). According to the UNESCO Science Report, the number of Iranian 
patents, in all areas, submitted to the United States Patent and Trademark Office, had 
increased from only 3 in 2008 to 43 in 2013 (357).  
Few studies have attempted to assess the status of KT in health-related fields in Iran. 
Two assessments of medical universities and research centres have reported the lack 
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of an appropriate KT environment in Iran’s academia; insufficiency of financial 
incentives; supportive regulations and facilities for KT activities; and limited 
opportunities for interaction between the academics and the knowledge users (390, 
391). KT activities in diabetes were assessed in 2015 and the overall status had been 
described as ‘lower than ideal’, and several barriers at the macro and the meso levels 
were found against improvement of the status quo (392). It was reported that the most 
commonly used KT activity by Iranian medical academics has been publishing 
research in journals, i.e. a passive KT strategy (323), although engagement in active 
KT strategies was reported to be significantly higher in Health Systems Research 
projects (393). 
A survey of medical interns at a teaching hospital affiliated with TUMS described the 
knowledge of the basic concepts of Evidence-Based Medicine in the majority of the 
respondents as insufficient although the interns were willing to receive training to learn 
about it (394). Another survey enquired 319 general practitioners (GPs) in 2008 about 
whether they had updated their knowledge of diabetes over the preceding two years, 
and if so, which sources of information they had been using (395).  It was reported that 
a total of 38% of the GPs had not updated their knowledge, and the ones who had, 
mainly relied on Iranian journals in Persian, showing that clinical guidelines did not 
have any place as a source of information and/or practice (395). The main barriers to 
the development and to the use of clinical practice guidelines in Iran were reported to 
be the lack of an evidence-based health care system and insufficient political support 
at the macro level (396). 
A survey of 304 nurses working in teaching hospitals in 2003 reported the following: 
80.6% had not been involved with the conduct of any research since qualifying as a 
nurse; 70% of those who had undertaken some research had done it as part of a course; 
about 30% had never used research in their practice; 44.3% read research once every 
2 or 3 months or more frequently; and the main information sources that the majority 
relied on for practice were nursing textbooks and/or asking the nurse supervisors (397). 
The barriers to research utilisation in nursing practice in Iran had been identified as 
follows: (i) insufficient time to read papers; (ii) inadequate facilities and time to 
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implement research; (iii) limited authority of nurses to change practice and limited 
cooperation of medical doctors in this regard; (iv) inaccessibility of scientist by whom 
the nurses could discuss relevant topics; and (v) inadequacy of relevant research (397-
399).  
The importance of ‘relevant research’ was also highlighted in an editorial in 2007, 
where it was noted that, despite the substantial growth of mental health research 
publications in Iran between 1997 and 2002, the country still lacked the required 
evidence for national-level decision-making in mental health (400). It was argued that 
this problem originated in the lack of a national policy that guides research investments 
towards mental health research priorities. Back then, conducting several systematic 
reviews was initiated to identify (i) the knowledge gaps, and (ii) the weaknesses in the 
quality of  the earlier research that needed to be addressed (400). Furthermore, an  
investigation of the views of 131 researchers and health research policymakers on how 
the development and the usage of evidence from systematic reviews could be promoted 
in Iran had recommended: (i) the introduction of national-level initiatives for making 
systematic reviews ‘wanted’, and (ii) improving the capacity to conduct high-quality 
research (401).  
Regarding the impact of medical and health research in Iran, most of the retrieved 
documents in this review - even the analyses that were commissioned by MOHME - 
(315) seemed to have been assessing the research impact solely by considering 
citation-based indicators. Only one study was found that had used a multi-dimensional 
approach; it had used the Payback Framework for impact assessment of a sample of 
238 research projects that had been completed by 2008 (321). The findings were as 
follows: half of the studies had published no articles in journals indexed in Scopus; the 
results of 12% of the studies had been used in systematic reviews; 12% had been used 
in clinical or public health guidelines; findings of only 5.3% had been used by 
MOHME in policy making; 62% were expected to directly lead to health impacts, of 
which only 38% had been implemented, and 60% had achieved the anticipated result; 
and of those with a potential of making an economic impact, nearly 36% had been 
implemented, of which 61% had made an economic impact, e.g. by reducing the cost 
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for the person and/or on the health system, and/or by reducing the number of work 
days missed due to illness/disability (321). A rare example of research with an impact 
found in the literature was from Royan Institute, an Iranian stem cell research centre 
approved by MOHME in 1998, where research is translated into medical services. It 
was reported that the centre provides stem cell therapy for skin and cartilage disorders 
(402). Finally, in 2003, it was reported that 13 national research studies had led to an 
improvement or change in the health system, while about 20 national guidelines for 
use in the health system had been reformulated based on the outcomes of locally 
conducted research (references to specific studies were not given) (244).   
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Chapter 4 Bibliometric analysis of Iran’s health 
research publications (1965-2014) 
4.1 Introduction 
As described in section 1.9.1, Iran is a remarkable example of emerging middle-
income scientific nations. Iran’s number of research publications has witnessed the 
fastest growth during recent decades, from publishing only 736 in 1996 to 13,238 in 
2008 (9). It was mentioned in section 1.10.5 that since 1985, the governance of medical 
education and research in Iran has been entrusted to MOHME (114). Therefore, it is 
important to study Iran’s publications in health research separately from other fields 
of science. It should be noted that in the bibliometrics studies that are presented in this 
chapter and in Chapter 5, health research publications are defined as publications that 
include clinical, biomedical, and or public health research.  
It has already been discussed in section 3.5.4, and summarised in Table 6, that multiple 
studies have thus far reported the quantitative increase in Iran’s health research 
publications in various areas, from general fields, e.g. paediatrics (366) or dental 
research (357) to more specific areas, e.g. breast cancer (381), diabetes (377), or the 
rationale use of drugs (367). However, an overall landscape of the changes across all 
fields of clinical, biomedical, and public health research is still lacking. Furthermore, 
some criticise Iran’s research publications for having a very low citation impact and 
for having had increased only in the quantity (66, 67), and this matter requires further 
investigation.  
In this chapter, I will seek to obtain a better understanding of Iran’s growth in health 
research, both in terms of the quantity and citation impact. This could firstly inform 
the national research policymakers about that which researchers, institutions, and 
fields have achieved an acceptable capacity to perform and publish health research, 
thus are worthy to be funded; and that which ones have lagged behind and could benefit 
from further capacity-building and/or investment. Secondly, the findings should help 
stakeholders from international organisations, e.g. the WHO, to better understand the 
local research capacity of Iran, which could be used in regional and global projects. 
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4.2 Aim 
The aim of this chapter was to obtain a better understanding of the changes in Iran’s 
health research publications over 50 years, both in terms of the quantity and citation 
impact, and identify the major contributors and key factors that have led to the changes. 
4.3 Objectives 
Using bibliometric methods in this chapter, I seek to (i) study the annual number of 
Iran’s clinical, biomedical, and public health publications over 50 years across 
different areas, and characterise some of the major trends; and (ii): compute the 
changes in h-index of publications over this period to investigate whether the growth 
has been limited to the quantity. 
4.4 Methods 
4.4.1 Methods to study the landscape of publications  
Given the advantages that the use of bibliometrics has over peer review and altmetrics 
in large-scale research assessment studies (as described in section 1.11.3), I used 
bibliometric methods for the purpose of this study. Then, after considering the 
strengths and limitations of different international databases that are explained in 
section 1.11.3, I chose WoS CC for the purpose of this study. As indicated in section 
1.11.3, the general consensus is that large-scale bibliometric analyses in WoS and 
Scopus seem to yield similar results (199). I chose WoS CC over Scopus as it offered 
better tools to refine and analyse search results at the time the study was conducted. It 
is likely that Scopus has developed some similar features by now. I accessed WoS via 
the University of Edinburgh Library. 
On February 28, 2018, I performed a search in WoS CC of all the publications from 
Iran between 1965 and 2014 by running an ‘Advanced Search’ with the country field 
tag: i.e. CU=Iran. To include papers with a topic relevant to clinical, biomedicine, 
and/or public health, I refined the search results by selecting 48 relevant items listed 
under the ‘Research Areas’ option on the refine panel. List of the included ‘research 
areas’ is provided in Appendix 2.  
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My goal was to study the longest possible period. The reason for which 1965 was 
chosen as the start year is that WoS currently only indexes the authors’ affiliations of 
publications since 1966, hence, articles published in earlier years cannot be captured 
by searching the country subfield (403). Year 2014 was chosen for the end of the 
period because once a new journal is indexed in WoS CC, the most recent three years 
of the journal’s back issues will be obtained by WoS (404), which increases the figures. 
Thus, it is better to exclude the publications of the last three years in such bibliometric 
analyses. I obtained information about IF and country of origin of the journals on 
Journal Citation Reports® (JCR).  
I used the ‘Results Analysis’ feature of the WoS CC for analysing the retrieved 
records, and then, ranked them in a descending order in the following fields: 
‘Countries/Territories’; ‘Organization-Enhanced’; ‘Source Titles’; ‘Research Areas’; 
‘Authors’; and ‘Document Types’. While most of these fields are self-explanatory, it 
is worth mentioning that ‘Organization-Enhanced’ that indicates authors’ affiliations, 
comprises the unified and the most accurate name variant of addresses (405). It should 
also be noted that regarding prolific authors, it is possible that some publications that 
belong to authors with the same surname and initial are incorrectly attributed to one 
author. Therefore, I performed an ‘Advanced Author Search’ to ensure the 
publications linked to prolific authors belonged to one person. 
To obtain the landscape of the growth across different research areas, I counted the 
number of publications in each year and in each research area by firstly, retrieving the 
publications in every year and secondly, analysing them for research areas. Finally, I 
exported the data to a Microsoft Excel (Microsoft Inc, Seattle WA, USA) file for 
calculations.  
4.4.2 Method to investigate the changes in h-index  
As described in section 1.11.3, h-index is a bibliometric indicator which was originally 
developed to measure the quantity and the impact of an individual’s research output, 
trying to capture both in a single number (217). However, h-index can be adapted to 
assess the characteristics of research from both institutions and countries and provide 
an understanding of their capacity for research (406); in such indications, it can be 
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called h-core (407). This analysis only included citations from sources that were 
indexed in WoS CC. The approach used to identify the 5-year h-indices is explained 
in the following text. 
Approach to identify the 5-year h-indices 
To assess the changes in h-index of publications over time, I employed a method that 
was co-developed by Anna Badenhorst (a student of Master of Public Health at the 
Centre for Population Health Sciences, The University of Edinburgh), Dr Kit Yee 
Chan (my principle supervisor), and myself (38). It should be noted that the 
methodology development was not part of my PhD although I contributed to that study. 
We had introduced the methodology for assessing the global public health research 
capacity (38). I followed the same method to calculate the 5-year h-indices of Iran’s 
health research publications as follows.   
I calculated h-indices over ten 5-year periods: 1965-1969; 1970-1974; 1975-1979; 
1980-1984; 1985-1989; 1990-1994; 1995-1999; 2000-2004; 2005-2009; and 2010-
2014. To minimise the expected lag between publications and getting cited (408), I 
added a ‘citation window’ of three years following each 5-year period (38). This means 
that, for instance, when calculating the h-index for the 5-year period between 2000 and 
2004, publications with dates 2000-2004 were included, while all the citations that 
those publications had received in the period 2000-2007 were taken into account in 
calculating the h-index. The search criteria were the same as the ones described in the 
previous section (section 4.4.1), except for the time span.  
Once the search was complete for each 5-year period, I found the citation information 
of the articles using the ‘Citation Reports’ feature of WoS CC. ‘Citation Reports’ 
shows the number of citations that every search result has received every year. To 
include the 8-year citations, I set the time span of the search for the 8-year period, 
while after running the search and before creating the ‘report’, I refined the publication 
years to only include the documents that were published within my desired 5-year 
period. To calculate the h-index, all the citation data was exported to a Microsoft Excel 
file, then the total citation counts of each document in an 8-year period was calculated, 
and the documents in each 5-year period were ranked by citation counts in a 
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descending order and documents were numbered accordingly. I computed the h-index 
by finding where the rank was lower or equal to its corresponding citation count.  
4.5 Results 
4.5.1 A landscape of Iran’s health research publications 
(1965-2014)  
On February 28, 2018, there were 244,290 research publications indexed in WoS CC 
with at least one author with an Iranian affiliation for the period 1965-2014; a total of 
72,686 (29.7%) were in clinical, biomedical, and/or public health. The absolute 
number of publications in each year, and the annual and the total number of 
publications in each research area are provided in Appendix 3. Figure 3 illustrates the 
landscape over 50 years.  
A substantial increase is evident in the quantity of publications over 50 years, rising 
from only 1 publication per year in the late 1960s to a total of 8,984 in 2014. An overall 
increase has started since 2000, and has become more substantial between 2006 and 
2007 (increasing from 3,587 to 6,058), and another surge has occurred between 2010 
and 2011. The growth peaked in 2011, reaching 9,646 publications, remained 
relatively steady in 2012, while decreased to 8,616 in 2013. It should be noted that the 
number of publications that are illustrated in Figure 3 are the summed up number of 
publications in different research areas, meaning that if a record had been assigned to 
multiple research areas by WoS, it had been counted more than once. That is why the 
number of publications indicated in Figure 3 are higher than the annual number of 
publications.  
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Figure 3 Iran's publications across clinical, biomedical, and public health research areas (1965-2014, indexed in Web of Science Core Collection) 
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Results of analyses of the publications and information about the journals where the 
highest proportions of papers have been published are summarised in Table 7. IF of 
the 10 journals where the majority of papers were published ranged between 0.57 and 
2.4; six of them were Iranian journals; and one of these 10 journals is no longer indexed 
in WoS CC (i.e. Life Science Journal - Acta Zhengzhou University Overseas Edition). 
Ten percent of the international collaborations has been with the USA, the UK, and 
Canada. The majority of publications were original articles (69.0%), followed by 
meeting abstracts (20.4%), letters (4.0%), and review articles (2.7%). The full analysis 
results is available in Appendix 3. 
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Table 7 Results of analysis of 72,686 Iranian health research publications (1965-2014), indexed in WoS CC, representing: research areas with most publications, the 
most prolific organisations and authors, journals that had published the majority of publications, and countries with which Iran has had the most collaboration* 
Rank Research areas with most publications Prolific organisations† Prolific authors‡ Journals that had published the most 
 Countries with most 
collaborations§ 
1 Pharmacology pharmacy (8,167) Tehran University of Medical sciences (17,401) 
Abdollahi, M 
(558) 
Iranian Journal of Public Health (1,442) – 
From Iran –IF in 2016: 0.76 
US ( 3,684) 
2 General internal medicine (6,075) Shahid Beheshti University of Medical sciences (6,728) Azizi, F (491) 
Iranian Red Crescent Medical Journal 
(1,146) – From Iran – IF in 2016: 0.86 
UK ( 2,331) 
3 
Biochemistry molecular biology 
(5,844) 
University of Tehran (6,086) Larijani, B (447) 
Journal of Research in Medical Sciences 
(1,005) – From Iran – IF in 2016: 1.2 
Canada (1,317) 
4 Neuroscience neurology (4,638) Shiraz University of Medical Sciences (5,241) Rezaei, N (429) 
Life Science Journal - Acta Zhengzhou 
University Overseas Edition (1,001) – From 
China – Indexed between 2008-2012 
Germany (1,050) 
5 
Public environmental occupational 
health (4,353) 
Isfahan University of Medical Sciences (3,876) 
Dehpour, AR 
(428) 
Clinical biochemistry (999) – From Canada 
– IF in 2016: 2.4 
Australia (1,020) 
6 
Biotechnology applied microbiology 
(3,712) 
Pasteur Institute of Iran & Le Réseau International des 
Instituts Pasteur (RIIP) combined (3,807) 
Zarrindast, MR 
(378) 
Archives of Iranian Medicine (931) – From 
Iran – IF in 2016: 1.2 
Sweden (736) 
7 Immunology (3,321) Tarbiat Modares University (3,732) 
Malekzadeh, R 
(353) 
African Journal of Biotechnology (694) – 
From Kenya - IF in 2016: 0.57 
France (693) 
8 Surgery (3,256) Mashhad University of Medical Sciences (3,588) 
Alavian, SM 
(345) 
European Psychiatry (642) –From France - 
IF in 2016: 3.1 
The Netherlands 
(675) 
9 Chemistry (3,182) Tabriz University of Medical Sciences (3,331) Zali, MR  (344) 
Iranian Journal of Pharmaceutical Research 
(619) - From Iran – IF in 2016: 1.5 
Italy (666) 
10 Veterinary sciences (3,017) Iran University of Medical Sciences (2,372) 
Ghavamzadeh, A 
(340) 
Iranian Journal of Pediatrics (597) - From 
Iran – IF in 2016: 0.7 
Malaysia (626) 
IF – impact factor; WoS CC: Web of Science Core Collection 
*The numbers in brackets show the number of the documents, based on the data from 72 686 publications in clinical, biomedical, and public health research areas (1965-2014) with at least one Iranian 
affiliation; †7474 documents were attributed to the Islamic Azad University, a very large private university with many branches all across Iran, which all seem to be using the same affiliation. It was 
impossible to distinguish the publications that originate in each branch, therefore, the Islamic Azad University was excluded from the results. Furthermore, in addition to Pasteur Institute of Iran, Le Réseau 
International des Instituts Pasteur (RIIP) was among the most productive organisations. Since the publications attributed to both of these two institutions belonged to one organisation, the number of their 
publications were summed up; ‡The names of two authors from the top list were excluded: Amini, M; and Karimi, M, which are both a very common combination of a surname and an initial among 
Iranians. The reason for exclusion was that an ‘Advanced Author Search’ revealed the records that were attributed to these two authors included publications of multiple authors with the same surname 
and initial; §Web of Science reports publications affiliated with England, Scotland, Northern Ireland, and Wales separately. Here, the summed up figure is reported for the UK.
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4.5.2 Changes in h-index of publications (1965-2014)  
Table 8 summarises the changes in h-index. In general, the 5-year h-index has had a 
growing trend over the last 5 decades, and it has become ~1.5 times greater every 5 
years between 1990 and 2004. The 5-year h-index of publications between 2005 and 
2009 was more than doubled compared to the figure for publications between 2000 
and 2004 (rising from 35 to 78). The h-index of documents published during 2010-
2014 reached 105, meaning that within this period 105 documents were published that 
each one had been cited at least 105 times until the date of conduct of this study.  
Table 8 Five-year h-indices of Iranian clinical, biomedical, and public health publications (1965-2014), 
indexed in Web of Science Core Collection 
Period Number 5-Year Period    Year H-Index 
1 1965-1969 0 
2 1970-1974 9 
3 1975-1979 16 
4 1980-1984 13 
5 1985-1989 10 
6 1990-1994 14 
7 1995-1999 21 
8 2000-2004 35 
9 2005-2009 78 
10 2010-2014 105 
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Chapter 5 Identifying the profile of Iranian h-
core health research publications 
5.1 Introduction 
Chapter 4 reported that the number of health research publications, with at least one 
Iranian author and abstracted in the WoS CC database had reached 72,686 by 2014. It 
also found some improvements in the h-index of the publications over the period that 
the quantitative growth has taken place. It is essential to identify the publications that 
contribute to the h-core of these publications and investigate who are supporting and 
conducting the research that have become highly-cited. Particularly, it is of much 
interest to characterise the publications that had only relied on Iran’s resources while 
have found their way into the h-core publications of the country.  
5.2 Aim 
In this chapter, I aimed to identify the h-core health research publications of Iran that 
were indexed in the WoS CC, during 1965-2014, and investigate their profile.  
5.3 Objective 
In this chapter, I sought to: (i) identify the h-core papers of Iran’s health research 
publications in the WoS CC, for the period 1965-2014; (ii) identify the major 
contributors to the conduct and publishing of the h-core papers and the most common 
document types and research areas; (iii) investigate different types of collaborations 
among the h-core papers and identify the papers that had only relied on Iranian 
resources; and (iii) identify the profile of the h-core papers that had only authors from 
Iranian institutions and investigate the origin of citations to these papers.  
5.4 Methods 
Firstly, the same search strategy described in section 4.4.1 was applied, and then, the 
retrieved publications were ranked by citation counts in a descending order for 
identification of h-index (Figure 4). Citations were counted until the time of 
conducting the search (February 28, 2018). By using the ‘Marked List’ feature of WoS, 
the h-core papers were selected for further analysis. In WoS, the allocation of articles 
to research areas is done automatically based on the scope of the journals where the 
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articles are published. Hence, through refining the search results by ‘Research Areas’ 
some articles may appear that were published in clinical, biomedical, and/or public 
health journals, while their content may not be fully relevant. To ensure that the 
research area of the included h-core papers was in clinical, biomedical, and/or public 
health, the titles, abstracts, and when necessary the full-texts of the records were 
screened and the ones with irrelevant topics were excluded. Excluded papers were 
replaced with their following publications, and this was done until the rank was lower 
than or equal to the citation counts (i.e. the h-index). Initially, there were 166 records 
which finally reached 155 records after excluding the irrelevant papers: h-core=155.  
Figure 4 Search strategy to identify the h-core publications 
 
I investigated different types of collaborations in the h-core papers by looking at the 
affiliation of the authors and their country of origin (to identify whether it was Iran or not). 
Author affiliations were found in the full-text of papers, while to explore the country of 
origin of authors, language of their names and also study/work background of the authors 
were investigated by searching the Web. Most Iranian names have distinguishable 
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characteristics. As a native Persian speaker, I investigated the language of the names and 
categorised the articles as explained below. 
• Authors with Persian names who only had Iranian affiliation(s) were considered 
as ‘Iranian in Iran’. 
• Authors with Persian names who only had non-Iranian affiliation(s) were 
considered as ‘Iranian abroad’. Since there might be people with Persian first 
and surnames who had never studied nor worked in Iran, education and work 
background of authors with Persian names but international affiliation(s) were 
also searched on the Web.  
• Publications of authors with Persian names but with dual affiliations (Iranian 
and international affiliations) were considered as a collaboration of ‘Iranian in 
Iran and Iranian abroad’. 
• Authors with non-Persian names and non-Iranian affiliation(s) were considered 
as ‘International’.  
• Authors with non-Persian names, but with Iranian affiliation were considered 
as ‘Foreigner in Iran’.  
• Articles which were clearly part of a large international collaborative project, 
funded by international organisations, and/or with collaborators from various 
parts of the world, and/or on topics that international collaboration was 
inevitable were considered as ‘Consortium’. 
The 155 h-core papers were analysed for: (i) authors; (ii) organization-enhanced; (iii) 
journals; (iv) document types; (v) research areas; and (vi) collaborating countries. A 
subset of the h-core papers comprising ‘only Iranian’ publications, meaning papers 
which solely had Iranian authors affiliated with Iranian institutions, was analysed for 
the first five abovementioned fields. These papers were also categorised into basic, 
clinical, and public health research according to their content. The journals where the 
‘only Iranian’ papers had been published were further analysed using JCR. To 
identify what proportion of the citations to each of the ‘only Iranian’ h-core papers 
originated in Iran, firstly, a ‘Cited Reference Search’ was performed to find items 
that had cited each of the papers. Secondly, by running an ‘Advanced Search’ with 
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the country field tag, all the publications with at least one author based in Iran were 
retrieved. A combination of these two search provided the citing documents that had 
at least one author in Iran, and the proportion of these publications to all citations 
was computed.  
5.5 Results 
Bibliographic information of the 155 h-core publications with their citation counts are 
provided in Appendix 4. Citation counts ranged between 156 and 3,959. The most-
cited paper was a systematic analysis for the Global Burden of Disease (GBD) Study 
2010, with contribution from 118 institutions (two of which were Iranian) and was 
published in 2012 in The Lancet. The oldest highly-cited record (published in 1973) 
was authored by three Iranians affiliated with Namazi Hospital of Pahlavi University, 
and one non-Iranian person with the same Iranian affiliation. Table 9 summarises the 
major results from analysis of the 155 h-core papers and the full results are provided 
in Appendix 5. Twelve international institutions appeared among the top contributors 
to the h-core papers, while the three Iranian ones included Tehran University of 
Medical Sciences—TUMS (51 papers), Shahid Beheshti University of Medical 
Sciences (19 papers), and Isfahan University of Medical Sciences (13 papers).  
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Table 9 The top contributors to the 155 Iranian clinical. Biomedical, and public health h-core publications (1965-2014), indexed in Web of Science Core Collection* 
Rank Research Areas with ≥6 h-core papers 
Organisations† contributed to 
≥13 h-core papers 
Authors (from Iran, 
contributed to ≥5 h-core papers) 




1 General Internal Medicine (31) 
Tehran University of Medical 
Sciences (51) 
Farzadfar, F (9) The Lancet (17) UK (74) 
2 Pharmacology Pharmacy (18) University of London (29) Naghavi, M‡ (8) Journal of Endodontics (7) US (65) 
3 Oncology (13) Harvard University (24) 
Forouzanfar, MH‡; 
Torabinejad, M‡ (7) 
New England Journal of 
Medicine (5) 
Canada (35) 
4 Biochemistry Molecular Biology (12) 
University of California System 
(22) 
Abdollahi, M; Azizi, F; 
Ezzati, M‡; Kelishadi, R; 
Pourmalek, F‡ (6) 
Advanced Drug Delivery 
Reviews; American Journal of 
Clinical Nutrition; Biosensors 
Bioelectronics; Diabetes Care; 
Journal of Allergy and Clinical 
Immunology; Nature Genetics 
(3) 
People’s Republic of 
China; Sweden (27) 
5 
Biotechnology Applied Microbiology; 
Endocrinology Metabolism; Nutrition Dietetics (9) 
University College London (20) 
Azadbakht, L; Esmailzadeh, 






6 Public Environmental Occupational Health (8) 
Shahid Beheshti University of 





Cell Biology; Chemistry; Dentistry Oral Surgery 
Medicine; Genetics Heredity (7) 
Karolinska Institutet (18); 
National Institute of Health 
(NIH USA) (18) 




Immunology; Neuroscience Neurology; Psychiatry; 
Science Technology other Topics (6) 
Imperial College London; 




University of Oxford; 
University of Toronto; (15) 
Argentina (18) 
10 
Isfahan University of Medical 
Sciences; Monash University; 
University of Sydney (13) 
Colombia; Turkey 
(16) 
*The names grouped in one cell have had equal number of contributions, as presented in brackets; †The same numbers were double reported for ‘University of Washington’ and ‘University of Washington 
Seattle’. Here, the figures are reported for ‘University of Washington’ as its preferred name variant; ‡Authors who at least in one of their publications were affiliated with international institutions. 
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Using the approach described in section 5.4, different types of collaborations were 
identified. As indicated in Figure 5, of the total 155 records, 48 (30.9%) were ‘only 
Iranian’ and the rest, included some sort of international collaboration.  
Figure 5 Distribution of different types of collaborations across the 155 Iranian clinical, biomedical, 
and public health h-core publications (1965-2014), indexed in Web of Science Core Collection 
 
Table 10 summarises the titles and bibliographic information of the 48 ‘only Iranian’ 
publications, the citation counts (until 28 February, 2018), and the proportion of 
citations to each that had originated in Iran. As explained in section 1.11.3, citation 
counts depend on the year of publication and the research field. Hence, higher or lower 
number of citations to the articles listed on Table 10 does not represent any 
superiority/inferiority. Distribution of document types and research categories across 
the 48 ‘only Iranian’ publications is presented in Table 10.  
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The majority of the ‘only Iranian’ h-core papers were basic research (64.5%). Also, 
62.5% of the 48 papers were original articles; and the remaining were review articles 
(Further details in Table 11). The 48 ‘only Iranian’ papers were published across 43 
journals. IF of these journals ranged between 0.4 and 8.3 with a median of 2.3 (based 
on the IF in the year when each paper was published). A full list of the 43 journals 
where the ‘only Iranian’ papers had been published and the IFs are available in 
Appendix 6.  
The research areas, institutions, and authors with most contribution to the 48 ‘only 
Iranian’ papers and the journals which have published at least two of these papers are 
listed in Table 12. The most-cited ‘only Iranian’ paper was a review article in basic 
sciences entitled ‘Hydrogel nanoparticles in drug delivery’, published in 2008 in 
Advanced Drug Delivery Reviews. The paper was a collaboration between three 
authors affiliated with Shiraz and Zanjan universities of medical sciences. It was cited 
778 times, and only 9.1% of its total citations were from sources affiliated to Iranian 
institutions. In general, the proportion of citations that originated in Iranian institutions 
ranged between 0.8% and 97.7%. All of the six papers which over 80% of their 
citations was Iranian were in public health. While five of them were national and sub-
national epidemiologic studies (addressing cancer; mental health; non-communicable 
diseases; cardiovascular risk factors; and metabolic syndrome), one was the 
preliminary results of a community-based programme for prevention and control of 
cardiovascular diseases. The papers which had less than 10% of their citations 
originated in Iran (including 17 papers) were predominantly in basic sciences (16 out 
of 17).  
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Table 10 List of the 48 ‘only Iranian’ h-core health research publications (1965-2014), indexed in Web of 
Science Core Collection, ranked by their year of publication, and then by citation count within each year 

















Extracellular biopolymeric flocculants - 









Azizi F, Rahmani 
M, Emami H, et al. 
Cardiovascular risk factors in an Iranian 
urban population: Tehran Lipid and 








Azizi F, Salehi P, 
Etemadi A, et al. 
Prevalence of metabolic syndrome in an 
urban population: Tehran Lipid and 
Glucose Study 
Diabetes Research and 






A Vessal M, 
Hemmati M, Vasei 
M 
Antidiabetic effects of quercetin in 
streptozocin-induced diabetic rats 
Comparative 
Biochemistry and 
Physiology - Part C: 
Toxicology & 
Pharmacology 2003 






Biochemical evidence for free radical-
induced lipid peroxidation as a 
mechanism for subchronic toxicity of 









Sadri G, Afzali 
HM, et al. 
Isfahan Healthy Heart Programme: a 
comprehensive integrated community-
based programme for cardiovascular 
disease prevention and control. Design, 
methods and initial experience 






Ranjbar A, Shadnia 
S, et al. 










Tabatabai SA, Faizi 
M, et al. 











Yasamy MT, et al. 
Mental health survey of the adult 
population in Iran 







Rahimi R, Nikfar S, 
Larijani B, et al. 
A review on the role of antioxidants in 











Esmailzadeh A, et 
al. 
Beneficial effects of a Dietary 
Approaches to Stop Hypertension eating 
plan on features of the metabolic 
syndrome 




Esmailzadeh A, et 
al. 
Dairy consumption is inversely 
associated with the prevalence of the 
metabolic syndrome in Tehranian adults 
American Journal of 






Safavi A, Maleki N, 
Moradlou O, et al. 
Simultaneous determination of dopamine, 
ascorbic acid, and uric acid using carbon 
ionic liquid electrode 
Analytical 
Biochemistry 2006 




Talebian F, et al. 
Aging of mesenchymal stem cell in vitro 
BMC Cell Biology 
2006 





Antioxidant activity, phenol and 
flavonoid contents of some selected 
Iranian medicinal plants 
African Journal of 
Biotechnology 2006 
13% 266 Basic 0.45 
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16 
Eidi A, Eidi M, 
Esmaeili E 
Antidiabetic effect of garlic (Allium 
sativum L.) in normal and streptozotocin-
induced diabetic rats 
Phytomedicine 2006 13% 163 Basic 1.403 
17 
Hamidi M, Azadi 
A, Rafiei P 
Pharmacokinetic consequences of 
pegylation 







Shahverdi HR, et al.  
Synthesis and effect of silver 
nanoparticles on the antibacterial activity 
of different antibiotics against 




Biology and Medicine 
2007 




Ghods S, et al 
Immunomodulating and anticancer agents 









20 Kelishadi R 
Childhood overweight, obesity, and the 












Shahverdi HR, et al. 
Rapid synthesis of silver nanoparticles 
using culture supernatants 








Atlasi Y, Mowla SJ, 
Ziaee SA, Bahrami 
AR 
OCT-4, an embryonic stem cell marker, 
is highly expressed in bladder cancer 
International Journal of 
Cancer 2007 
11.6% 173 Basic 4.555 
23 Hosseinimehr SJ 
Foundation review: Trends in the 
development of radioprotective agents 









Amini H, et al 
Celecoxib as adjunctive therapy in 
schizophrenia: A double-blind, 
randomized and placebo-controlled trial 
Schizophrenia 
Research 2007 





M, et al. 
Phase 1 trial of autologous bone marrow 
mesenchymal stem cell transplantation in 
patients with decompensated liver 
cirrhosis 
Archives of Iranian 
Medicine 2007 





Hamidi M, Azadi 
A, Rafiei P 
Hydrogel nanoparticles in drug delivery 
Advanced Drug 








Review of pharmacological effects of 











Health-related quality of life in breast 
cancer patients: A bibliographic review 










29 Jouyban A 
Review of the cosolvency models for 
predicting solubility of drugs in water-
cosolvent mixtures 










Pharmacological and therapeutic effects 








31 Gill P, Ghaemi A 
Nucleic acid isothermal amplification 
technologies - A review 
Nucleosides 













hydroquinone double-wall carbon 
nanotube paste electrode for simultaneous 
determination of epinephrine, uric acid 
and folic acid 
Biosensors & 
Bioelectronics 2008 
65.6% 168 Basic 5.149 
33 
Soleimani M, Nadri 
S 
A protocol for isolation and culture of 
mesenchymal stem cells from mouse 
bone marrow 




Ramazani R, et al. 
Cancer incidence and mortality in Iran 
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35 
Safavi A, Maleki N, 
Farjami E 
Fabrication of a glucose sensor based on 
a novel nanocomposite electrode 
Biosensors & 
Bioelectronics 2009 
14.3% 218 Basic 5.429 
36 
Azizi F, Ghanbarian 
A, Momenan AA, 
et al and the Tehran 
Lipid and Glucose 
Study Group 
Prevention of non-communicable disease 
in a population in nutrition transition: 
Tehran Lipid and Glucose Study phase II 







Alikhani S, et al. 
First Nationwide Study of the Prevalence 
of the Metabolic Syndrome and Optimal 
Cutoff Points of Waist Circumference in 
the Middle East The National Survey of 
Risk Factors for Noncommunicable 
Diseases of Iran 






Jafari S, Raisi F, et 
al. 
Clinical trial of adjunctive celecoxib 
treatment in patients with major 




12.9% 171 Clinical 2.926 
39 Ranjbar B, Gill P 
Circular Dichroism Techniques: 
Biomolecular and Nanostructural 
Analyses- A Review 
Chemical Biology & 









Antioxidant activity, phenol and 
flavonoid contents of 13 citrus species 
peels and tissues 
Pakistan Journal of 
Pharmaceutical 
Sciences 2009 





Using the concept of Chou's pseudo 
amino acid composition for risk type 
prediction of human papillomaviruses 
Journal of Theoretical 
Biology 2010 
6.6% 258 Basic 2.371 
42 Mohabatkar H 
Prediction of Cyclin Proteins Using 
Chou's Pseudo Amino Acid Composition 
Protein and Peptide 
Letters 2010 
4.7% 215 Basic 1.849 
43 
Mohabatkar H, 
Beigi  MM, 
Esmaeili A 
Prediction of GABA(A) receptor proteins 
using the concept of Chou's pseudo-
amino acid composition and support 
vector machine 
Journal of Theoretical 
Biology 2011 
6.6% 183 Basic 2.208 
44 
Jadidi-Niaragh 
F, Mirshafiey A. 
Th17 Cell, the New Player of 
Neuroinflammatory Process in Multiple 
Sclerosis 
Scandinavian Journal 








Manoochehri S, et 
al. 
Polylactide-co-glycolide nanoparticles for 
controlled delivery of anticancer agents 







Nabavi SM, Nabavi 
SF, Eslami S, et al. 
In vivo protective effects of quercetin 
against sodium fluoride-induced 
oxidative stress in the hepatic tissue 




Pesticides and human chronic diseases: 











Biparva P, Hatami 
M. 
A novel modified carbon paste electrode 
based on NiO/CNTs nanocomposite and 
(9, 10-dihydro-9, 10-ethanoanthracene-
11, 12-dicarboximido)-4-ethylbenzene-1, 
2-diol as a mediator for simultaneous 
determination of cysteamine, 




63.5% 192 Basic 6.541 
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Table 12 The top contributors to the 48 ‘only Iranian’ h-core health research publications (1965-2014), 
indexed in Web of Science Core Collection 
No. 
Research areas with 
≥3 papers 
Organisations 
contributing to ≥3 papers 
Authors contributing 
to ≥3 papers 
Journals that have 
published ≥2 papers 
1 Pharmacology 
pharmacy (14) 
Tehran University of 
Medical sciences (17) 




molecular biology (7) 
Shahid Beheshti 
University of Medical 
sciences (9) 
Abdollahi, M; 
Mirmiran, P (4) 
Diabetes Care; Journal of 
Theoretical Biology; 
Phytotherapy Research (2) 










Shiraz University (5) 
 
5 Science Technology 
other Topics (5) 
Mazandaran University of 






Isfahan University of 
Medical Sciences; 
Ministry of Health and 
Medical Education; Shiraz 










 Original Article Review Article Total 
Basic  18 13 31 
Clinical 4 1 5 
Public Health 8 4 12 
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Chapter 6 Iran’s health research system moving 
forward: a national-level health 
research priority-setting exercise  
6.1 Introduction 
As explained in section 1.12, and chapters 3, 4, and 5, although Iran has significantly 
progressed in terms of expanding its capacity to conduct health research and even to set 
health research priorities over the last three decades, it still lacks systematic and inclusive 
mechanisms to set the national health research priorities. Furthermore, as described in 
section 3.5.2, Iran’s investment in research, particularly in health research has remained 
limited, and even has declined over the last decade (409). There seems to be a substantial 
need to a proper prioritisation process to clarify the research priorities and align them 
with Iran’s national and international health agendas.  
6.2 Aim 
This chapter aimed to adapt the CHNRI method to identify health research priorities in 
Iran to assist with the efficient use of resources towards achieving the long-term health 
targets. It should also provide a model to other low- and middle-income countries on how 
to effectively adapt this prioritisation process to improve funding allocation for health 
research.  
6.3 Objectives 
• Create an appropriate management group to run the exercise 
• Identify and invite the group of policymakers and funders  
• Identify and invite the group of prominent Iranian researchers with expertise relevant 
to the scope of the study 
• Identify and invite the wider group of stakeholders 
• Identify the context of the study, e.g. the timeframe, the topic, the level 
• Compile a list of research questions after collecting the generated questions from the 
researchers 
• Identify the scoring criteria with clear definitions 
Describing the evolution of Iran’s health research system, understanding the profile of its publications 
over 50 years, and setting the national health research priorities  
 134 
• Calculate the scores obtained by each research question against every criterion and 
the total score, before and after the assignment of the input from stakeholders 
• Calculate the average level of agreement among the researchers on each research 
question 
6.4 Methods 
I conducted this study between July-December 2017, using the CHNRI method, as 
described in sections 1.7 and 1.12. All of the original materials and correspondences with 
participants in this exercise were in Persian, and I translated the ones which required 
further discussion within the steering committee into English.  
6.4.1 Defining the context of the health research priority-setting 
study 
In the first step, I formed a steering committee for running the CHNRI exercise in Iran. 
As the coordinator of the steering committee, I invited four people to sit on the committee 
as follows: (1) Professor Igor Rudan (IR); (2) Dr Kit Yee Chan (KYC); (3) Professor 
Reza Majdzadeh (RM); and (4) Dr Zhaleh Abdi (ZA). IR and KYC were invited for their 
expertise in the CHNRI methodology and extensive experience in its implementation in 
multiple national and global exercises. RM and ZA were invited for ensuring that the 
CHNRI method was adapted properly within the context of Iran. They also facilitated 
identification of and access to the study participants. I was based in Tehran, Iran during 
the conduct of this study and coordinated communications between the members of the 
steering committee through e-mail correspondences and WhatsApp group calls.  
Through several meetings and discussions within the steering committee, different 
components of the context of the exercise were defined, including, (i) health targets on 
which the exercise focused and the agendas where the targets were outlined (i.e. Iran’s 
long-term health targets as outlined in Iran’s GHPs and in the Sustainable Development 
Goals (SDGs), listed in appendices 1 and 7, respectively); (ii) geographic limits (i.e. 
national); and (iii) the time scale within which the research is expected to be funded and 
conducted (i.e. the next 5 years). In terms of the time scale of the exercise, a short-term 
period was aimed, because most of the national plans in Iran are made for 5-year periods. 
Furthermore, as described in section 3.5.2, the majority of health research funding bodies 
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in Iran are run by the government, thus their funding policies often change every four to 
eight years with the change of the President of the country and/or his Cabinet.  
In terms of the long-term health targets, it should be noted that currently Iran has two 
major commitments for improving population health: one national and one international 
commitment. Aligning the national and international commitments facilitates the 
monitoring and evaluation of the progress towards achieving the long-term targets. 
Therefore, in this exercise, Iran’s health targets as outlined in both its national and 
international major commitments were included.  
Iran’s national commitment for improving health is to achieve the GHPs by 2025. The 
English translation of the GHPs is presented in Appendix 1. The GHPs are a set of 14 
long-term health targets that were announced in 2014 by Iran’s Supreme Leader, who as 
explained in section 1.10.4, is responsible for outlining the general policies for the 
country. The GHPs aim to provide Iran with a framework to achieve the health-related 
goals of Iran’s Vision 2025. The Vision 2025 is a 20-Year national strategic plan that was 
released in 2004 and outlines political, economic, and social goals, which achieving them 
presumably could facilitate Iran’s broader ambition, i.e. ‘becoming the Middle East’s top 
power by 2025’ (310, 410).  
One of the major international commitments of Iran is to deliver the SDGs by 2030, and 
this also includes achieving the health targets that are outlined in the SDGs. The SDGs 
were adopted by the UN General Assembly in 2015, and Iran is one of its signatories. The 
SDGs are a set of interconnected goals that build on the successes of the Millennium 
Development Goals, while introducing new areas, such as climate change, economic 
inequality, and sustainable consumption (411). Among the 17 goals that are proposed in 
the SDGs, Goal 3 specifically addresses health issues and is described as a goal for 
‘ensuring healthy lives and promoting the well-being of all at all ages’ (411). In this 
study, in addition to the 13 targets outlined under Goal 3 (i.e. 3.1-3.9, and 3.a; 3.b; 3.c; 
and 3.d), eight additional SDG health targets were included from goals other than Goal 
3. This consists of the targets that were proposed in the 2016 report of the WHO on 
Monitoring Health for the SDGs (412). The full list of the SDG targets that were included 
in this study is provided in Appendix 7.  
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In reviewing the content of the GHPs and the health targets of the SDGs, I found a high 
degree of overlap between the targets across the two agendas. Only five of the GHPs are 
not covered by the SDGs due to being quite specific to the context of Iran, including GHP 
1, GHP 2, GHP 12, GHP 13, and GHP 14 (Further details in Appendix 1).  
6.4.2 Identification, invitation, and participation of the experts  
I identified a total of 70 experts—in the fields relevant to the health targets that were 
included in this exercise—across a reasonably wide range of disciplinary backgrounds 
and views. To identify experts, I searched the Web of Science and Scopus databases for 
the most prolific researchers in Iran in the areas related to the included health targets in 
this study. To do so, I went through a random sample of the publications of the most 
productive authors to identify whether the papers were original research and could 
confirm that their authors were real experts in the field (Further details is provided in 
Appendix 8). I also searched the web in Persian for experts who have held leading 
academic roles in Iranian scientific societies and or universities, or have held scientific 
roles in executive organisations, e.g. MOHME and or NGOs. I gave careful consideration 
to ensure that the invitees had a good understanding of research in their field, and were 
not solely holding executive roles. The final list of experts were checked and overseen by 
RM and ZA to ensure that the list had a comprehensive coverage of experts. 
To diversify the range of expertise of identified researchers, which was predominantly 
from medical sciences backgrounds, I used snowballing, by asking the identified experts 
in less represented areas (e.g. in social sciences, humanities, environmental sciences) to 
nominate other experts in their field. Despite such efforts, education background of the 
majority of the invitees (70%) was clinical, biomedical, and/or public health sciences. 
This figure for those who contributed to generating RQs and to the scoring of the RQs 
was 74% and 75%, respectively.  
I sought contact information of the identified experts through combined searches in 
PubMed, Google, and in accessible contact and mailing lists. Of the 70 identified experts, 
I could not find updated contact information for two (one anthropologist and one lawyer 
who were both based outside Iran). Therefore, eventually, 68 experts were invited to the 
exercise. To encourage participation, I prepared individualised inviting letters on Iran’s 
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NIHR letterheads, got them manually signed by RM, the then Head of the NIHR, scanned 
the signed letters, and attached the digital invitations to individualised inviting e-mails 
which RM sent to the invitees and copied me in. The English content of the letters and a 
sample of an original inviting letter are provided in Appendices 9 and 10, respectively. 
The e-mails also included the instructions for generating RQs (Appendices 11 and 12) 
and the list of the health targets based on which the researchers were asked to propose 
research questions. The list included the GHPs (Appendix 1) and the health targets of the 
SDGs (Appendix 7). All the original material were in Persian, including the health targets.  
Figure 6 summarises how many experts participated at each stage of the exercise. An 
overview of experts’ background information and participation is provided in Appendix 
13. 
  Figure 6 Experts’ participation in the health research priority-setting exercise 
Describing the evolution of Iran’s health research system, understanding the profile of its publications 
over 50 years, and setting the national health research priorities  
 138 
6.4.3 Generating research questions 
In the first instance, the identified experts were invited to participate in the exercise by 
independently generating three to five RQs. Fifty experts (73.5% of all 68 invitees) agreed 
to participate and generated a total of 251 RQs. The steering committee of this exercise 
(including myself, IR, KYC, RM, and ZA) retained 128 RQs after removing apparent 
duplicate questions and merging very similar ones. This stage included several rounds of 
translating and back translating between Persian and English, because the original RQs 
were in Persian, while the list should have been discussed among the committee members, 
who two of them were non-Persian speakers. Finally, the agreed list of RQs had to be 
translated into Persian to share with the Iranian experts for scoring. The consolidated list 
of 128 RQs, the five criteria, and scoring instructions were sent to the original 68 experts 
with an invitation to score the RQs. The 5 scoring criteria (presented in Table 13) were 
chosen and defined specifically for this exercise using input from a management group 
of nine persons which included Iranian health research policymakers and funders, and the 
steering committee. The process through which the criteria were selected is described in 
the following section. 
6.4.4 Selecting and defining the criteria  
The CHNRI method introduces a transparent set of criteria that could discriminate 
between many competing research options. CHNRI’s ‘standard’ criteria include (i) 
answerability, (ii) effectiveness, (iii) deliverability, (iv) potential for a substantial 
reduction of disease burden, and (v) impact on equity (42). However, the CHNRI method 
provides flexibility to modify the criteria according to the context (42). Using this 
flexibility, the selected criteria and their definitions were modified for this exercise, based 
on the input from a management group. The management group comprised the steering 
committee members (including myself, IR, KYC, RM, and ZA) and four other people 
who held positions that allowed them to influence Iran's major health research policy 
making and/or funding decisions.  
On the first step, I coordinated discussions among the steering committee regarding the 
context suitability of the ‘standard’ CHNRI criteria and the other criteria that have been 
used in previous CHNRI exercises. Two new criteria were proposed as they seemed to fit 
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within the context of Iran. After several discussions where each of the members of the 
steering committee argued for inclusion and/or exclusion of any of the criteria, a 
consensus on a shortlist of 9 criteria and a definition for each was achieved (Appendix 
14). The shortlist included the following: (i) feasibility; (ii) impact on health; (iii) impact 
on economy; (iv) capacity-building; (v) equity; (vi) impact on Iran’s scientific rank; (vii) 
potential for translation; (viii) impact on creating wealth; and (ix) long-term impact.  
On the second step, the other four members of the management group were invited to 
independently rank the nine criteria, choose the top-five, and provide comments that 
could improve the proposed definitions of the criteria. These participants were invited 
from the Academy of Medical Sciences; Department of Research and Technology of 
MOHME; Department of Curative Affaires of MOHME; and Department of Research 
and Technology of Tehran University of Medical Sciences. Except for the first invitee 
who represented the Academy of Medical Sciences, the other three chose to express their 
personal opinion.  
On the third step, each of the steering committee members ranked all the nine criteria too. 
By counting the total votes for each criterion as well as counting the scores that each 
criterion had received (based on the ranking system), the top-five criteria were selected 
as follows: (i) feasibility; (ii) impact on health; (iii) impact on economy; (iv) capacity-
building; and (v) equity. The top-five criteria turned out to be the same using both 
approaches (counting the votes or counting the value based on ranking). Finally, to obtain 
the definition for each criterion, I summarised the comments from all. At this step, I also 
asked a colleague from the Knowledge Utilization Research Center at Tehran University 
of Medical Sciences who has extensive knowledge and experience in health research 
impact assessment in Iran to assist with improving the final definitions.  
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Table 13 List of the included five criteria and the agreed definition for each 
Number Criterion Definition 
1 Feasibility 
(i) There is sufficient capacity (e.g. data infrastructure, laboratory equipment) 
to carry out this research; (ii) It is possible to provide training for the staff who 
would undertake this research; (iii) This research can be conducted in an 




Results of this research have high potential to improve health by: (i) reducing 
disease incidence and/or prevalence;(ii) reducing social, environmental, and/or 
individual risk factors of ill-health; (iii) shaping future health planning and 
implementation; (iv) improving health services delivery by improving 
acceptability, accessibility, suitability, efficiency, efficacy, effectiveness, 
and/or safety of treatment or service; and/or (v) improving societal and system 




Results of this research have high potential in: (i) having direct effect on the 
production of materials or consumer services; (ii) optimising the earlier goods 
and/or products (increasing quality and/or reducing production costs); (iii) 
creating knowledge-based entrepreneurship; (iv) decreasing days of work 
missed due to illness or disability for patients and caregivers; (v) reducing 
opportunity costs for patients and caregivers; (vi) reducing impact on direct 
patient costs as well as health and welfare systems; and/or (vii) reducing 





Results of this research have high potential to lead to: (i) education and training 
in Iran's human resources; (ii) the acquisition of new skills by the research 
team; and/or (iii) investment to improve research facilities/amenities where the 
study will be undertaken, e.g. purchasing software/equipment 
5 Equity 
Results of this research have high potential to: (i) lead to interventions or 
services that will be accessible and affordable to everyone, including members 
of vulnerable groups; (ii) lead to policy, plans, interventions or services that 
could reduce health inequality. This could be achieved by policies or 
interventions that target and empower vulnerable groups to reduce risk and 
disease exposures and/or improve access to services or interventions. 
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6.4.5 Scoring research questions 
On the scoring step, I prepared individualised scoring sheets for each researcher in 
Microsoft Excel where all the 128 RQs were listed against the 5 criteria. The RQs were 
sorted randomly on each scoring sheet so that all of the RQs would have an equal chance 
of standing on higher or lower rows on the list. Similar to the initial invitation, I prepared 
individualised inviting letters on Iran’s NIHR letterhead, got them manually signed by 
RM, scanned the letters (Appendices 15 and 16), and attached them to the scoring inviting 
e-mails and along with the scoring instructions (Appendices 17 and 18) sent to the 
researchers. After sending out the e-mails, the researchers were initially given 2 weeks to 
send back their responses. After 2 weeks, I followed up the invitees on a weekly basis 
and the majority responded within the following 2-3 weeks. To the researchers who 
wanted to decline participation due to time constraint, an option of scoring RQs against 
fewer criteria—instead of all the 5 criteria—was given. Of this group of researchers, only 
one of them accepted this offer and scored the RQs for only one criterion, and the rest of 
invitees who initially wanted to decline scoring due to time constraint scored the RQs 
against all the 5 criteria. One of the scorers argued that it was only possible to score the 
RQs for ‘Feasiblity’, therefore he was encouraged to do so. In sum, 46 of the experts 
scored the RQs against the 5 criteria and two experts scored the RQs only for ‘feasibility’. 
The scoring sheets on Microsoft Excel did not read well for two of the researchers 
(possibly because of the incompatibility of Arabic fonts with Mac systems), for whom I 
prepared the scoring sheets in Google Docs. 
The CHNRI method provides four response options for scoring: 0; 0.5; 1; or leaving blank 
in case the expert does not feel sufficiently informed to respond. However, within the 
steering committee of this exercise, it was agreed that typing a 3-digit response—i.e. 
‘0.5’— may not seem convenient. Hence the instructions were adapted as follows: scoring 
‘3’ for ‘yes’; ‘2’ for ‘informed but undecided’; ‘1’ for ‘no’; and ‘0’ for ‘insufficiently 
informed’. For calculating the results, all responses were re-coded to the standard CHNRI 
scoring system. In total, 48 of the initial 68 invited experts (70.6%) completed scoring. 
To ensure that the researchers felt free to express their opinions while generating and/or 
scoring RQs, they were informed that nobody outside the steering committee of the 
exercise would be able to link their input to their real names.  
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6.4.6 Engaging stakeholders from the wider society 
To ensure that the prioritisation exercise considered views of a wider group of 
stakeholders, relative weights for each of the five criteria were calculated using the input 
from a larger reference group as explained below.  
Engaging laypersons, frontline health workers, and patients in health research 
prioritisation processes is highly recommended because these people have their own 
specialised knowledge and a real stake in the outcome of the process (35). I identified 
participants in the stakeholders’ group using snowballing in addition to sharing a public 
invitation in online forums of patients and healthcare professionals in Iran. The online 
platform that I used for this purpose was an instant messaging service: i.e. Telegram app. 
Telegram app which was widely used among Iranians at the time the study was conducted 
allows easy sharing of information across various online forums. The stakeholders were 
given a brief summary of the aims of the exercise and the definition of the criteria in plain 
language, and were invited to rank the five criteria in a descending order based on their 
system of values and send back their response to an account (called 
@health_research_priorities in English) which I had created for this purpose. The English 
translation of the inviting message and the original message in Persian are provided in 
appendices 19 and 20, respectively. The inviting message was ‘seen’ by a total of 4,000 
people. In total, sixty-eight stakeholders from the following groups participated: 16 
patients with chronic diseases; 14 caregivers; 23 healthcare professionals (including 12 
medical doctors, 6 nurses, 3 pharmacists, 1 dentist, and 1 midwife); 3 social workers; 9 
social and environmental activists; and 3 pharmacists from industry. Once I would have 
received a response from participants, I would have asked them (via text messaging in 
the online application), if they could indicate the group which they wanted to represent. 
This was important because one person could belong to several groups, e.g. a medical 
doctor with a chronic disease who was a social activist too. Indeed, at the end, the precise 
categorisation of the stakeholders’ group was not possible and was outside the scope of 
this study. I only wanted to have a rough idea to ensure a reasonable coverage of a wide 
range of stakeholders. Appendix 21 provides further information on the profile of the 
engaged stakeholders. 
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The group of stakeholders collectively allocated the highest average score to the criterion 
impact on health (4.13). This was followed by feasibility (3.44), impact on economy 
(2.71), equity (2.56), and capacity building (2.19). To calculate the weight of each 
criterion, these average scores were divided by 3.00; i.e. the average score in case of equal 
value of all the five criteria. The amount of average scores to each criterion is provided 
in Table 14.  
Table 14 Stakeholders' input calculation 
Criteria Mean score (1-5) Mean suggested weight 
Impact on Health  4.13  1.38 
Feasibility 3.44 1.15 
Impact on Economy 2.71 0.90 
Equity  2.56 0.85 
Capacity Building 2.19 0.73 
To rank the RQs, ‘weighted research priority scores’ were calculated. This score took into 
account the average score provided by the experts to each RQ across the 5 criteria, and 
the weights assigned by the stakeholders to each criterion. The average scores—that 
initially were between 0 and 1—were multiplied by 100 to provide scores in a range 
between 0 and 100. The RQs were also ranked based on the scores for each criterion. 
Average expert agreement (AEA)—i.e. the level of agreement among the scorers—on 
each RQ was also computed as the frequency of the mode (i.e. the most common score 
divided by the total number of scores). All the independent responses of scorers, 
calculations that led to the final scores, weights, and AEA are provided in Appendix 22. 
6.4.7 Ethics 
The CHNRI method relies on input from human subjects. Hence, ethical aspects of 
conducting CHNRI exercises should be considered. After the CHNRI method was 
developed and proposed for implication, the method itself, underwent ethical assessment 
at the institution where it was developed–i.e. the Croatian Centre for Global Health at the 
Faculty of Medicine of the University of Split, Croatia. That ethical assessment of the 
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method resulted in a list of recommendations by following which, alignment of CHNRI 
studies with research ethics would be ensured. The recommendation are extensively 
explained elsewhere (34), and in short, they address the issues regarding voluntary 
participation and consent of the participants if the findings are shared without 
anonymisation (34). I ensured to address all the ethical concerns and recommendations 
regarding implementation of the CHNRI method. Still, I had to seek for ethics approval 
from Iran, because all research applications related to health sciences should obtain ethics 
approval, according to a new regulation in Iran. Following the Iranian academic 
regulations, I sought for and received ethics approval from the Ethics Committee of Iran’s 
National Institute of Health Research (NIHR) for conducting the CHNRI exercise. A copy 
of the approval letter is provided in Appendix 23.  
In terms of anonymity of participants of the CHNRI exercise, the researchers were 
informed that their real name will appear on the reports and or manuscripts resulting from 
this exercise, unless they wish not to (two of the researchers requested anonymity). 
However, the researchers were informed that nobody except the study’s steering 
committee members could link the individual generated research questions and the 
individual allocated scores to research questions to the real names of the researchers. 
Meaning that they were informed that only the collective results will be reported. To 
ensure confidentiality, I created a key list where a code was assigned to each researcher, 
and I kept the key list in an electronic file to which only I had access. The key list was 
kept separated from where the files including the real names of the researchers was kept.  
6.5 Results 
As described in section 6.4, in total, 128 RQs were systematically scored by 48 experts 
against five criteria, and 68 representatives from stakeholder groups provided weights to 
the five criteria. The weighted Research Priority Scores (wRPS) ranged from 84.5% to 
28.5%. Table 15 shows the top 10 priorities, the wRPSs, the score that each priority has 
received for each criterion, and the AEA. Full list of the ranked 128 RQs is provided in 
Appendix 22.  
Ninety-two of the 128 RQs (71.8%) fell entirely or partially under health policy and 
systems research (HPSR). To identify HPSR questions, the definition proposed by the 
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Alliance for Health Policy and Systems Research was followed (20), which describes 
HPSR as a field that: ‘…seeks to understand and improve how societies organise 
themselves in achieving collective health goals, and how different actors interact in the 
policy and implementation processes to contribute to policy outcomes. By nature, it is 
interdisciplinary, a blend of economics, sociology, anthropology, political science, public 
health and epidemiology that together draw a comprehensive picture of how health 
systems respond and adapt to health policies, and how health policies can shape − and 
be shaped by − health systems and the broader determinants of health (20).’ 
Forty-five RQs addressed specific causes of morbidity, mortality, and or interventions for 
their diagnosis, prevention, and or management. Sixteen RQs fell into the category of 
‘Planetary Health’—i.e. addressing human health effects of accelerating environmental 
changes– the term was coined in 2014 (414). Other themes that were found across the 
128 RQs were traditional Iranian medicine and Iranian-Islamic values (9 RQs), medical 
education, science, and innovation (6 RQs), and community participation (5 RQs). 
6.5.1 Top-10 health research priorities 
The top 10 priorities comprised a wide range of RQs: 9 contained HPSR components with 
one RQ being focused on medical education; 6 entirely or partially fell into the scope of 
epidemiological research; and one addressed planetary health. The top priority RQ ‘How 
do we reform Iran's health insurance system to improve equity?’ also scored highest for 
impact on economy (RPS= 90.7) and equity (RPS= 91). The second, the third, and the 
fifth priorities all addressed NCDs: two HPSR and one epidemiological question. They 
focused on NCD prevention strategy for Iran and its integration into the primary health 
care; seeking effective and cost-effective population-level interventions for reducing and 
managing NCDs and road traffic injuries; and an epidemiological assessment of NCDs 
and their underlying causes across Iran and making projections for 2030. Both of the 
HPSR questions that addressed NCDs have also scored highest for impact on health.  
The 4th priority focused on tailoring medical qualifications to better serve the needs of 
the nation, and it was agreed among the experts that this RQ would provide the greatest 
opportunity for capacity building. The experts collectively proposed that the 6th priority, 
which focused on ways to achieve UHC, was identified as a rather feasible question to 
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address (ranked 8th for feasibility) and with a good potential for making an impact on 
health (ranked 4th). This priority was followed by proposing investigation of the current 
and the future common health problems in Iran’s elderly population and identifying 
strategies to reduce their economic burden. The consensus of experts suggested that this 
question is the most feasible among all the 128 RQs.  
One planetary health question that was identified as a top-10 priority addressed health 
impacts of water crisis in Iran and how the health system should respond to it. Another 
priority suggesting a health systems research to replace physician-centred system with a 
team-based one was found to provide a great opportunity for capacity building. Another 
top-10 priority proposed assessing the status of antibiotic resistance in Iran and 
investigating ways to promote rational use of antibiotics. 
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Table 15 Top 10 health research priorities in Iran, ranked by wRPS 








1 How do we reform Iran's health insurance system to improve equity? 84.5 68 14.63 81 91 91 63 91 
2 
What should be Iran's non-communicable diseases prevention strategy? How could it be integrated into 
primary health care? 
84.2 66 10.54 86 93 83 69 83 
3 
What are the most effective and cost-effective population-level interventions for reducing and managing 
non-communicable diseases (e.g. ischemic heart diseases, diabetes, stroke, hypertension, and dementia) 
and road traffic injuries in the Iranian context?  
84.2 65 13.14 84 91 88 64 88 
4 
How do we tailor our primary qualifications (e.g. Doctor of Medicine, and Doctor of Pharmacy) and higher 
qualifications (e.g. specialist training in psychiatry) in medical and health sciences in Iran to better serve 
the needs of the nation? 
81.2 60 2.90 84 83 79 80 79 
5 
What are the leading non-communicable diseases (e.g., diabetes, stroke, cardiovascular disease, 
hypertension, and cancer) in Iran now and in 2030? How are they distributed across the country and what 
are their underlying causes?  
79.6 60 15.61 86 87 79 57 79 
6 
To what extent are health resources and services equally distributed across the country? To what extent do 
they meet the needs of the people? How do we reduce inequality in health service access in Iran and achieve 
Universal Health Coverage?  
79.2 65 14.46 85 89 76 60 76 
7 
What is the health status and common health problems in Iran's elderly population? How will these change 
by the year 2030? What is the economic burden of these problems and how can we reduce this burden? 
78.6 58 16.31 87 89 74 58 74 
8 
What is the current status of antibiotic resistance in Iran and future predictions? What is the current 
antibiotic prescription pattern(s) of medical practitioners in Iran? What can we do to promote more rational 
use of antibiotics? 
78.1 53 19.30 85 88 77 51 77 
9 
What are the health impacts of Iran's water crisis? For example, how has the Lake Urmia water crisis 
impacted the health of residents in nearby provinces? What can the Ministry of Health and Medical 
Education and health centres across the country do to respond to water crises? 
78.0 58 13.14 75 86 81 60 81 
10 
How can we replace the current physician-centred system with a team-based care approach (i.e. the 
provision of health services by at least two health professionals including medical doctors, clinical 
pharmacists, nurses who work collaboratively with patients, family caregivers, and community service 
providers to achieve care)? 
77.8 60 6.23 73 84 78 72 78 
RQ: research question; wRPS: weighted research priority score; AEA: average expert agreement; CV: coefficient of variation
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6.5.2 Top-quartile health research questions 
Other questions that were ranked among the top quartile of the 128 RQs (including 33 
RQs with wRPS≥74.3) focused on a range of issues in the Iranian context, as follows: 
optimising resources to produce the 18 vaccines specified in the national programme 
(wRPS=76.4); epidemiological assessment of the current and the future leading causes of 
death and morbidity (wRPS=77.1) and estimating the economic burden of the leading 
NCDs (wRPS=75); evaluating the existing national programmes for improving nutrition 
(wRPS= 75.9), and developing urban spaces that promote healthy lifestyles (wRPS= 75); 
impact of climate change on air quality and on population health (wRPS= 75.1), and 
community-based strategies to reduce energy consumption and environmental pollutants 
(wRPS= 74.3); socioeconomic risk factors of addiction (wRPS= 75.8); community-based 
interventions for reducing high-risk behavior (e.g. intravenous drug use, unprotected sex) 
amongst adolescents in deprived areas (wRPS= 74.3); engagement of private sector in 
health services provision (wRPS= 77.2) and health promotion (wRPS= 75.9); achieving 
sustainable health financing (wRPS= 75.3); roles of the public and private health 
insurance towards achieving the GHPs (RPS= 75.5); the cost–effectiveness threshold and 
criteria for making health interventions decisions (wRPS= 75.6); application of Health 
Technology Assessment for incorporating new therapeutic interventions (wRPS= 75.6); 
identifying the rates and patterns of health services usage (wRPS= 75.3); best model for 
providing pharmaceutical services (wRPS= 74.8); best healthcare payment models to use 
at different levels of Iran's health system (wRPS= 74.6); reforming the health system to 
cope with rapid urbanization (wRPS= 76.1); identifying the major gaps in Iran's health 
surveillance and information systems (wRPS= 76.2); establishment of a national data 
platform for informing evidence-based policy making across different ministries to tackle 
major health issues (wRPS= 75.1); and reforming Ministry of Health and Medical 
Education’s organisational structure and culture (wRPS= 74.7). The AEA for these 
proposed priorities (RQs ranked between 11th and 33th) ranged between 62% and 48%.  
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6.5.3 Research questions which received the lowest scores 
Among the 10 RQs from the bottom of the ranking (wRPS range= 52.5-28.4), 8 addressed 
traditional Iranian medicine and Islamic-Iranian values, while two were very specific 
questions related to dementia. Examples of low-scoring RQs related to dementia were 
‘How do behavioural and psychiatric symptoms of dementia patients differ between Iran 
and other countries?’ (wRPS= 41.4); or ‘At which stages of dementia do people seek 
medical assistance in Iran, and how does this vary between groups with different levels 
of education?’ (wRPS= 52.5). The RQ that received the lowest score (wRPS= 28.4) was: 
‘How should we remember and honour the most influential medical scientists in Iran's 
history? 
6.5.4 Average expert agreement 
In general, the level of agreement among the experts was between 67.5% and 34.58%. 
The RQs for which the greatest level of expert agreement was observed were generally 
those that received the highest RPS (Correlation: 0.79). Seven of the top 10 priorities had 
the greatest agreement scores, with the top-3 RQs having had received the highest AEA 
(65%, 66%, and 68%). On the other hand, RQs that had been the most controversial were 
those that ranked lower than the median based on the expert scoring (68.3).  
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Chapter 7 Discussion  
7.1 Introduction 
In this chapter, I will discuss how my findings address the knowledge gaps about health 
research in Iran by interpreting the findings of my studies. To achieve this outcome, I 
sought for similarities and contrasts of my findings with those reported in the existing 
literature, while also explained the findings within the context of Iran, as described in 
Chapter 1. I will then make recommendations for policymakers and organisations seeking 
to improve HRSs in LMICs.  
7.2 Interpretation of findings in light of the existing 
literature 
7.2.1 Evolution of Iran’s health research system 
The narrative review presented in Chapter 3 showed that Iran has successfully developed 
necessary structures for both formulating and implementing health research policies. 
However, perhaps too often the policies are not well implemented because of several 
constraints, such as the absence of qualified people at executive roles. Stewardship seems 
to be the Achilles heel of the HRS of other countries in the WHO EMR too (6). In 2008, 
it was reported that (415) in a sample of 10 EMR countries, only four had structures for 
national governance of HRS, and just two countries had national health research policies 
(415). The review presented in Chapter 3 indicated that although Iran seems to be at a 
better position regarding having the structures, national policies, and mechanisms for 
oversight in place, as well as some familiarity with health research priority-setting 
approaches, it does not seem to function much better in terms of effective use of this 
capacity. 
The narrative review also found multiple exercises that had attempted to identify the 
health research priorities although a need for more systematic, inclusive, and less time-
consuming approaches to research prioritisation was evident. Some of the barriers to 
initiation of health research prioritisation exercises in Iran and to the utilisation of their 
findings have been identified in the literature as follows: (i) the rapid turnover of people 
at executive roles, which makes individuals at such relatively temporary positions 
reluctant to engage with time-consuming processes (240); (ii) poor knowledge of the 
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majority of research directors of priority-setting methods (240); (iii) the highly centralised 
and top-down decision-making process in Iran’s HRS (240, 241); (iv) inadequate 
interaction between academia and the end-users of health research (240); (v) lack of 
incentives for the researchers who are invited to participate in priority-setting exercises 
(240); (vi) the identified priorities often being too general (240, 241); (vii) most decision-
makers attending the meetings only as a formality, without providing any ‘intellectual 
input’ (240); (viii) in consensus-based prioritisation exercises, ‘powerful’ individuals 
with louder voices influencing the opinion of others, including the representatives from 
NGOs (240). 
Global literature shows that lacking systematic and transparent priority-setting exercises 
is a mutual problem of the HRSs in most LMICs (36, 39). Moreover, it has been reported 
that the majority of health research priority-setting exercises in LMICs have failed to 
engage the key stakeholders (e.g. the community) in the processes, and they have heavily 
relied on the input from researchers and representatives from the governments (36, 40). 
For the context of Iran, there seems to be a need to seek for prioritisation methods that, 
firstly, obtain actual intellectual input from decision-makers rather than having them 
invited to meetings only as a formality, and secondly, methods that can provide adequate 
freedom to the participants to express their opinions.  
The reviewed evidence show that research and publication integrity in Iran’s academia 
still require significant improvements. Of the identified obstacles for improvement, 
overcoming some of them requires fundamental changes. Examples of this category of 
obstacles are to improve meritocracy in recruiting faculty members, because faculty 
members train the future academics; or changing the education system, perhaps from 
primary school to higher education, to improve the level of English and writing skills of 
the graduates. On the other hand, addressing some other constraints seem more feasible 
in medium term, such as modifying the regulations that mandate academics and students 
to publish papers; provision of further training on how to avoid and address plagiarism; 
and improving interaction between academia and the end-users of research. 
It has been reported that the majority of EMR countries have established national-level 
structures to oversight health research ethics. However, they often lack administrative 
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support and financial resources to work effectively (6). A survey published in 2009 (416) 
found that only 21% of respondents from national ethics committees all across the EMR 
had received any formal training on ethics (416). A retrospective analysis of proposals 
from the EMR, published in 2008, had called for increased training of researchers in the 
EMR about the concepts of research ethics as well as development of further guidelines 
for strengthening ethical review systems (417).  
Finally, it is promising that a system is in place for monitoring health research activities 
of medical academic institutions in Iran although for ranking purposes there seems to be 
a demand for: adjustment of the scores by the input of each unit (e.g. the core funding); 
less reliance on bibliometric indicators; further attention towards the quality and the 
impact of research; and additional rewards for collaborative projects between academia 
and the users of research. 
Another key function of a HRS is financing which includes: (i) securing of research 
funds from different sectors, i.e. public and private, both national and international; and 
(ii) allocating the funds efficiently and transparently (15). One basic step towards 
improving financing of the HRS, which Iran has already taken, should be to ensure that 
the official budget plans allocate a proportion to R&D – no matter how small. Although 
since 1996, GERD has been specified in Iran’s annual national budget plan, there is still 
a huge gap in data on financing, particularly about the proportion of GERD that is 
invested in health, or the share of research budget from the total health expenditure. 
Having limited and fragmented data on financial resources for health research is quite 
universal across LMICs and countries of the EMR (6, 15).  
A seemingly successful attempt has been requiring executive entities in the health sector 
to allocate a certain percentage of their annual budget to health research (for the case of 
Iran it was around 2%).  
The 1990 report of the Commission on Health Research for Development (1) had 
recommended that developing countries should allocate at least 2% of their health 
budget to research. The reviewed literature suggested that investing in health research 
has never become a priority in Iran. Iran’s R&D expenditure has even been decreasing 
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in recent years (reaching only 0.3% in 2014). This downward trend is in contrary to the 
ambitious figures that are envisioned for GERD in some of Iran’s major macro-policy 
documents. Allocating limited financial resources to research is a common problem 
across the majority of LMICs (2) and most parts of the EMR (having an average GERD 
of 0.3%, 97% of which is publicly funded) (6). Exceptions in the EMR are a few Gulf 
countries that have been increasing their research investments in recent years (6). For 
instance, GERD in Saudi Arabia suddenly increased from only 0.04% in 2008 to 0.8% 
in 2010 (409). However, these countries have a quite weak national capacity for health 
research and, hence, their research highly depends on international academics (6). For 
example, according to the data abstracted in Scopus database, 75.8% of Saudi Arabia’s 
publications in 2017 had international collaborators (64).  
In terms of resource allocation mechanisms, it is proposed that the allocation of research 
funds should be decided based on a transparent peer review-based processes (15). While 
transparent information on the mechanisms of distribution of research funds was absent 
in the retrieved documents in Chapter 3, it was implied that health research funds are 
somehow distributed equally among academics. Such a mechanism does not seem 
appropriate in a country where research budget is limited and mainly dependent on the 
government, while receiving funds from international sources is rare too. However, 
distributing equal funds among academics seems aligned with the egalitarian values of 
the 1979 Islamic Revolution which perhaps had aimed to make education and research 
universal all across the universities (10). While this approach could provide equal 
opportunities for all to partake in research activities, distribution of equal funds within 
this system could leave insufficient resources for the academics with potentials to conduct 
high-quality research which often demand larger funds. Furthermore, in medical fields, it 
seems that the individual-level financial incentives for clinical and or teaching activities 
are far more than that for health research activities in Iranian universities of medical 
sciences. An investigation of the institutional constraints on the Iranian academics in non-
medical science fields had reported that the outstanding academics were the most 
frustrated ones, while the mediocre researchers seemed rather satisfied with their career 
in Iran (129).  
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Another essential function of a HRS is to create and sustain human resources and 
infrastructural resources (15). This review showed that over the last five decades, Iran has 
largely developed its higher education capacity in medical sciences, as reflected in the 
increased number of universities of medical sciences and schools and research centres 
within the universities, as well as the substantial rise in the figures for academic staff and 
students. Nevertheless, it was reported that some of these increases have occurred without 
sufficient oversight or without having had the essential capacity and facilities for 
expansion. An analysis of the structure of scientific community in Iran, in non-medical 
fields, during 2002 and 2004 had identified insufficiency of facilities in academic 
institutions as one of the major difficulties of Iranian academics (129). 
The literature also emphasises that this function of HRS is not only regarding recruiting 
and training new researchers or founding new institutions, but also is concerned about 
sustaining the existent capacity to conduct, absorb, and utilise health research (15). In 
terms of capacity-building, numerous training courses relevant to health research have 
been offered since 1990. However, the literature suggested that the number of skilled 
researchers in the country is still limited. Some have corresponded this issue to Iran’s 
high rate of the so-called ‘brain drain’: approximately 150,000 Iranian specialists 
emigrate every year (418). Many LMICs, despite having research-intensive universities, 
lose their trained human resources to brain drain (6, 15). This is because in addition to 
availability of good academic institutions and facilities to undertake health research, a 
favourable research environment, encouraging remuneration and career prospects, 
sufficient research funds, and opportunities to openly discuss research should exist to 
encourage talented individuals to stay (6, 15).  
An investigation of the institutional constraints on the emerging scientific community in 
Iran (in non-medical fields) had reported that the outstanding scientists in Iran were the 
most frustrated, thus more vulnerable to emigrate, while the mediocre researchers seemed 
rather satisfied with their academic institutions (129). Furthermore, in terms of medical 
sciences, the review presented in Chapter 3 found that, in general, the individual-level 
financial incentives for clinical and/or teaching activities in Iran seem to be far more than 
that for health research activities. This could discourage academics with expertise and 
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interest in conducting research. Some universities in the EMR, e.g. the King Abdullah 
University of Science and Technology in Saudi Arabia are attempting to invite 
researchers back to the region, by offering financial incentives, including enormous 
research grants and high salaries. However, these institutions are concentrated in the Gulf 
States where the existing research base is rather weak (6).  
To encourage the return of the Iranian diaspora, particularly in science, the current 
President (2013 – present) has made several efforts (418). Although figures on the 
outcome of the government’s efforts are unavailable, sporadic reports show no significant 
success in this regard (419). One rather recent example was a prominent Iranian 
environmental scientist at Imperial College London, who was invited by the President’s 
administration to return home to serve as the Deputy Head of Iran’s Department of 
Environment (419). Although he did accept the invite, less than a year later, he decided 
to step down and leave the country consequent to receiving substantial pressure from 
hardliners in Iran (419).  
It should be highlighted that inviting back the diaspora is only one way to address brain 
drain. Finding other ways to connect with diaspora and their international networks is 
critical. Many emigrated scientists are often willing to ‘informally’ collaborate with their 
peers back home, by providing intellectual, technical, or material assistance (8, 15). I have 
provided some examples of successful collaborations of Iranian diaspora with academics 
based in Iranian institutions in Chapter 5 (14). Given the international isolation of Iran 
which has declined ‘formal’ exchange of academics between Iran and international 
institutions and has restricted Iranians’ access to international research grants, 
establishing and maintaining ‘informal’ collaborations with the Iranian abroad seems 
more feasible. 
Drawing on the data provided in the reviewed literature in Chapter 3, another hypothesis 
to explain the limited number of skilled researchers in Iran is that students in Iran’s higher 
education programmes do not receive training to develop skills in communication, 
writing, management, or teamwork, which are necessary for becoming competent 
researchers. Assessments of health research-relevant skills among researchers in the EMR 
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have identified weak knowledge of research methods, poor understanding of data analysis 
techniques, limited communication and computer skills (6). 
Furthermore, research-relevant courses are optional and are not included in the core 
curriculum of programmes in medical sciences. Hence, only those with an interest in 
research would attend such courses and acquire research skills. The literature also 
criticises the medical education curriculum and even the national entry exam by which 
university seats are reserved for students for being too oriented towards the students 
passively learning facts, rather than looking for critical thinking or creative problem-
solving. It was also emphasised that Iran’s higher education programmes do not provide 
training to develop skills in communication, writing, management, or teamwork, which 
are requisite for becoming competent researchers.  
More importantly, it seems that the majority of the research trainings have focused on 
research methods, and or on teaching some mere ‘techniques’ to write and publish 
research papers. There is a lack of an environment which educates students and academics 
about why to do research and why to publish it.   
The reviewed literature also described the collaboration among Iran’s medical researchers 
and research institutes as rather poor in Iran. An investigation of collaborations in non-
medical fields in Iran has found that the majority of the collaborations are between the 
academics and their PhD students (129). Limited coordination and collaboration in 
research activities is a universal problem in LMICs, which leads to the waste of a large 
proportion of the already scarce resources (15).  
The fourth function of HRS is regarding producing, disseminating and using valid 
research (15). The publication of research findings is considered to be the primary output 
of the research process. Therefore, dissemination could be publications in peer-reviewed 
journals, policy briefs, reports, books, discussion papers, etc. Utilisation of research could 
be either for developing new tools, e.g. new drugs, devices, applications, or for 
contributing to improvement of policy and practice, particularly within health systems 
(15). While several factors, such as the increases in infrastructural and human resources, 
the introduction of policies that promote research, and the improved facilities for 
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disseminating research have led to a substantial growth of health research publications in 
Iran, a vast amount of these publications seem irrelevant to the needs of the end-users of 
research. Furthermore, limited use of research is reflected in the poor evidence-based 
decision-making and practice. Particularly use of research findings that are published in 
international journals seemed insignificant in practice. 
Inadequate use of knowledge has been reported in other LMICs too. Some of the 
constraints on knowledge translation in the EMR are identified as: (i) limited 
opportunities for engagement of researchers during the policy making processes; (ii) lack 
of institutional and financial incentives that support knowledge translation; and (iii) 
concerns over the political sensitivity of research findings (6). The first two, are similar 
to the problems that were identified for Iran in Chapter 3.  
To improve KT in the EMR, in 2009, the WHO EMR Office established a regional 
Evidence Informed Policy Network (EVIPNet) to host workshops that bring together 
researchers and policymakers (420); Iran has been one of the active members of the 
network (420). In general, compared to the other countries in the EMR, Iran has a higher 
output of systematic reviews and clinical trial registration (6). It has even been reported 
that the rise that is evident in the number of clinical trial registrations from the EMR since 
2004, is largely due to the output from Iran (6). 
Still, the existing capacity in Iran’s HRS could be better used with an improved research 
governance. There seems to be a need for educating the students and academics about the 
role of research for better health rather than solely teaching them research-relevant 
methods. Furthermore, fundamental changes are required to address the existing gap 
between the knowledge producers and users and to improve the use of research in policy 
and practice.  
7.2.2 Bibliometric analysis of Iran’s health research (1965-2014) 
The study presented in Chapter 4 was successful in providing a 50-year overview of Iran’s 
health research publications that are indexed in WoS CC. Health research publications 
for this bibliometric study were defined as publications in the areas relevant to clinical, 
biomedical, and or public health research. This bibliometric analysis also identified the 
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year in which the growth of health research publications in Iran peaked; and characterised 
main trends across the publications. Furthermore, it suggested that the rise in the quantity 
to some extent has led to improvements in citation impact.  
Several bibliometric studies had previously reported the substantial quantitative growth 
of Iranian research publications over the last three decades, as summarised in Table 6 (9, 
11-13). In Chapter 4, I visualised the changes in the number of Iranian clinical, 
biomedical, and public health research publication over 5 decades and found a significant 
rise until 2011 and a drop afterwards. Some of the proposed possible contributory factors 
to the quantitative increase in Iran’s research publications are the following: improved 
economy after recovery from the Iran-Iraq war (1980-1988) (66, 421); increased number 
of universities, research centres, students and faculty members; multiplication of 
postgraduate programmes (11, 66, 422); requiring students to have publications; 
providing academics with financial rewards per publication (66, 423); increased number 
of  Iranians who study abroad and maintain international collaborations after returning to 
Iran (421); or improved access to data sources (424).  
Even if such assumptions justify the overall research growth in Iran, still the accelerated 
increases in certain periods require further explanation. For example, one surge is evident 
in 2007 which could partially be explained by the addition of a significant number of 
regional journals to the WoS CC between 2005 and 2010 (200). Regional journals were 
defined as journals publishing outside the US or the UK and containing the scholarship 
of authors from a particular region or country, and covering topics of regional interest 
(200). Within that 5-year period, Thomson Reuters—the former owner of the WoS—
indexed 1,600 new regional journals that met the standard editorial criteria of the WoS 
(200), while concurrently, MOHME was supporting Iranian medical journals to improve 
their quality to meet international editorial and publishing standards (425). Consequently, 
between 2005 and 2010, the number of Iranian journals indexed in WoS CC increased 
from only five to 41; 15 of the new additions were in clinical medicine (200). 
Furthermore, once a new journal is indexed in WoS CC, the most recent three years of 
the journal’s back issues would also get indexed (404), and this suddenly adds up to the 
number of indexed documents. Finally, looking at the top-10 journals where the majority 
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of Iranian clinical, biomedical, and public health papers have got published, six of the 
journals were Iranian. Parallel increases in the number of research publications and the 
number of journals that are indexed in international databases had been reported from 
other countries, e.g. Brazil (426). In sum, the addition of Iranian journals to WoS CC 
seems to have had contributed to the 2007 surge. 
Another substantial rise in research output occurred between 2010 and 2011. Considering 
an often three- to four-year time lag between the initiation of research projects and their 
publication, the contributory factors to the 2011 peak should be traced back in a few years 
earlier. For instance, the surge could possibly be associated with that Iran had its highest 
GERD—i.e. 0.75%—in 2007 (316). This may had led to increased resources allocated to 
health research. Furthermore, in 2009, a policy document entitled ‘Iran’s Comprehensive 
Scientific Map’ was developed and released by ‘Iran’s Supreme Council of Cultural 
Revolution’ (245, 410). As shown in Figure 2, this council holds the highest level of 
authority for setting education and research policies in Iran. The so-called ‘Scientific 
Map’ provided a set of goals, policies and requirements for development of science, 
technology and innovation system in Iran (245). It partially outlined the targets by 
meeting which Iran presumably could achieve its broader ambition: i.e. becoming the 
Middle East’s leading country by 2025 based on scientific and technological indicators 
(310, 410). Examples of targets included increased number of research centres, faculty 
members, and PhD students (316).  
Some correspond the drop in publication counts in 2013 to the tightening up of the 
economic and banking sanctions imposed on Iran (427). Regarding the peak that was seen 
in 2011, it should be noted that this study included the publications by the end of 2014 
and it is likely that publication counts have already exceeded the figures for 2011, or may 
exceed it in the future. Analyses of the data retrieved from PubMed show a continued 
growing trend until 2015 (316).  
In terms of the most prolific institutions, TUMS stands on top with nearly three times as 
many publications as the next institution, i.e. Shahid Beheshti University of Medical 
Sciences (also located in the capital city, Tehran). As bibliometric analyses’ results are 
often not adjusted by size of the unit (e.g. by the number of students or academics), it is 
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anticipated that TUMS—i.e. the largest Iranian university of medical sciences—would 
lead the national ranking tables for output (312). More importantly, TUMS, has an 
excellent reputation for medical education and research among most Iranians. Hence, 
many top students and competent early-career academics intensively compete for 
admission in TUMS (428), therefore it is possible that the researchers at TUMS are 
potentially more productive than their peers. It could also be hypothesised that TUMS—
which is based in the capital city Tehran and in many periods has been directed by leading 
scientists with strong networks inside and outside academia—may have been closer to 
the sources of funding. It is worth mentioning that the top-3 prolific Iranian universities 
of medical sciences also have the highest number of research centres, which could be 
another contributory factor to greater research publication productivity (310).  
This is similar to the global pattern that research hubs are increasingly becoming the 
states, cities, or even certain academic institutions rather than countries. Meaning in most 
countries there is a degree of concentration of research activity in certain places. For 
instance, in 2004, more than 60% of the US R&D expenditure was invested in only ten 
states—with California alone accounting for over 20% (8). Another example is that half 
of Russian research publications originate in its capital city, Moscow (8). Likewise, other 
capital cities, e.g. Buenos Aires, Budapest, and Prague each account for more than 40% 
of their national research outputs, and the figure for London, Beijing, Paris and Sao Paolo 
is also over 20% each (8). Examples of research-intensive institutions who dominate the 
ranking tables are Harvard University in the US which its publication output in 2004 to 
2008 was greater than that of the whole of Argentina, or The University of Cambridge 
where 98 of its affiliates have thus far been awarded a Nobel Prize (429).  
Having known the work background of the prolific authors, it seems that the majority of 
the top-10 are either (i) well-reputed mentors who attract many student projects that could 
lead to publications; and/or (ii) had held executive roles that has either facilitated access 
to resources, and/or has provided them with necessary skills to initiate and effectively 
manage teamwork. Among the top-5 prolific authors two are pharmacologists, another 
two are clinicians in endocrine and metabolic disorders, and one is a paediatric 
immunologist. The landscape for research areas with most publications has been fairly 
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similar. Pharmacology was the research area with the largest proportion of publications 
(11%), followed by General Internal Medicine, and Biochemistry Molecular Biology, 
each comprising ~8% of the total publications. 
It could be suggested that Pharmacology and Biochemistry Molecular Biology are fields 
that most of their publications originate in schools of pharmacy. Schools of pharmacy in 
Iran seem to be more research-oriented than schools of medicine. This assumption is 
partially made based upon the structure of MOHME (as described in section 1.10.5), 
where the schools of medicine are not only responsible for medical education and 
research, but also for providing healthcare services (113). It has been suggested that the 
workload of medical faculty members and students within this structure does not leave 
sufficient time for research (113).  
In terms of document types, it is interesting that following original articles (comprising 
~69.0% of total publications), the second most common document type was ‘meeting 
abstract’ (over 20.4%). This could be a result of the support and incentives that MOHME 
has been providing to promote participation of Iranian academics in international 
conferences (318). In the research performance assessment of the universities of medical 
sciences that MOHME runs annually, accepted abstracts in international conferences 
contribute to extra points (271).  
It is noticeable that the journals where larger proportions of Iranian research had been 
published generally had relatively low IFs (0.57-2.4). It could be hypothesised that 
Iranians have found easier ways for publishing papers, e.g. submitting to Iranian and/or 
international journals with possibly higher acceptance rates. Other countries, e.g. Turkey 
and Australia, had previously reported a decrease in the average IF of the journals where 
the total national publications were getting published after implementation of policies that 
strongly emphasised the value of the quantity of publications (430, 431).  
On the one hand, some criticise Iranian publication growth on account of the fact that a 
large proportion of the papers were published in journals with relatively low IFs (67). On 
the other hand, it could be argued that increased visibility of publications in Iran, even if 
achieved by publishing in mediocre journals, could have benefits. Firstly, partaking in the 
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international scientific community by publishing could provide a sense of 
accomplishment to the young researchers and encourage the competent ones to improve 
their research activities. Secondly, it assists international institutions and researchers to 
identify potential Iranian collaborators, which could lead to opportunities for exchange of 
knowledge, expertise, and resources (312). Last but not least, visibility of publications to 
a larger group of peers attracts wider criticism which could lead to early detection of 
possible problems. For instance, the international criticism that the alleged Iranian cases 
of research misconduct have received urged the national science policymakers to take 
further steps for addressing issues regarding research and publishing integrity in Iran’s 
academia (67, 432). It would also promote a discourse on research ethics in Iran, which 
in the long term could strengthen its growing scientific community (432).  
Similar to the global patterns where intra-regional collaboration is not dominant, Iran’s 
major collaborators have all been outside the EMR (8). Generally, collaboration between 
LMICs is globally small (8). An investigation of the collaborations in production of 
biomedical research papers from Africa between 2004 and 2008 found that while 77% of 
the publications involved international collaborators, only 5% were the output of 
collaborations with another African country (433).  
The majority of international collaborations of Iran, has been with the USA, the UK, and 
Canada, which—interestingly—all the three have had fairly challenging international 
relations with Iran over the last four decades. While the negative impacts that the imposed 
trade sanctions have had on Iran’s research activities should not be overlooked (427, 434-
436), it seems that international scientific collaborations had been established and/or 
maintained regardless of the political atmosphere (337). Also, these countries are three of 
the most common destinations that Iranians choose for studying and/or immigration 
(437). The ones who return to Iran after completion of their academic programmes may 
continue collaboration with their former supervisors, or with the international network 
which they have established (421), while those who emigrate may continue collaborating 
with colleagues back home. Another point is that many of research consortiums are led 
by American and/or British institutions, and publications arising from such projects, if 
having Iranian collaborators too, would be counted as collaborative publications between 
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Iran, the US, and/or the UK. Globally, the US is the dominant collaborator in research 
publications (17% of all internationally collaborative papers are in partnership with the 
US) (8). European collaborations have increased since the 1990s, mainly as a result of the 
EU funding initiatives, but the US remains the major partner for most European countries 
too (8). 
The bibliometric analysis presented in Chapter 4 indicated that h-index of Iran’s 
publications has had a growing trend over ten 5-year periods. This means that along the 
substantial quantitative growth of publications, citation counts have increased to a certain 
degree, which confirms some previous reports on this (313, 318, 385). My colleagues and 
I had previously reported on similar significant growing trends of 5-year h-indices of 
public health research publications in some other LMICs (38). For instance, it was shown 
that the 5-year h-index of public health research publications of China had increased from 
36 in the period 1996-2000 to 100 during 2006-2010. This figure for South Africa was 
30 in the first 5-year period and was 32 for Brazil, while it increased to 78 publications 
in both countries for the period 2006-2010 (38). 
As described in section 1.11.3, some may criticise the use of h-index for assessing citation 
counts (438). Firstly, one argument could be that since the maximum of h-index is the 
number of publications in a research unit, h-index is more strongly formed by publication 
counts rather than citation counts (153). However, if the rise had been restricted to the 
quantity, it would have been impossible to see any improvements in the h-index over 
time. Secondly, another objection could be that h-index is insensitive to the total number 
of publications, thus it does not provide any information about the large proportion of 
publications that possibly have received minimal or zero citations (153). This is a valid 
point and this study did not aim to investigate improvements in the average citation 
counts, nor in citations per document. Nevertheless, what this paper could suggest is that 
in the long term, the increase in the quantity has promoted the number of the publications 
that had a potential to receive a ‘reasonable’ number of citations. Thirdly, many of the 
papers contributing to 5-year h-indices might be a result of international collaborations; 
even so, this is an achievement for a country that has been internationally isolated for four 
decades (337).  In fact, international collaboration is crucial for scientists in LMICs as 
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they enable access to facilities, funding, equipment and networks that are often limited in 
LMICs. Finally, some may criticise the improved citation counts of the publications for 
having been self-citation in most cases. But the effect of author self-citations on global or 
national analyses is so insignificant that there is no need to exclude them (152).  
7.2.3 Identifying the profile of Iranian h-core health research 
publications 
The study presented in Chapter 5 identified a set of 155 most-cited Iranian clinical, 
biomedical, and or public health publications and highlighted where the capacity for 
producing highly-cited papers lies.  
I analysed the 155 h-core publications, among which nearly 70% were the product of an 
international collaboration. In general, papers with multi-national contribution often 
receive more citations (152). This could be because a multi-national paper will probably 
be seen by people in various networks, due to the so-called network effect. Analysis of 
Elsevier data had previously shown a three-fold increase on the publication’s citation 
counts of publications that include international authorship compared to a standard 
domestic publication (8). For instance, the most-cited publications from Mexico have 
reported to be their collaborative publications with Germany and Italy (8). Chinese 
publications in collaboration with Russia receive 4 times more citations than publications 
with authors only affiliated to China (8).  Russian publications also receive a significantly 
higher number of citations while being written collaboratively with each of the country’s 
G8 partners or with China (8). The fact that the leading collaboration hubs such as US, 
UK, France and Germany have an impact on citation rates is perhaps not surprising, 
particularly given the size of the scientific communities and the citation rates generated 
within these countries. Other collaboration pairs bring a noticeable increase in citation 
impact. Australia’s collaborations with Spain and China benefit from the strength of 
research in those countries in medicine (mostly clinical drug studies) and 
genetics/genomics respectively (8).  
Moreover, through international collaborations, scientists can enhance the quality of their 
work, increase the effectiveness of their research, and overcome logistical obstacles by 
sharing costs, tasks and expertise (8) 
Describing the evolution of Iran’s health research system, understanding the profile of its publications 
over 50 years, and setting the national health research priorities  
 165 
Thirty-four of the identified most-cited papers in the bibliometric study presented in 
Chapter 5, had at least one Iranian co-author who was affiliated with international 
institutions. Iran has a high rate of brain drain as described in section 7.2.1, which is 
difficult to control given the country’s increasing unemployment rate among the educated 
population, the social and economic instability, and political challenges (437).  
This study highlighted that one way to use the capacity of the Iranians abroad could be 
provision of further opportunities for collaboration with them. Over the past decade, the 
focus of debates over ‘brain drain’ have shifted from preventing ‘brain drain’ to turning 
it to ‘brain gain’, and in a way calling the phenomenon ‘brain circulation’. Meaning that 
this phenomenon could even benefit developing countries, rather than only being a loss. 
Some governments appreciate the value of ‘brain circulation’ and allocate resources for 
attracting national talent back home to start a new business or take up a senior position in 
academia, while maintaining useful links back to the US or Europe (8).  
Few examples are China, India, and Malaysia (8). Over 70% Of the 1.06 million Chinese 
who studied abroad between 1978 and 2006 did not return home. To attract these 
emigrated academics, in 2008, China initiated a programme called ‘The Thousand 
Talents’, which provided personal and professional facilities and incentives. This 
programme had brought back 600 Chinese academics abroad to return to China by 2011 
(8).  
India established a specific ministry, i.e. the Ministry of Overseas Indians, to organise 
policies related to remittances and investment flows, and eased the previously strict 
citizenship requirements to make it easier for potential returnees (8). Elsewhere, Malaysia 
established a new ‘Talent Corporation’ which will be charged with connecting with 
diaspora communities. Ecuador’s President also announced a US$1.7 million 
‘Prometheus Old Wiseman’ plan to attract senior scientists who see Ecuador as ‘the 
retirement destination of brilliant minds’ (8). 
As discussed in section 7.2.2, attracting back the overseas is only one way of using the 
capacity of emigrated academics, and may not necessarily work for Iran given the 
ongoing challenges. Still, benefiting from the global networks of the Iranian diaspora can 
be critical. ‘Nomadic scientists’ are often keen to maintain scientific and informal links 
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with their home countries. Many are eager to contribute but are unsure where to start. In 
supporting international collaboration, these diaspora communities are an untapped 
resource (8).  
Two of the highly-cited papers had an international author affiliated with an Iranian 
university: Pahlavi University, which was renamed to Shiraz University of Medical 
Sciences following the 1979 Islamic Revolution. This university was modelled after 
American schools, and used several international academics aiming to educate Iranian 
medical doctors (437). The majority—if not all—of international academics left Iran 
following the 1979 Revolution (as described in section 1.10.6).  
Studying the most-cited papers suggests that the GBD studies had a significant share in 
Iran’s h-core papers. The majority of these papers had an internationally well-known 
Iranian collaborator affiliated with TUMS, and were published in The Lancet. In terms of 
the research area, GBD papers should be attributed to ‘public health’ area, but WoS 
attributes the papers that are published in general medical journals—e.g. The Lancet— to 
‘General Internal Medicine’. Across the 155 h-core papers, five prolific Iranian authors 
who are based abroad were identified. It appears that these academics have interest and 
ability in establishing successful collaborations with their peers in Iran; thus, further 
collaboration with them should be encouraged.  
In terms of authors of the 48 ‘only Iranian’ papers, five researchers had contributed to 
publishing at least three impactful papers (by relying on Iranian research resources). It 
should be ensured that these academics would receive adequate resources to continue 
their research activities.  
Regarding where the 48 ‘only Iranian’ papers were published, it should be highlighted 
that they were not published in journals with very high IFs (IF ranged between 0.4 and 
8.3 with a median of 2.3). As explained in section 1.11.3, the use of journal-level metrics 
for evaluating individual publications and their authors is rejected by many, because the 
distribution of citations over the publications in a journal is highly skewed (439). 
However, still many decisions by funding bodies or academic employers are made upon 
IF (152). This study showed that at least in the case of clinical, biomedical, and public 
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health research publications that had only relied on Iranian resources, the likelihood of 
getting cited in the future was independent of the IF of the journals where they were 
published. Another finding worth noticing is that while the proportion of review articles 
among the total publications of Iran was small (2.7%), 37.5% of the ‘only Iranian’ highly-
cited papers were review articles. In general, review articles tend to attract more citations 
than other document types (152). Perhaps countries or institutions who wish to contribute 
to the global science and get recognised, while lack sufficient resources for conducting 
high-quality original research could promote publication of review articles.  
The 48 ‘only Iranian’ h-core papers were categorised into basic, clinical, and public health 
research and the majority were in basic sciences. This should trigger further thinking in 
Iranian medical research policymakers regarding how best the financial and human 
resources in clinical, biomedical, and public health research should be distributed. For 
instance, one approach could be to always allocate a certain proportion of resources to 
basic sciences, where some potential for attracting recognition seems to exist. 
Particularly, supporting publication of review articles in basic sciences could be a strategy 
when resources are scarce. Then, in deciding where to invest the rest, one approach could 
be identifying the neglected research areas across the total publications and investigate 
whether research in some areas is less promoted or less supported.  
7.2.4 The national-level health research priorities 
The priority-setting exercise described in Chapter 6 identified the research priorities that 
have a potential to assist Iran in addressing the knowledge gaps to achieve its long-term 
health targets as outlined in the National GHPs by 2025 and the SDGs by 2030. This was 
the first national-level health research priority-setting exercise in Iran that aggregated 
independent input from prominent Iranian researchers, policymakers and funders, and a 
group of stakeholders from the wider society. While the identified research priorities 
covered a diverse range of issues related to health, the majority of the proposed RQs, as 
well as 90% of the top-ranked questions, had aspects of HPSR. This is not surprising 
given the context of this study, which addressed a set of broad national health targets 
within a relatively short period (i.e. the next 5 years) (42).  
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The HPSR questions that ranked among the top quartile of the 128 RQs predominantly 
related to financing, governance, and/or service delivery. This corresponds quite well 
with Iran’s ongoing Health Transformation Plan—launched in 2014—which aims to 
provide UHC by 2025, improve the quality of healthcare services, and achieve financial 
protection (described in section 1.10.5) (107). Furthermore, seeking ways to improve 
efficiency of the health system was reflected in several of the top-10 RQs, e.g. reform of 
the insurance system; prevention and management of NCDs at different levels of the 
health system; and replacing the physician-centred healthcare system with a team-based 
one. This may suggest that, although Iran’s investment in healthcare has substantially 
increased since 2015 (107). the system has not yet succeeded in efficiently using its 
resources, either financial or human resources. 
The priorities also clearly highlighted the significance of addressing questions that seek 
cost-effective population-level interventions and health system strategies to prevent 
NCDs and road traffic injuries in Iran. It was also agreed that studying the current and the 
estimated future distribution of NCDs and their underlying causes across Iran as well as 
the common health problems in Iran’s elderly population should be prioritised. Such 
results reflect the need for further investment in addressing the knowledge gaps in a 
country facing a rapidly increasing burden of NCDs (106) with an ageing population 
(described in section 1.10.5) (440). Such challenges reinforce the need for improving 
efficiency of the health system.  
Although Iran continues to struggle with infectious diseases (441), as described in 1.10.5, 
the greatest contemporary challenge is the transition to NCDs (106). According to a 
national NCD Survey conducted in 2011, 20% of Iranian men and women were 
hypertensive. During the last four decades, the prevalence of adult obesity has increased 
from 13% to 30% in women and from 4% to 17% in men (442), which may have been 
the contributor to the doubling of the prevalence of diabetes prevalence between 1980 
and 2015, from 5% to 10% (443). 
Consensus of the participants also indicated that Iran’s success in achieving its long-term 
health targets requires investment in studying the health impacts of environmental 
challenges, e.g. water crisis. It has been argued previously that securing sustainable water 
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resources in Iran requires immediate coordinated multi-sectorial action (444). Another 
top-10 priority highlighted the importance of tailoring medical education to better serve 
the needs of the society. This question was raised for the primary qualification (e.g. 
Doctor of Medicine) and was also specified for the curriculum of specialist training in 
psychiatry.  
The questions related to the values embedded in the rich history of medical sciences in 
Iran were relatively prevalent among the originally proposed RQs (9 out of 128). 
However, the majority of them were ranked near the bottom of the list. This could suggest 
that, although a number of Iranian academics agreed that knowledge gaps regarding these 
issues should be addressed, it seems that it was difficult for these questions to meet the 
criteria of this exercise. It is likely that in a prioritisation exercise within a different 
context, e.g. considering a longer time scale, or using a different set of criteria, these 
questions could receive a higher average score.  
It is worth mentioning that since 2000, Iran’s MOHME has been building capacity in 
medical universities across the country and in different departments of the Ministry to 
carry out research prioritisation exercises (271). Research priorities had been identified 
either at the national level in specific areas, e.g. prevention of cervical cancer (445), HIV 
and AIDS (446), and patient safety (447), or at the institutional level, e.g. in health 
systems research (448), or medical education (449). However, none of these studies had 
engaged stakeholders from the wider society; the majority lacked a clearly-defined 
context; and all had used methods that included a panel of experts, rather than a structured 
and replicable approach. 
Furthermore, while efforts to improve governance of health research in a developing 
country are admirable, it is unclear how the priorities were being set at the national level. 
It was reported in 2016 that a total of 6,723 ‘research priorities’ were collected from Iran’s 
medical universities (248), but this number is too large to consider each idea a ‘priority’. 
The report (248) continued that the collected research questions were grouped into nine 
‘main areas’, but those were also too broad to be considered priorities that could direct 
national health research investments. A qualitative study investigated the barriers to 
evidence-based decision-making in Iran’s health system in 2012 (241). The participants 
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identified the following issues: (i) lack of a systematic prioritisation mechanism; (ii) 
priorities being identified by MOHME and not being communicated with academics; and 
(iii) priorities being too general, thus failing to guide researchers.  
My study adapted the CHNRI method, which has several advantages discussed in Chapter 
1 (4, 19, 28, 42). Compared to previous national-level CHNRI exercises conducted in 
South Africa, India, Brazil, China, and one study that included Malawi, Nigeria, and 
Zimbabwe (42, 45), this study had a relatively similar time scale, i.e. 5-10 years. Perhaps 
this shows that it is of more interest for national-level studies to set the priorities with 
shorter periods in mind. This study had several strengths compared to previous CHNRI 
exercises. As the method has already been applied in over 50 exercises (42), plenty of 
published guidance was available to help adapt the method to our needs. The management 
group considered the modifications in the previous CHNRI studies (42) and this helped 
to easily reach a consensus over the five criteria most relevant to the present study. 
Furthermore, previous CHNRI exercises had a response rate between 30-70%, (42) while 
in this exercise more than 70% of contacted participants responded both to a request to 
generate RQs and to score them. This shows that the exercise has been successful in 
engaging the experts with the process and the results are less likely to be biased. 
Moreover, the wide range of final research priority scores (84.5-28.5%) indicated a good 
level of discrimination between the RQs in meeting the five criteria. Finally, only about 
20% of previous CHNRI exercises had managed to engage an appropriate group of 
stakeholders in the process (35).  
I explored the impact that the stakeholders’ assigned weights had on the final ranking of 
the RQs. Their input led to minor changes in the order of the questions, and also promoted 
two new RQs among the top-10 priorities, one addressing the common health problems 
in the elderly and another regarding antibiotic resistance. In the top quartile, notable 
examples of questions that were helped by the stakeholders' input were: (i) impact of 
climate change on air quality of Iranian cities and its health effects; (ii) community-based 
strategies to reduce energy consumption and environmental pollutants to improve health; 
and (iii) community-based interventions for reducing high-risk behaviours (intravenous 
drug use, unprotected sex) amongst adolescents living in deprived areas. In summary, the 
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stakeholders’ input did not lead to a drastic change in the final ranks, but it helped several 
RQs with a focus on community participation to improve their ranks.  
In terms of the level of agreement among experts, the AEA ranged between 67.5 and 
34.5%. All of the RQs that were the most controversial were RQs that have ranked lower 
than the median RPS of 68.3. The greatest level of controversy seems to have been 
observed among the questions that were either too broad or too specific.  
The identified priorities seem plausible within the context of the study, which involves a 
country with an ageing population, facing a high burden of NCDs and road traffic injuries 
while in parts still struggling with endemics of infectious diseases, experiencing 
accelerated environmental changes, having a large number of students at universities of 
medical sciences, and undergoing a Health Transformation Plan to achieve UHC. On the 
other hand, we should analyse why the majority of questions addressing mental health, 
substance abuse, or dementia did not score highly despite a high burden of disability and 
death which they cause in Iran (105).  
Mental and behavioural disorders have become the main group of diseases causing years 
of life with disability (YLDs) in Iran (450). Furthermore, substance abuse imposes a large 
burden among the youth and opium use is still the most prevalent drug use disorder among 
Iranian adults (451).  
It is possible that firstly, the way in which the questions in those areas were framed did 
not seem feasible enough to the scorers. Secondly, the low scores that these questions 
have received for impact on economy may suggest insufficient awareness of the majority 
of the engaged experts about the burden that non-physical health conditions could cause. 
It is also worth mentioning that while the consensus of experts in this exercise strongly 
supported the need for investment in further studies on NCDs, one of the top-10 priorities 
addressed antimicrobial resistance. This highlighted that although communicable 
diseases are contributing to less DALYs in Iran, they continue to remain important. 
Diseases such as influenza, brucellosis, and tuberculosis are still major endemics in Iran 
(452), and the country’s capacity in studying and controlling outbreaks of neglected, 
emerging, and/or re-emerging infectious diseases requires improvements (452). 
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7.3 Implications for policy 
Drawing on the findings from this PhD, Iran’s endeavours towards improving the 
quantity, impact, and quality of health research publications is admirable (312, 315). 
What requires further attention is to firstly, be aware of the challenges posed by using 
bibliometric tools in assessment of research activities. Chapters 4 and 5 pointed out the 
misleading allocation of research areas of documents in WoS; and highlighted that journal 
IFs cannot be representative of the citation impact of individual papers. Secondly, the 
limitations of bibliometric tools in assessment of research output and/or impact should be 
considered (147, 210). One inherent limitation of relying only on bibliometrics is that 
scientific outputs other than papers—e.g. clinical guidelines, policy documents, or 
datasets—could be neglected (147, 210, 439). Similarly, it is likely that studies with less 
chances of publication in prestigious journals—despite having great potentials of leading 
to societal, economic, or health impacts—would be undervalued, both by the funders and 
by researchers.  
[One paragraph was removed from here] 
Furthermore, drawing on the findings of this thesis, the following suggestions could be 
shared with other LMICs who are to improve their health research output: (i) invest in 
developing national journals and in supporting them to get indexed in international 
citation databases for increased international visibility of publications (11, 313). This 
could help with early identification of potential existing problems in research practices, 
thus would help with addressing the problems in time; (ii) provide opportunities for 
collaboration with academic nationals who have emigrated to developed countries, 
particularly support collaborations with those who have already proved competency and 
interest in establishing successful collaborations with peers back home; (iii) identify and 
support researchers who are able to produce high-quality research output while relying 
only on resources from LMICs; (iv) while resources for conducting high-quality original 
basic research is limited, promote publication of review articles which could receive 
international recognition; and finally, (v) avoid over-relying on bibliometrics in academic 
assessment practices, particularly be aware of the challenges of using journal IF for 
evaluation of individual papers, and/or researchers. 
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While increased health research investment is recommended to better use the existing 
health research capacity in Iran, the investments should be governed in a way that 
resources would be used efficiently. The identified priorities described in Chapter 6 guide 
research that is likely to be feasible to be conducted within the next five years, and bear 
a higher impact on health and economy and lead to capacity building and equity. I hope 
that this paper will firstly contribute to the field of health research priority-setting as one 
of the most recent applications of the CHNRI method at a national level. Secondly, this 
was the first application of the CHNRI method in Iran and we hope that the findings of 
this study will be utilised in making funding decisions within the next five years. Iran’s 
NIHR has already expressed willingness to use the identified priorities in its upcoming 
grant application calls. Further advocacy of the findings could be done through holding 
meetings with decision-makers at different departments of MOHME, the Islamic 
Parliament Research Center, Academy of Medical Sciences, and research departments of 
major Iranian universities of medical sciences. Summaries of the results should become 
available online for open and easy access of all researchers and stakeholders. We also 
encourage different funding agencies to compute the weights for the criteria using the 
input from their own major stakeholders to adjust the priorities with their organisations’ 
targets.  
It is worth comparing the research papers that were identified as the most impactful 
research publications, based on the number of citations, with the RQs that were identified 
as the top priorities. While the identified research priorities covered a diverse range of 
issues related to health, 90% of the top-ranked questions, had aspects of HPSR. Except 
the GBD-relevant questions, the rest do not seem to be RQs with a high potential for 
leading to a large number of citations. Even so, the “crowd wisdom”, i.e. the collective 
input of different researchers, funders and policymakers and other stakeholders who got 
engaged with the prioritisation study presented in this thesis – identified these research as 
unmet questions that should be addressed within the next 5 years. This disconnect 
between the macro investments of countries in research that potentially leads to higher 
impact based on bibliometric indicators, with research that addresses the real needs of the 
country is not limited to Iran and is evident in many other LMICs. Therefore, the 
recommendations from this study has implications in other countries, too.  
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In Iran, investing and formulating education and research policies towards improvement 
of bibliometric indicators has been the result of a political will at the macro level. This 
could be the same case in other countries given the contemporary global competition 
around scientific achievements as measured by bibliometric indicators. I would 
recommend that in a similar situation, a proportion of the resources could be allocated to 
research and research units which have proved that can lead to publications with a 
potentially high bibliometric impact, while a certain amount of the resources should be 
allocated to research that would be identified as priorities in a systematic, inclusive, and 
transparent prioritisation processes. Using a method such as CHNRI has the merit of 
engaging high-level decision-makers at an early stage which would increase the chances 
of the results being used by them.  
Iran has got a substantial health research capacity (385) and proved interest in prioritising 
research (271). Now that the CHNRI method has been successfully introduced in Iran, I 
recommend its application to identify the research priorities in more specific domains, 
e.g. for certain health conditions with a high burden in Iran, or for specific target 
populations. It is also recommended to conduct the CHNRI studies at a sub-national level. 
The development of a Massive Open Online Course (MOOC) for the Iranian audience 
could facilitate implementation of the method at a larger scale. I also recommend this 
national-level exercise to be repeated every five years to be aligned with Iran’s 5-Year 
Development Plans. Finally, this exercise was the first implication of the CHNRI method 
in the WHO EMR. I would encourage Iranian health research policymakers to pursue 
efforts to share the results with the WHO EMR Office that may assist conduct of the 
exercise in countries with a similar context to Iran and or at the regional level. 
Chapter 8 Concluding remarks 
In this chapter, I will firstly reflect on the strengths and limitations of this PhD, will then 
draw out the key conclusions, and highlight the data gaps that should be addressed in 
future research. 
8.1 Reflections on strengths and limitations 
• Strengths 
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The narrative review presented in Chapter 3 was thus far the most comprehensive review 
of the changes in Iran’s health research system over 50 years. The transparent and 
systematic bibliographic search and the use of an established framework for categorising 
the retrieved information minimised the limitations of a narrative review while served the 
advantages of a comprehensive review.  
The bibliometric studies presented in chapters 4 and 5 had several advantages as follows: 
(i) careful inclusion of research areas to increase the coverage, while maintaining the 
specificity; (ii) using the ‘country filed tag’ rather than the ‘address’ filter, which is more 
specific; (iii) using ‘organization-enhanced’ for analysing the institutions instead of 
‘organization’, which the former searches the unified name variant of affiliations; (iv) 
using a novel approach to find different types of collaborations across the Iranian h-core 
papers; and (v) studying the publications over half a century. 
Finally, the health research priority-setting study presented in Chapter 6 was a good 
example of a national-level health research priority-setting process and a rare example 
where a national research funding body adapted the process to decide on health research 
funding in a holistic way. This helped to overcome problems of previous research 
priority-setting exercises that were described in section 1.12.2, with further 
implementation now underway in Iran. This exercise also provides a model to public 
research funding bodies in other countries that could be adapted to improve decision-
making on funding allocation for health research, especially in low resource settings. 
• Limitations 
The review of the literature on Iran’s HRS (presented in Chapter 3) is subjected to the 
inherent limitations of a narrative review. One main limitation is that unlike systematic 
reviews for which there exist established guidelines to ensure rigor of the methods, there 
are no specific guidelines for conducting and reporting narrative reviews (243). 
Nonetheless, there are some ‘best practice recommendations’ to improve transparency 
and reproducibility of narrative reviews and reducing selection bias (243). This is mostly 
done by employing an effective bibliographic search strategy and reporting it explicitly 
(243), which was performed in Chapter 3 of this thesis. In terms of reporting, the structure 
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of section 3.5 was guided by the established HRS framework of the WHO, as described 
in section 1.5.1.   
Still, narrative reviews remain prone to bias as they represent the interpretation of the 
author from the existing literature. Some potential biases in Chapter 3 could result from 
my past experiences as follows. Before moving to the University of Edinburgh, I had 
obtained my first degree from TUMS, had attended several research-relevant courses 
offered outside the main curriculum at my school, and had contributed to a number of 
clinical trials. Also, at a smaller Iranian medical university, Mazandaran University of 
Medical Sciences, I had served both as a Research Associate and a medical journal 
editorial assistant (published in English). Although I have made substantial efforts to 
remain committed to the reviewed documents and evidence, my education and work 
background could have potentially led to some biases.  
Finally, it should be noted that although the review presented in Chapter 3 conducted the 
search only in two databases, this should not be a dramatic limitation as one of the two 
databases was Google Scholar. As explained in section 1.11.3, Google Scholar indexes 
literally any scholarly literature that is available on the web (152). Another concern could 
be that the search only used English keywords, which could have excluded the documents 
that were fully in Persian. One could argue that this might be the reason for the identified 
data gaps in many areas. However, it should be mentioned that several of the retrieved 
and reviewed documents were studies commissioned by MOHME, to evaluate Iran’s 
HRS; this makes it quite unlikely that further relevant information could have been found 
in the public domain. A more comprehensive review may be possible through a 
documentary analysis which was outside the scope of this thesis.  
The bibliometric studies presented in chapters 4 and 5 had limitations, too. One limitation 
originates in the way WoS attributes research areas to each document, which is done 
automatically based on scope of the journals where the documents are published. One 
consequent problem is that some documents may be included because of having been 
published in journals with a clinical, biomedical, and/or public health scope while the 
articles’ content may be irrelevant. For the same reason, the retrieved number of 
publications in each research area could be misleading. It should also be noted that this 
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study only included publications from WoS CC, which are not representative of all the 
publications arising from Iran. Finally, although careful considerations were made in 
investigation of the country of origin of the authors (based on the language of the names 
and/or searching the study and work background of the authors on the Web) and in 
understanding different types of collaborations (e.g. deciding on whether a project was a 
consortium) across the h-core papers, this approach could be susceptible to subjective 
assessment. 
Regarding the limitations of the priority-setting study presented in Chapter 6, in general, 
the findings of the CHNRI exercises may represent a biased opinion of a limited group of 
involved experts. In terms of the initially proposed RQs, some valid RQs will not be 
proposed and this is an inherent limitation. In terms of scoring, it has been shown that the 
collective opinion of the experts in CHNRI processes stabilises with involving 45-50 
participants (453). Thus, the number of experts in this study (48 persons) was sufficient 
to produce robust results, which would be highly unlikely to change with adding further 
scorers. Regarding diversity of the sample, a considerable effort was made to include 
experts with a wide range of disciplinary backgrounds and views. Even so, more than 
70% of the identified experts had a background in medical sciences. It appears that health 
research in Iran is very much dominated by medical scientists, even though some may 
have focused their research on areas that are not purely medical. There does not seem to 
be a significant difference between the disciplinary backgrounds of the initial invitees, 
those who generated RQs, and/or the scorers, while the high response rate makes such a 
bias less likely. 
The potential bias in this priority-setting exercise could result from the process through 
which the experts were identified, because this relied on the input from three members of 
the steering committee (RM, ZA, and myself), with a snowballing for less represented 
fields. Following the standard CHNRI guidelines (34), one third of the experts were 
identified by searching for the most prolific researchers in the fields relevant to the health 
targets of this exercise. No time limit was considered in the search strategy. The experts 
were found among the most productive 50 authors in research areas relevant to the scope 
of this study through searching in Web of Science and Scopus. As described in Appendix 
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8, I went through a random sample of the publications of the most productive authors to 
identify whether the papers were original research and could confirm that their authors 
were real experts in the field. Another applied approach was to identify people who have 
held scientific roles in Iranian scientific societies, universities, or executive organisations. 
Careful consideration was given to ensure that the invitees had a good understanding of 
research in their field, and were not solely holding executive roles.  
In total, 11 invitees to the CHNRI exercise presented in Chapter 6 did not participate in 
generating RQs, nor in the scoring of RQs. Only one invitee declined participation due to 
concerns over the CHNRI methodology, questioning its ability to replace debate. Of the 
50 experts who participated in generating RQs, but did not score them, only one declined 
for a specific reason, believing that the RQs needed a more comprehensive assessment 
rather than numerical scores against a set of criteria. The most likely reason for others to 
decline was time constraint, i.e. failing to meet the deadline for responding.  
A review of 50 CHNRI studies has found that the redundancy rate in the initial list of 
proposed RQs is nearly over 50% (42). In this study it was almost the same: a total of 251 
RQs was reduced to 128. During this step, some of the initially proposed descriptive RQs 
were merged with interventional RQs that addressed the same health problem, and this 
could have led to biased responses towards one part of the question. Another issue worth 
mentioning was that, although the compiled list of RQs was refined and revised multiple 
times by the steering committee before sending out to the scorers, there were still RQs 
that had some degree of overlap, which was very difficult to avoid completely. Finally, it 
should be noted that all RQs were initially proposed in Persian, then translated into 
English by myself to be discussed in the steering committee, and then the compiled list 
of 128 RQs was back-translated into Persian. Within this process, very careful 
consideration was taken for translations being well-representative of the original 
meaning. 
8.2 Conclusions 
This PhD reviewed Iran’s evolution of HRS during the past 50 years. It bears essential 
lessons to share with three audiences: national-level health research decision-makers in 
Iran and in other LMICs, as well as international stakeholders, e.g. the WHO - to guide 
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future health research capacity strengthening initiatives. The findings emphasised that 
improvement of HRS functions requires addressing context-specific problems. For 
instance, while formulating policies for the governance of health research is a critical 
component of the stewardship function of the HRS, having the policies in place will not 
suffice unless the barriers to the implementation of the policies are addressed. In this 
review, multiple examples were given of success stories regarding different functions of 
Iran’s HRS, that for instance, how one individual with links to influential decision-makers 
could promote medical research ethics in Iran. Or that how specific regulations in Iranian 
medical journals increased online accessibility to Iranian clinical trials. Several examples 
of context-specific challenges were found too, such as the barriers to research priority 
setting processes, and the obstacles that impede improving publication integrity. 
Reviewing the documents in the light of the world literature particularly triggered further 
thinking about possible approaches that can effectively strengthen HRS in contexts that 
struggle with the following: (i) high dependence on very few sources of research funds; 
(ii) centralised decision-making in HRS; (iii) sub-optimal meritocracy in the recruitment 
of academics and or in appointing individuals to research-relevant executive roles; (iv) a 
high rate of brain drain and failure in attracting back the diaspora; and (v) limited 
transparency in resource allocation processes. Indeed, these problems are not exclusive 
to Iran, EMR, or LMICs, but could be found across the developed world, too. 
It was also concluded that Iran has built a great human resource capacity for research, a 
large number of research centres, and several medical journals that disseminate research 
originating in Iran and beyond. Nonetheless, the reviewed literature confirmed that 
research-intensive institutions should also offer an enabling and favourable environment 
and career prospects to encourage the trained academics to stay in the country. Some 
recommendations for improvement were increasing health research funds along with 
accountable allocation mechanisms; ensuring that the competent researchers receive 
enough resources to pursue high-quality research projects; and incentivising research 
activities in medical universities as much as the clinical and teaching activities are 
supported. Finally, it was concluded that the identified barriers to knowledge utilisation 
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should be addressed so that high-quality and need-based research could be translated into 
policy and practice. 
This PhD also indicated that the number of clinical, biomedical, and public health 
research publications in Iran has significantly increased over the last 5 decades. The 
output in certain fields, such as pharmacology research has been greater. It seems that in 
the long term, the quantitative increase has led to an increase in the citation impact. The 
majority of the highly-cited papers from Iran have been the product of international 
collaborations, many of the collaborations had become possible with the contribution of 
Iranian academics abroad. Regarding the Iranian papers that had only relied on national 
resources, the likelihood of getting cited in the future had been independent of the IF of 
the journal where the papers were published. The Iranian science policymakers are 
encouraged to (i) support the researchers and institutions that have proved research 
capacity; (ii) direct further resources towards research areas and/or institutions that are 
lagging behind; (iii) facilitate further international collaboration with the academics 
and/or institutions that have shown the capacity for conducting successful research 
projects with Iran. 
The main messages of the priority-setting study presented in this PhD were that 
addressing equity by reforming insurance system and improving equality in health 
services access should be prioritised in Iran. Furthermore, research on preventive 
strategies for the leading NCDs and road traffic injuries are needed, as well as further 
epidemiological research on NCDs and the health problems of the elderly population. 
This should happen in parallel to a tailored curriculum of qualifications in the universities 
of medical sciences, where a team-based healthcare system should be promoted. Research 
is also needed on over-/mis-use of antibiotics and the health impacts of water crisis.  
8.3 Recommendations for future research 
Considering the data gaps that were identified in Chapter 3 regarding the financial, 
infrastructural, and human resources, a documentary analysis of the health research 
system in Iran is recommended. Such a study should have access to official documents 
that may contain unpublished data and or policies regarding health research in Iran. 
Furthermore, a qualitative investigation of the contributory factors to the growth of health 
Describing the evolution of Iran’s health research system, understanding the profile of its publications 
over 50 years, and setting the national health research priorities  
 181 
research publications in Iran could provide a more in-depth insight into the underlying 
reasons of the growth.  
As highlighted in the findings of chapters 3, 4, and 5, given the continued international 
isolation of Iran due to political circumstances, strengthening formal and informal 
research collaborations between Iranian diaspora and academics in Iran is key to 
improvement of health research in the country. Therefore, future research in health 
research system in Iran should investigate the facilitators of and the barriers to scientific 
international collaboration between academics in Iran and Iranian diaspora. Such a study 
should lead to recommendations on how the capacity of Iranian academics abroad could 
be used more effectively. 
Regarding health research priorities, now that the CHNRI method has been successfully 
introduced in Iran, I recommend its application to identify the research priorities in more 
specific domains, e.g. for certain health conditions with a high burden in Iran, or for 
specific target populations. I would also recommended to conduct the CHNRI studies at 
a sub-national level. This would assist with identifying the priorities based on the needs 
of each region of this relatively large and populous country, where each part deals with 
particular health challenges ranging from water scarcity and air pollution to substance 
abuse or challenges imposed by sharing borders with countries in conflict. I would also 
recommend this national-level exercise to be repeated every five years to be aligned with 
Iran’s 5-Year Development Plans. 
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Appendix 1. English translation of the General Health 
Policies of the Islamic Republic of Iran (GHPs) 
GHP 1: Providing health services (including medical and health sciences education and 
research services, and preventive, curative, and rehabilitative care services) based on 
human and Islamic principles; and institutionalising such principles in the society as 
follows:  
Improving the system of recruitment, assessment, teaching, and training of the students, 
faculty members, and directors in scientific and academic environments according to the 
Islamic, professional and medical codes of ethics  
GHP 1.1: Raising awareness in the public about their [health-related] social rights and 
responsibilities and use the capacity of the healthcare centres to promote spirituality and 
Islamic ethics in the society  
GHP 2: Fulfilling Universal Health Coverage (UHC) in all the laws, regulations, and 
policies through:  
GHP 2.1: Prioritising prevention over treatment   
GHP 2.2: Updating national medical and health plans  
GHP 2.3: Reducing environmental health hazards and the relevant risk factors based on 
credible scientific evidence  
GHP 2.4: Preparing ‘Health Attachments’ for the national development projects [‘Health 
Attachment’ was a term proposed for the first time in the 5th National Development Plan 
of Iran—in Section B of Article 32—stating that the national development projects should 
have an attachment that would discuss the potential health impacts of the project]  
GHP 2.5: Improving the health indexes for becoming the first country of the Southwest 
Asia  
GHP 2.6: Improving and complementing the current assessment and monitoring systems 
to protect [health-related] rights of the patients and the nation and to ensure the proper 
implementation of the GHPs  
GHP 3: Improving mental health of the nation by: promoting the Islamic-Iranian 
lifestyle; strengthening family foundation; removing factors that cause tension in 
individual and social life of the people; promoting moral and spiritual teachings; and 
improving mental health determinants  
GHP 4: Establishing and strengthening the required infrastructure for manufacturing 
pharmaceutical active ingredients and products, vaccines, biologic drugs, and medical 
devices and equipment that meet the international quality standards  
GHP 5: (i) Inhibiting induced demand; (ii) Inhibiting  prescription of medications that 
are outside the clinical guidelines and the Generic National Pharmaceutical System of 
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Iran; (iii) Policymaking and efficient oversight on manufacturing, use, import of 
pharmaceuticals, vaccines, biologic drugs, and medical devices aiming to support 
domestic production and increasing national capacity for export  
GHP 6: Supplying food security; and equitably providing healthy and adequate food, 
clean air and water, public sports facilities, and safe sanitary products that are all approved 
by the national, regional, and international standard criteria  
GHP 7: Sharing the duties regarding stewardship, financial supplying, and providing 
health services with the aim of responding to the needs, achieving equity, and providing 
appropriate medical services to the community as follows:  
GHP 7.1: Stewardship of the health system by the Ministry of Health and Medical 
Education (MOHME), including policymaking, designing and implementing plans, 
designing strategies, evaluation, and oversight of the plans  
GHP 7.2: Management of resources in the health sector through the insurance system 
with the central role of MOHME and the cooperation of other organisations and entities  
GHP 7.3: Providing services by resources from the government [e.g. the ministries], the 
public resources [e.g. the municipalities] and the private sector [e.g. charities]  
GHP 7.4: Organising the abovementioned tasks based on the mechanisms that are 
determined by law  
GHP 8: Increasing and improving the quality and the safety of the [health] services and 
developing a comprehensive and integrative healthcare [system] that focuses on equity 
and is responsive [to the nation’s needs] and emphasises transparent informing, efficacy, 
efficiency, and productivity within the Primary Health Care (PHC) and is in line with the 
referral system by:  
GHP 8.1: Promoting decision-making and operation based on scientific evidence; and 
codifying standards and guidelines; undertaking Health Technology Assessment; 
establishing the referral system by prioritising prevention and health improvement and 
integrating them with the medical education system  
GHP 8.2: Increasing the quality and the safety of healthcare services by promoting 
clinical authority and determining standards  
GHP 8.3: Codifying a comprehensive healthcare plan to support disabled people and 
disabled Iranian veterans aiming to improve their health status and to empower them  
GHP 9: Improving the quantity [the number of people who are covered] and the quality 
of health and medical insurance aim to:  
GHP 9.1: Achieving universal public health insurance  
GHP 9.2: Achieving full coverage of basic medical needs by insurance companies for all 
to reduce the patients’ share in medical expenses  
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GHP 9.3: Providing services beyond the basic insurance by complementary insurance that 
follows transparent regulatory frameworks   
GHP 9.4: Preparing packages of comprehensive health and medical services at the levels 
of basic and complementary insurance by MOHME  
GHP 9.5: Strengthening a competitive market for medical insurance companies  
GHP 9.6: Codifying tariff policies based on evidence  
GHP 9.7: Modifying the payment models, in a way that it would be based on the quality 
of services, be more efficient, and would pay special attention to health promotion 
activities and to prevention in deprived areas  
GHP 10: Sustainable health financing  
GHP 10.1: Making the amount of expenses, activities, and earnings [within the health 
system] transparent  
GHP 10.2: Increasing the proportion of the Gross Domestic Product (GDP) and the public 
budget that is invested in health. In this way Iran’s investment in [healthcare] should 
exceed the average investment of the countries in the region [The Middle East], thus it 
would fulfil the targets as set in the Vision policy [Iran’s 20-year national strategic plan 
by 2025].  
GHP 10.3: Adding taxes on products that can be harmful to health  
GHP 10.4: Improving the equitable distribution of government healthcare subsidies  
GHP 11: Raising awareness, responsibility, capability, and systematic and active 
participation of individuals, families, and the community in supplying, maintaining, and 
improving health by using the capacity of different cultural and educational entities as 
well as the media, under the supervision of MOHME.  
GHP 12: Studying, understanding, developing, promoting, and institutionalising 
traditional Iranian medicine  
GHP 12.1: Prompting cultivation of medicinal plants under the supervision of the 
Ministry of Agriculture Jihad and supporting the development of technical and scientific 
innovations in manufacturing traditional medicines under the supervision of MOHME  
GHP 12.2: Standardising and updating the diagnostic and curative methods that are 
recommended in traditional Iranian medicine  
GHP 12.3: Exchanging knowledge with other countries regarding traditional medicine  
GHP 12.4: MOHME supervising the provision of health services and products that use 
traditional Iranian medicine  
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GHP 12.5: Establishing links between traditional Iranian medicine and modern medicine  
GHP 12.6: Modifying people’s lifestyle, particularly their diet [by using traditional 
Iranian medicine]  
GHP 13: Improving the quantity [increasing the capacity] and the quality of the medical 
education system [in Iran] to make it become targeted, health-oriented, and based on the 
needs of the nation; and efficiently training human resources to respond to the needs in 
an equitable manner, and [training people in a way that they] would be committed to the 
Islamic and professional ethics and would have essential skills to respond to population 
health needs across different parts of the country  
GHP 14: Revolutionising medical research [medical research system in Iran] 
strategically with an approach to [promote] innovation system and planning for making 
Iran a pioneer in science, technology, and in the provision of medical services and making 
Iran to become a medical hub in Southwest Asia and in the Islamic world  
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Appendix 2. List of the 48 included biomedical, clinical, 
and public health research areas  
‘Research Areas’ is a classification scheme aiming to be the indexing backbone by which 
all WoS products have their content classified. The forty-eight included research areas 
were the following: 
Pediatrics or tropical medicine or urology nephrology or endocrinology metabolism or 
pathology or reproductive biology or radiology nuclear medicine medical imaging or 
toxicology or pharmacology pharmacy or life sciences biomedicine other topics or allergy 
or research experimental medicine or obstetrics gynecology or physiology or general 
internal medicine or microbiology or biochemistry molecular biology or psychiatry or 
hematology or neurosciences neurology or medical laboratory technology or 
gastroenterology hepatology or health care sciences services or orthopedics or cell 
biology or virology or public environmental occupational health or genetics heredity or 
rheumatology or biotechnology applied microbiology or respiratory system or infectious 
diseases or immunology or transplantation or nutrition dietetics or mycology or veterinary 
sciences or surgery or dentistry oral surgery medicine or ophthalmology or 
otorhinolaryngology or dermatology or rehabilitation or nursing or integrative 
complementary medicine or oncology or parasitology or cardiovascular system 
cardiology 
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Appendix 3. Analysis results of all the 72,686 retrieved 
Iranian biomedical, clinical, and public health research, 
indexed in Web of Science Core Collection, published 
1965-2014 
Sheet 3 of the Microsoft Excel (Microsoft Inc, Seattle WA, USA) file available at: 
http://www.jogh.org/documents/issue201802/jogh-08-020701-s001.zip 
 
Appendix 4. List of the 155 Iranian h-core publications 
(1965-2014), indexed in Web of Science Core Collection, 
ranked by their year of publication, and then by citation 
count within each year 
Table S2 of the Microsoft Word (Microsoft Inc, Seattle WA, USA) file available at: 
http://www.jogh.org/documents/issue201802/jogh-08-020701-s001.zip 
 
Appendix 5. Analysis results of the 155 h-core Iranian 
biomedical, clinical, and public health publications 
indexed in Web of Science Core Collection (published 
1965-2014) - Citations counted by the end of 2017 
Sheet 4 of the Microsoft Excel (Microsoft Inc, Seattle WA, USA) file available at: 
http://www.jogh.org/documents/issue201802/jogh-08-020701-s001.zip 
 
Appendix 6. Journals that had published the 48 'only 
Iranian' h-core papers, information retrieved from 
Journal Citation Reports 
Sheet 5 of the Microsoft Excel (Microsoft Inc, Seattle WA, USA) file available at: 
http://www.jogh.org/documents/issue201802/jogh-08-020701-s001.zip 
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Appendix 7. Health-related targets of the United Nations’ 
Sustainable Development Goals (SDGs)  
SDG (3.1) By 2030, reduce the global maternal mortality ratio to less than 70 per 
100,000 live births  
SDG (3.2) By 2030, end preventable deaths of newborns and children under 5 years of 
age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 
1000 live births and under-5 mortality to at least as low as 25 per 1,000 live births  
SDG (3.3) By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected 
tropical diseases and combat hepatitis, water-borne diseases and other communicable 
diseases.  
SDG (3.4) By 2030, reduce by one third premature mortality from non-communicable 
diseases through prevention and treatment and promote mental health and well-being.  
SDG (3.5) Strengthen the prevention and treatment of substance abuse, including narcotic 
drug abuse and harmful use of alcohol.  
SDG (3.6) By 2020, halve the number of global deaths and injuries from road traffic 
accidents. 
SDG (3.7) By 2030, ensure universal access to sexual and reproductive healthcare 
services, including for family planning, information and education, and the integration of 
reproductive health into national strategies and programmes.  
SDG (3.8) Achieve universal health coverage, including financial risk protection, access 
to quality essential healthcare services and access to safe, effective, quality and affordable 
essential medicines and vaccines for all. 
SDG (3.9) By 2030, substantially reduce the number of deaths and illnesses from 
hazardous chemicals and air, water and soil pollution, and contamination. 
SDG (3.a) Strengthen the implementation of the WHO Framework Convention on 
Tobacco Control in all countries (including controlling production and consumption)  
SDG (3.b) Support the research and development of vaccines and medicines for the 
communicable and non-communicable diseases that primarily affect developing 
countries, provide access to affordable essential medicines and vaccines, in accordance 
with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the 
right of developing countries to use to the full the provisions in the Agreement on Trade-
Related Aspects of Intellectual Property Rights regarding flexibilities to protect public 
health, and, in particular, provide access to medicines for all.  
SDG (3.c) Substantially increase health financing and the recruitment, development, 
training and retention of the health workforce in developing countries  
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SDG (3.d) Strengthen the capacity of all countries, in particular developing countries, for 
early warning, risk reduction and management of national and global health risks.  
SDG (2.2) By 2030 end all forms of malnutrition, including achieving by 2025 the 
internationally agreed targets on stunting and wasting in children under five years of age, 
and address the nutritional needs of adolescent girls, pregnant and lactating women, and 
older persons.  
SDG (6.1) By 2030, achieve universal and equitable access to safe and affordable 
drinking water for all  
SDG (6.2) By 2030, achieve access to adequate and equitable sanitation and hygiene for 
all and end open defecation, paying special attention to the needs of women and girls and 
those in vulnerable situations  
SDG (7.1) By 2030, ensure universal access to affordable, reliable and modern energy 
services (Clean household energy to use for cooking, heating and light)  
SDG (11.6) By 2030, reduce the adverse per capita environmental impact of cities, 
including by paying special attention to air quality and municipal and other waste 
management  
SDG (13.1) Strengthen resilience and adaptive capacity to climate-related hazards and 
natural disasters in all countries  
SDG (16.1) Significantly reduce all forms of violence (i.e. physical, mental, or sexual 
violence) and related death rates and conflict-related deaths  
SDG (16.2) End abuse, exploitation, trafficking and all forms of violence against and 
torture of children  
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Appendix 8. The bibliometric method for identification of 
experts to invite to the priority-setting study 
I searched through two international bibliographic databases (Web of Science and 
Scopus) for prolific authors who could potentially be identified as experts. Instead of 
searching keywords, I first retrieved all the publications with at least one author affiliated 
to Iranian organisations. This was done by the ‘Advanced Search’ feature on Web of 
Science and running the search for ‘CU= Iran’, while in Scopus’s ‘Advanced Search’, I 
searched ‘Iran’ as the ‘Affiliation Country’. In this way, in both databases, all the 
publications with at least one Iranian author were retrieved. Then, I refined the search 
results by research areas to get closer to the health targets included in this prioritisation 
exercise. Refining the results in Web of Science was back then carried out by the option 
‘Research Areas’, which pretty much serves the same purpose of ‘Subject Category’ in 
the current version of the product. In Scopus, the research areas were represented by 
‘Subject Area’, which is a less elaborated version of the refine panel on Web of Science. 
Meaning that it has fewer options, thus I looked into all of them. In Web of Science, at 
the first step, to broadly identify any publication relevant to biomedical, clinical, and 
public health, first, the search results were refined by the following areas:  
‘pediatrics or tropical medicine or urology nephrology or endocrinology metabolism or 
pathology or reproductive biology or radiology nuclear medicine medical imaging or 
toxicology or pharmacology pharmacy or life sciences biomedicine other topics or allergy 
or research experimental medicine or obstetrics gynecology or physiology or general 
internal medicine or microbiology or biochemistry molecular biology or psychiatry or 
hematology or neurosciences neurology or medical laboratory technology or 
gastroenterology hepatology or health care sciences services or orthopedics or cell 
biology or virology or public environmental occupational health or genetics heredity or 
rheumatology or biotechnology applied microbiology or respiratory system or infectious 
diseases or immunology or transplantation or nutrition dietetics or mycology or veterinary 
sciences or surgery or dentistry oral surgery medicine or ophthalmology or 
otorhinolaryngology or dermatology or rehabilitation or nursing or integrative 
complementary medicine or oncology or parasitology or cardiovascular system 
cardiology’.  
This refinement resulted in retrieving the Iranian publications with some relevance to 
health research. Then, once again, I narrowed down the results by excluding the irrelevant 
and including some further relevant areas, as listed in the table on the following page 
(ordered alphabetically).  
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Included research areas  
Number of 
the area 
Included research areas 
1 Anthropology 36 Pathology 
2 Cardiac & Cardiovascular Systems 37 Pediatrics 
3 Clinical Neurology 38 Peripheral Vascular Disease 
4 Critical Care Medicine 39 Pharmacology & Pharmacy 
5 Demography 40 Plant Sciences 
6 Ecology 41 Primary Health Care 
7 Economics 42 Psychiatry 
8 Education & Educational Research 43 Psychology 
9 Education, Scientific Disciplines 44 Psychology, Applied 
10 Emergency Medicine 45 Psychology, Clinical 
11 Endocrinology & Metabolism 46 Psychology, Multidisciplinary 
12 Environmental Sciences 47 
Public, Environmental & 
Occupational Health 
13 Family Studies 48 Rehabilitation 
14 Gastroenterology & Hepatology 49 Religion 
15 Genetics & Heredity 50 Reproductive Biology 
16 Geriatrics & Gerontology 51 Respiratory System 
17 Gerontology 52 Rheumatology 
18 Health Care Sciences & Services 53 Social Sciences, Biomedical 
19 Health Policy & Services 54 Social Sciences, Interdisciplinary 
20 Hematology 55 Social Work 
21 Immunology 56 Sociology 
22 Infectious Diseases 57 Substance Abuse 
23 
Integrative & Complementary 
Medicine 
58 Surgery 
24 Management 59 Toxicology 
25 Marine & Freshwater Biology 60 Transplantation 
26 Medical Informatics 61 Transportation 
27 Medicine, General & Internal 62 Tropical Medicine 
28 Medicine, Research & Experimental 63 Urology & Nephrology 
29 Neurosciences 64 Virology 
30 Nursing 65 Water Resources 
31 Nutrition & Dietetics 66 Women's Studies 
32 Obstetrics & Gynecology   
33 Oncology   
34 Orthopedics   
35 Parasitology   
In both databases, I retrieved the publications in each ‘research area’ and analysed them 
for ‘authors’ to get the authors’ names ranked based on publication counts. What should 
be highlighted in this regard is that in the refine panel of the Web of Science, there is a 
limit for the number of ‘shown’ research areas. Therefore, I had to exclude irrelevant 
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research areas, (e.g. nanomedicine nanotechnology, anesthesiology, sport sciences, 
radiology nuclear medicine medical imaging, biochemistry molecular biology) to ensure 
that relevant areas with possibly fewer number of publications (e.g. geriatrics 
gerontology, sociology) would not be missed. I repeated this exclusion up to the point 
where the areas with less than 20 records appeared in the refine panel. In terms of the 
research areas that I looked into, as it is shown in Table 1 in this letter, in addition to 
certain areas that seemed very relevant (e.g. public environmental occupational health; 
health care sciences services), I analysed the results for any area that could possibly be 
relevant. For instance, any area that could cover communicable or non-communicable 
diseases, or could provide publications of studies with aspects other than medical 
sciences, e.g. sociology, economics. It should be emphasised that the records in each area 
were analysed for authors separately, instead of looking for the most productive authors 
in the total publications.   
Regarding the strategy for going through the publications, I screened the titles and 
abstracts of nearly 25-50% of a random sample of the records by the top 20 authors (with 
seemingly Iranian names) in each area to ensure that the publications were original 
research in the respective fields of our interest. In the areas with fewer number of 
publications, I went through more than 25% of the records. 
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Appendix 9. English translation of letters to the experts 
for invitation to generating research questions for the 
priority-setting study 
Dear [Title and Surname], 
Greetings and respect [This is how formal Iranian letters begin], 
As you know, there are two major commitments in the country for health that the first one is the 
General Health Policies, notified by the Grand Supreme Leader and the second one are 
Sustainable Development Goals that include targets to ensure healthy lives and to promote well-
being for all at all ages, which is of prime concern to all of the people who work in the health 
field. Undoubtedly, our success in achieving the targets as set by these two documents depends 
on the strategic and effective use of our country’s resources, such as in the use of available 
resources for health research. To assist with this process, we would like to invite you as one of 
the 40 distinguished experts in the relevant research fields to take part in a health research 
priority setting exercise; an exercise that brings together funders, researchers and stakeholders in 
deciding the most targeted, yet feasible research ideas or questions in the next five years that could 
help Iran meet its longer term health targets. For example, the National Institute of Health 
Research has decided to use the results of this prioritisation to inform funding decisions in its 
future funding cycles. 
 
In this exercise, the Child Health and Nutrition Research Initiative’s (CHNRI) method is used; a 
method that has been co-developed by Professor Igor Rudan and Associate/Professor Kit Chan. 
Dr Mansoori, who is undertaking her PhD thesis under the supervision of Ass./Prof. Chan, Prof. 
Rudan and me is keen on implementing this method for the first time in the Middle East, in our 
country Iran. The CHNRI method has so far been used to identify health research priorities in 
over 50 studies led by multilateral organisations (e.g. WHO, UNICEF), national governments 
(e.g. Chin, India and South Africa) and various funding agencies [1-5]. Unlike the older methods, 
CHNRI uses a systematic and transparent approach to priority setting and it allows researchers 
complete independence in the generation and scoring of the collected research questions.  
 
Furthermore, it involves funders and other stakeholders early in the process to ensure relevance 
and ownership of the findings [6]. Should you be interested in reading more about the CHNRI 
method and its applications, at the end of this email various links to the relevant publications are 
kindly provided. It should be mentioned that many CHNRI exercises have thus far been 
published in prestigious journals including The Lancet, Lancet Neurology, and PLoS 
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Medicine, and are often open-access to encourage broad readership [2-4]. While we cannot 
guarantee the journal in which the paper resulting from this exercise will be published, we do 
intend to submit the manuscript to a relevant journal of the same prestige, and would like to invite 
all research participants to join us in corporate or group authorship.   
 
If you are willing to participate, in the first instance, please complete the attached Instruction file 
by jotting down 3 to 5 research questions or ideas that in your opinion, if they are carried out 
within the next 5 years would assist Iran in achieving its long term targets as set by the 
abovementioned documents. As right now is an exceptional time to conduct this exercise, we 
would be extremely grateful if you could kindly email the questions/ideas by [insert date] to me 
or to Dr Mansoori at (parisamansouri87@gmail.com). Should you have any questions, please 
do not hesitate to contact me or her by email or by phone at (0098)912-3135299.  
The success of this priority-setting exercise completely depends on the collective inputs of the 
most distinguished health researchers of the country particularly yourself. Hence, we hope you 
will participate in this endeavour.  
Yours sincerely, 
Dr Seyed Reza Majdzadeh 
Head of the National Institute of Health Research [signed manually] 
List of References: 
[1] Rudan I. Global health research priorities: mobilizing the developing world. Public Health. 2012 
Mar;126:237-40:  http://www.publichealthjrnl.com/article/S0033-3506(11)00390-8/pdf 
[2] Shah H, Albanese E, Duggan C, Rudan I, Langa KM, Carrillo MC, Chan KY, Joanette Y, Prince M, 
Rossor M, Saxena S, Snyder HM, Sperling R, Varghese M, Wang H, Wortmann M, Dua T. Research 
priorities to reduce the global burden of dementia by 2025. Lancet Neurology. 2016;15:1285–94: 
http://www.thelancet.com/pdfs/journals/laneur/PIIS1474-4422(16)30235-6.pdf 
[3] Rudan I, El Arifeen S, Bhutta ZA, Black RE, Brooks A, Chan KY, Chopra M, Duke T, Marsh D, Pio 
A, Simoes EA, Tamburlini G, Theodoratou E, Weber MW, Whitney CG, Campbell H, Qazi SA; 
WHO/CHNRI Expert Group on Childhood Pneumonia. Setting research priorities to reduce global 
mortality from childhood pneumonia by 2015. PLoSMedincine: 
http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001099 
[4] Tomlinson M, Swartz L, Officer A, Chan KY, Rudan I, Saxena S. Setting priorities for research on the 
health of persons with disabilities: an expert opinion exercise. The Lancet. 2009; 374:1857-1861: 
http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(09)61910-3.pdf 
[5] Tomlinson M, Chopra M, Sanders D, Bradshaw D, Hendricks M, Greenfield D, Black RE, El Arifeen 
S, Rudan.Setting priorities in child health research investments for South Africa. PLoS Med. 2007 
Aug;4(8):e259:http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0040259 
[6] Rudan I, Yoshida S, Chan KY, Cousens S, Sridhar D, Bahl R, Martines J. Setting health research 
priorities using the CHNRI method: I. Involving funders. Journal of Global Health. 2016;6(1):010301: 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576461/ 
 
-cc: Dr Parisa Mansoori 
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Appendix 10. A sample of an original letter to the experts 
for invitation to generating research questions for the 
priority-setting study 
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Appendix 11. English translation of the instructions sent 




Greetings and respect [This is how formal Iranian letters begin] 
 
Thank you very much for your interest to participate in setting health research priorities 
Your participation involves 2 steps, both of which will be completed only via email 
correspondences and there is no need to attend meetings 
 
In the first instance, we would ask you to write down, in the next page, 3 to 5 distinct research 
questions that are answerable in the next five years and could help Iran achieve its General 
Health Policies and health-related targets of the Sustainable Development Goals (The General 
Health Policies and a list of health-related targets of the Sustainable Development Goals are 
attached in a PDF file for your kind reference). We would ask you to kindly next to each one of 
your proposed research questions/ideas write down the number of policy/policies and/or 
target/targets that your question is covering. Indeed, it is likely that one research question would 
cover several policies and/or targets at the same time. [We expected that the researchers might 
propose research questions without being attentive to their relevance to the health targets that are 
considered in this study. That is why they were asked to specify which target/targets each of their 
proposed research idea/question was covering]. 
 
We would be grateful if you could kindly email back your research questions/ideas by [insert 
date] to me or to Dr Mansoori 
 
Once we have received research questions/ideas from all our participants, we will compile the 
questions into a list, and ask you to score the questions against a set of pre-determined criteria.   
If, for any reason, you would not be able to provide us with your research questions at this 
stage but would like to participate in the scoring of the research questions, please kindly inform 
me or Dr Mansoori by email or by phone at (0098)9123135299. 
 




Seyed Reza Majdzadeh [with no signature] 
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Research question/idea number 1 covers policy/policies/target/targets 
number/s_______________________________________        
______________________________________________________________________
______________________________________________________________________
Research question/idea number 2 covers policy/policies/target/targets 
number/s  _______________________________________         
______________________________________________________________________
______________________________________________________________________ 
Research question/idea number 3 covers policy/policies/target/targets 
number/s _______________________________________                                                
______________________________________________________________________
______________________________________________________________________
Research question/idea number 4 covers policy/policies/target/targets 
number/s _______________________________________                                                
______________________________________________________________________
______________________________________________________________________
Research question/idea number 5 covers policy/policies/target/targets 
number/s  _______________________________________                                               
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Appendix 12. A sample of an original instruction sent to 
the experts for generating research questions for the 
priority-setting study 
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Appendix 13. Overview of the experts’ background, 
participation in the priority-setting exercise, and 
responses 
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Appendix 14. The initial nine agreed criteria for the priority-setting study 
No. Potential Criteria Definition 
1 Impact on health 
Results of this research have a high potential to improve health by: (1) reducing disease incidence and/or prevalence;  (2) reducing social, 
environmental and individual risk factors of ill health; (3) shaping future health planning and implementation; (4) improving health services 
delivery by improving acceptability, accessibility, suitability, efficiency, efficacy, effectiveness, and/or safety of treatment or service; and/or (5) 




Results of this research have high potential in: (1) having direct effect on the production of materials or consumer services; (2) optimising the 
earlier goods and/or products (increasing quality and/or reducing production costs); (3) creating knowledge based entrepreneurship; (4) decreasing 
days of work missed due to illness or disability for patients and caregivers; (5) reducing opportunity costs for patients and caregivers; (6) reducing 
impact on direct patient costs as well as health and welfare systems; and (7) reducing caregiver burden and its associated financial costs (including 
health care costs for caregivers). 
3 
Impact on Iran's 
scientific rank 
Results of this research have high potential to lead to: (1) multiple publications in peer-reviewed journals; (2) publications in prestigious journals; 
and/or (3) highly cited publications. 
4 Capacity building 
Results of this research have a high potential to lead to: (1) education and training in Iran's human resources; (2) the acquisition of new skills by 
the research team; and/or (3) investment to improve research facilities/amenities where the study will be undertaken, e.g purchasing 
software/equipment 
5 Feasibility 
(1) There is sufficient capacity to carry out this research; (2) It is possible to provide training for the staff who would undertake this research; (3) 
The research is doable in an ethical way within the next 5 years. 
6 Equity 
Results of this research have high potential to: (1) lead to interventions or services that will be accessible and affordable to everyone, including 
members of vulnerable groups; (2) lead to policy, plans, interventions or services that could reduce health inequality. This could be achieved by 





Results of this research have high potential to be used in Iran 
8 
Impact on creating 
wealth 
Results of this research have high potential to lead to: (1) production of new products/services; (2) improvement of existing products, i.e. by 
increasing their quality/reduction of manufacturing costs; and/or (3) knowledge-based entrepreneurship. 
9 Long-term impact 
Results of this research have high potential to lead to impact in the long run. 
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Appendix 15. English translation of letters to the experts 
for invitation to scoring research questions for the 
priority-setting study  
[Version 1: To those who participated in generating research questions] 
[The letter was written in the NIHR letterhead]. 
 
In the Name of God 
Dear [title and name], 
Greetings and respect [this is how Iranian formal letters begin], 
Thank you again for your continuous interest and support in participating in the first step of the 
national health research priority setting exercise in Iran.  
 
Fifty distinguished researchers (see file attached) have participated in generating a total of 251 
research questions/ideas for funding in the next five years that could help our nation achieve 
the health targets set out in our General Health Policies and SDGs. As many of the research 
questions overlapped, we have consolidated them into a list of 128 research questions. All 
research questions were reworded to provide consistency in style and format. We have invested 
a lot of effort to ensure the consolidated questions remain truthful to the ideas and meaning of 
the original research questions, but sincerely apologise for any unintended oversights.  
 
We would now like to invite you to extend your support by participating in the next step of the 
exercise by independently scoring the consolidated list of research questions in the attached 
Excel file. The task could take a couple of hours of your time. You will not be required to attend 
any meetings. If you choose to participate (which we hope you do), we would like to invite you 
to be a corporate/group author on the publication resulting from this exercise. 
 
We have taken the liberty of attaching with this email the ‘Instructions for Scoring’, ‘The 
Criteria Sheet’, and the ‘Scoring Sheet’ in three separate files.  
 
We would be extremely grateful if you could kindly return the completed Scoring Sheet tome 
by [insert date]. Should you have any 
questions regarding scoring, please do not hesitate to contact me or her. 
We sincerely hope to have your support in for this extremely important study that could help 




Dr Seyed Reza Majdzadeh [He is a professor, but the title ‘Professor’ is not used in Iran] 
Head of the National Institute of Health Research  
[Signature] 
 
-cc: Dr Parisa Mansoori 
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[Version 2: To those who did not generate research questions] 
 
In the Name of God 
 
Dear [title and name], 
In the first step of the health research priority setting exercise in Iran, fifty 
distinguished researchers (see file attached) have participated in generating a total of 251 
research questions/ideas for funding in the next five years that could help our nation 
achieve the health targets set out in our General Health Policies and SDGs. By investing 
a lot of effort in merging overlapping questions, we have consolidated them into a list of 
128 research questions, which each should be scored independently against 5 
criteria. The research questions that score higher would be identified as the research 
priorities. 
 
We would now like to invite you to participate in the second step of this exercise by 
independently scoring the consolidated list of research questions in the attached 
Excel file. The task could take a couple of hours of your time although it does not require 
attending any meetings. If you choose to participate (which we hope you do), we would 
like to invite you to be a corporate/group author on the publication resulting from this 
exercise. Unfortunately, at this step adding new research questions/ideas to the list is not 
possible.  
 
We have taken the liberty of attaching with this email the ‘Instructions for Scoring’, ‘The 
Criteria Sheet’, and the ‘Scoring Sheet’ in three separate files.  
 
We would be extremely grateful if you could kindly return the completed Scoring Sheet 
by [insert date]. Should 
you have any questions regarding scoring, please do not hesitate to contact me or her. 
We sincerely hope to have your support in for this extremely important study that could 




Dr Seyed Reza Majdzadeh [He is a professor, but the title ‘Professor’ is not used in 
Iran] 
Head of the National Institute for Health Research  
[Signature] 
 
-cc: Dr Parisa Mansoori 
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Appendix 16. A sample of an original letter to the experts 
for invitation to scoring research questions for the 
priority-setting study  
[Version 1: To those who participated in generating research questions] 
 
 
[Version 2: To those who did not generate research questions] 
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Appendix 17. English translation of the instructions sent 
to the experts for scoring research questions in the 
priority-setting study 
Scoring Instructions 
Please kindly follow the following steps: 
 
1. Open the PDF file <Criteria>. You will find definitions of the 5 criteria you will need for scoring 
the research questions. Please print this out for easy reference while scoring.  
 
2. Now open the Excel file <Scoring Sheet>. You will see a list of 128 research questions in 
Column C, and the 5 criteria in Row 2. Please score each research question against the 5 criteria by 
placing ‘1’ for ‘no’, ‘2’ for ‘informed but undecided’,‘3’ for ‘yes’, and ‘0’ if you feel you are ‘not 






Feasibility Impact on Health Impact on Economy Capacity Building Equity 
1.  RQ1 2 3 2 3 3 
2.  RQ2 2 2 2 2 2 




a. Each research question should be scored independently, without being compared to other 
research questions. 
b. Do not leave any cells blank.  
c. If you enter an invalid score (e.g. if you accidentally type ‘11’ instead of ‘1’), an error message 
box will appear.  
 
3. As a participant of this CHNRI exercise, we would like to invite you to be a group/corporate 
author on the manuscript resulting from the exercise. If you would like to accept this offer, please kindly 
with your reply send us your full name, affiliation and contact information in the way that you would 
like the information to appear on the manuscript, using Latin spelling. If you would rather, please 
send the information in a separate email.  
 
Please be assured that: 
(i) Nobody outside the research team will be able to link your name to the scores you provide; 
and  
(ii) You will have no further responsibility in the writing or submission of the paper, unless you would 
like to. 
4. Please kindly email back the completed scoring sheet by 27/Oct/2017 to me or to Dr Mansoori at 
. Should you have any questions about this exercise, do not hesitate to 
contact me or Dr Mansoori. 
 
We highly appreciate your support for this exercise. 
 
Seyed Reza Majdzadeh 
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Appendix 18. A sample of an original instructions sent 
to the experts for scoring research questions in the 
priority-setting study 
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Appendix 19. English translation of the inviting message 




As an Iranian citizen who is either providing healthcare services, or using health services 
(either yourself or family members), you are invited to participate in a research priority-
setting study. If you agree to participate, please rank the 5 criteria that are listed below 
and send back your results by Thursday, 25/Nov/2017 to the following ID: 
@health_research_priorities 
 
The question is that if our country wants to investigate what are the research that should 
be funded within the next 5 years, in your opinion, how should the five criteria, including, 
feasibility; impact on health; impact on economy; capacity building; and equity be ranked, 
once ordered by importance.  
 
Please put the criterion which you find the most important on the first line, and rank the 
remaining 4, below it, ordered by their importance based on your opinion. 
Definition of the criteria: 
 
• Feasibility: The study can be conducted using the facilities and resources in Iran. 
• Impact on health: The findings of the study can lead to prevention and or treatment of 
diseases. 
• Impact on economy: The findings of the study can lead to reduced financial costs on 
patients and or the health system. 
• Capacity building: The conduct of the study would lead to capacity building, such as 
increasing the skills in students and or development of laboratories in the universities.  
• Equity: The findings of the study would lead to services to which are accessible and 
affordable for all people. 
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Appendix 20. Original inviting message to the 
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Appendix 21. The profile and the responses of the 
stakeholders who participated in the priority-setting 
study 
Table S6 of the Microsoft Word (Microsoft Inc, Seattle WA, USA) file available at:  
http://www.jogh.org/documents/issue201802/jogh-08-020702-s001.zip 
Appendix 22. All the individual scoring responses to the 
research questions in the priority-setting study 
Sheet 1 of the Microsoft Excel (Microsoft Inc, Seattle WA, USA) file available at:  
http://www.jogh.org/documents/issue201802/jogh-08-020702-s001.zip 
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Appendix 23. Ethics approval from the Ethics Committee 
of Iran’s National Institute of Health Research (NIHR) for 
conducting the priority-setting study in Iran 
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Appendix 24. The scores and ranks of all the research 
questions against the 5 criteria of the priority-setting 
study 
Sheet 2 of the Microsoft Excel (Microsoft Inc, Seattle WA, USA) file available at:  
http://www.jogh.org/documents/issue201802/jogh-08-020702-s001.zip 
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Appendix 25. Publications rising from this PhD 
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Appendix 27. Publication rising from a collaboration that 
led to methodology development used in Chapter 4 
Full text version available at: http://www.jogh.org/documents/issue201601/jogh-06-
010504.pdf 
 
 
